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Abstract 
This study investigates the use of palladised Escherichia coli as a biometallic catalyst 
with a view to its use in deracemisation reactions. Some bacteria can reduce metals by 
their use as the terminal electron acceptor in the respiratory chain, and recent work 
using Desulfovibrio spp. and other obligate and facultative anaerobes has led to the 
generation of palladium bionanocatalysts with superior activity to commercially 
available carbon-supported Pd(0) nanoparticles. This current study has investigated 
the use of formate as an electron donor for the reduction of soluble Pd(II) to insoluble 
Pd(0) nanoparticles by E. coli, and investigates the biological mechanisms responsible 
for the bioreduction, and for the extracellular location of the nanoparticles. 
 
Previous work has been done at the Manchester Interdisciplinary Biocentre with the 
directed evolution of the monoamine oxidase enzyme of Aspergillus niger (known as 
MAO-N), which catalyses the oxidative deamination of terminal amines. The result has 
been to produce an enzyme with enhanced activity in the production of 
enantiomerically pure chiral amines. The modified enzyme catalyses the oxidation of 
the (S)-enantiomer to the corresponding imine, which is then reduced using a 
chemical reductant back to either the (S)- or the (R)-enantiomer, leading to an 
enantiomeric excess (e.e.) of the latter. After several cycles, enantiomerically pure 
amines are produced. In this study, E. coli transformed with a plasmid containing the 
variant mao-N-D5 gene insert demonstrated good activity in catalysing the oxidation 
of the (S)-enantiomer of the secondary amine 1-methyltetrahydroisoquinoline (MTQ) 
to the imine 1-methyl-3,4-dihydroisoquinoline (MDQ), as measured by HPLC. The 
ability of E. coli to reduce Pd(II) to Pd(0) was exploited in order to use the supported 
nanoparticles in place of the chemical reductant, catalysing the reduction of the imine 
back to MTQ. Following five cycles of oxidation and reduction, racemic MTQ was 
converted to (R)-MTQ with an enantiomeric excess of up to 93%. The activity of the 
biometallic catalyst immobilised in alginate beads was also assessed, and found to be 
the same as planktonic cells. The recyclability and long-term storage of the 
immobilised biocatalyst was also investigated, and it was found that freeze-drying 
maintained the stability of the beads for up to six weeks, which was the limit of the 
experiment. 
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catalyst for multi-step transformations. This publication is in preparation for 
submission to Applied Microbiology and Biotechnology. 
Contributions of co-authors and collaborators: 
Joanne M. Foulkes – first author, designed and performed experimental work. 
Kirk L. Malone – technical support for HPLC analyses, proof-reading. 
Nicholas J. Turner – co-supervisor, discussion of experimental work. 
Jonathan R. Lloyd – main supervisor, assistance with design of experimental work, 
assistance with manuscript preparation, proof-reading. 
Valentin Koehler – assistance with developing HPLC protocol. 
John Waters – provision of XRD data, assistance with ESEM. 
Roger Meadows (EM facility) – preparation of sections for TEM, assistance with 
imaging. 
Paul Lythgoe – provision of ICP-MS data. 
 
22 
 
 
Chapter 7 is the fourth publication, The use of monoamine oxidase and biogenic 
palladium in the deracemization of the secondary amine 1-methyltetrahydroiso-
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Chapter 8 provides the conclusions and proposals for future work in this area. 
 
Appendix 1 – this section includes a description of the experimental techniques 
throughout this project, and provides information on the information that can be 
provided using these techniques and their limitations. 
 
Appendix 2 – this section includes any experimental work that has not been published. 
 
Appendix 3 – this section includes the conferences I have attended. 
 
 
1.2 Aims and objectives 
At present, multi-step chemical biotransformations require the use of separate, 
sequential processes. This thesis describes work to generate a novel dual function 
biometallic catalyst as a model system for deracemisation reactions. The project used 
E. coli as this bacterium grows easily under laboratory conditions without strict 
environmental controls, and is amenable to genetic engineering. The microorganism 
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can also reduce Pd(II) to nanoscale bioPd without H2S production, which is a problem 
with the sulfate-reducing bacteria that have been used in previous studies (Redwood 
et al., 2008a). 
 
The aims of this study were to demonstrate the feasibility of the manufacture of a 
genetically engineered biometallic whole cell catalyst and to optimise its activity as 
appropriate, attempting to demonstrate expression of the recombinant enzyme and 
bioreduction of palladium in a single bacterial culture. An assessment of the impact of 
cell immobilisation on the biometallic catalyst was made, including the selection of an 
appropriate immobilisation matrix and the impact of freeze-drying on prolonging the 
activity of cells during storage. The biochemistry of the process of Pd(II) reduction in 
aerobic cultures was also studied, using physiological and genetic approaches. 
 
A number of techniques were used to achieve these aims in an attempt to build a full 
picture of the processes involved, including spectroscopy, electron microscopy, 
molecular biology and the use of deletion mutants, physiological manipulations, 
analytical chemistry, and immobilised cell technology. 
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Chapter 2: Introduction 
The requirement for enantiomerically pure chiral amines in the pharmaceutical and 
agrochemicals industries has led to the need to develop dynamic kinetic resolution 
(DKR) and deracemisation techniques that can efficiently and rapidly produce 
products, theoretically with 100% yield and 100% enantiomeric excess (e.e.) (Alexeeva 
et al., 2002). Previously published work has investigated the use of lipases and 
transaminases, using lipases for hydrolysis reactions and transaminases for the 
conversion of ketones to chiral amines. Lipases are also suitable for use with primary 
amines and some secondary amines only, with no activity towards tertiary amines 
(Dunsmore et al., 2006). Using a conceptually different approach, monoamine 
oxidase-N (MAO-N), attracted attention as a result of its enantioselectivity towards 
the (S)-form of the primary amine α-methylbenzylamine (Alexeeva et al., 2002).  
MAO-N is a tetrameric flavoprotein that catalyses the oxidative deamination of 
terminal amine groups. Use of a modified version of the enzyme (MAO-N-D5) for the 
cyclic deracemisation of chiral amines is based on the creation of imine intermediates 
by oxidation of the (S)-enantiomer (see Figure 2.1).  
 
Pd(0)
+ HCOO–
Pd(0) + H2
(S)-MTQ
(R)-MTQ
MDQ MIQ
Pd(0) + H2
MAO-N-D5
 
Figure 2.1: The cyclic deracemisation of 1-methyltetrahydroisoquinoline (MTQ) via the 
imine 1-methyl-3,4-dihydroisoquinoline (MDQ) using palladised biocatalyst with the  
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mao-N-D5 gene (adapted from Carr et al, 2003). 1-methylisoquinoline (MIQ) is formed 
when using formate as the electron donor in the reduction step (see section 3.2.5). 
 
The addition of a chemical reductant such as ammonia-borane or palladium results in 
the non-selective conversion of the imine back to the racemic amine. After several 
oxidation/reduction cycles, a very high enantiomeric excess and yield of the (R)-
enantiomer is achieved.  
 
It has been known for more than a century that some bacteria can reduce metals by 
use as the terminal electron acceptor in the respiratory chain. For example, the 
sulfate-reducing bacterium (SRB) Desulfovibrio desulfuricans has been shown to 
reduce soluble Pd(II) to insoluble Pd(0), which is located in the periplasm as 
nanoparticles (Lloyd et al., 1998a). This property has allowed the use of the palladised 
organism (known as bioPd) directly in industrially important reactions, showing good 
activity compared with a commercially available carbon-supported palladium catalyst 
(Baxter-Plant et al., 2003; Creamer et al., 2007b; De Windt et al., 2005; Mabbett et al., 
2004; 2006). 
 
This research project investigates the activity of palladised E. coli transformed with 
the MAO-N-D5 enzyme towards the secondary amine 1-methyltetrahydroisoquinoline 
(MTQ), and assesses its potential in the development of a one-pot method for the 
deracemisation of chiral amines. 
 
 
2.1 Bacterial respiration 
During respiration in eukaryotic cells, the electrons donated by a low-redox-potential 
molecule such as nicotinamide adenine dinucleotide (NADH) are transferred to a high-
redox-potential electron acceptor such as oxygen, by means of a series of redox 
reactions involving molecules embedded in the mitochondrial membrane known as 
the electron transport chain (ETC). The molecules in the ETC include enzymes, 
quinones (electron and proton carriers), flavoproteins  and cytochromes (electron 
carriers with heme groups). The energy generated during this process is used to drive 
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the flow of protons across the mitochondrial membrane, which sets up an 
electrochemical gradient, or protonmotive force (Δp) (Richardson, 2000). The return 
flow of protons through the membrane generates the high-energy molecule 
adenosine triphosphate (ATP). The electron-transfer process is similar in bacteria, 
although the ETC molecules vary depending on the availability of organic molecules 
for oxidation, and a much wider range of electron acceptors is utilised. This includes 
sulfate (Hamilton, 1998), nitrate and nitrite (Berks et al., 1995), arsenate (Macy et al., 
1996), selenate (Macy et al., 1989), transition metals (Lovley, 1991), and radionuclides 
(Lloyd et al., 2000; Lloyd & Renshaw, 2005; Lovley et al., 1991). Such substrate 
flexibility allows microorganisms to exploit a diverse range of environments. 
 
2.1.2 Respiration in Escherichia coli 
E. coli may obtain energy for growth by aerobic  or anaerobic respiration, or by 
fermentation, depending on environmental conditions. The ETC consists of several 
different dehydrogenases and terminal reductases or oxidases, linked by quinones 
(mobile electron shuttles). 
 Aerobic respiration: during aerobic respiration, one of two terminal oxidases may be 
used to transfer electrons to oxygen – the cytochrome o oxidase complex, or the 
cytochrome d complex, depending on whether oxygen is abundant or limited 
respectively (Anraku & Gennis, 1987; Poole, 1983).  
Anaerobic respiration: during anaerobic respiration, one of ten different terminal 
reductases may be expressed, depending on the electron acceptor available. There 
are also 15 different dehydrogenases, leading to a considerable amount of variability 
in the ETC, although not all combinations of enzymes are possible due to energetic 
constraints (Unden & Bongaerts, 1997). Each dehydrogenase requires a redox pair, of 
which one molecule is oxidised and the other reduced, and the midpoint potential 
(energy in volts released upon oxidation/reduction, Em) for these redox pairs varies. 
Table 2.1 lists all dehydrogenases, reductases, and oxidases of E. coli and their redox 
pairs (similar enzymes such as formate dehydrogenases are listed together). 
Fermentation: fermentation occurs under anaerobic conditions in the absence of 
electron donors suitable for respiration. During the process of fermentation, sugars 
are converted to acetate, ethanol, lactate, formate and succinate, with the production 
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of substantial amounts of hydrogen and carbon dioxide. The ETC does not operate 
under fermentative conditions, and so the recycling of NADH (which is normally 
reoxidised by the ETC) occurs during the conversion of pyruvate to fermentation 
products. 
 
Table 2.1: Respiratory chain enzymes of E. coli, with redox couples and midpoint 
potentials (adapted from Unden and Bongaerts, 1997) 
Enzyme Redox couple Em (V) 
FDH 
Hydrogenase 
NADH dehydrogenase 
Glycerol-3-phosphate dehydrogenase 
Pyruvate oxidase 
Lactate dehydrogenase 
Amino acid dehydrogenase 
Glucose dehydrogenase 
Succinate dehydrogenase 
Quinol oxidase (cytochrome complex o/d) 
Nitrate reductase 
Nitrite reductase 
DMSO reductase 
TMAO reductase 
Fumarate reductase 
HCO3
–/ HCO2
– 
H+/H2 
NAD+/NADH 
DHAP/Gly-3-P 
acetate+CO2/pyruvate 
pyruvate/lactate 
2-oxoacid+NH4
+/aa 
glucose/gluconate 
fumarate/succinate 
O2/H2O 
NO3
–/ NO2
– 
NO2
–/ NH4
+ 
DMSO/DMS 
TMAO/TMA 
fumarate/succinate 
–0.43 
–0.42 
–0.32 
–0.19 
     ? 
–0.19 
     ? 
–0.14 
+0.03 
+0.82 
+0.42 
+0.36 
+0.16 
+0.13 
+0.03 
? = no information available 
 
 
2.2 Microbial reduction of metals 
A wide range of bacteria and Archaea are capable of reducing metals in order to 
conserve energy for growth (known as dissimilatory metal reduction processes). For 
example, a diverse group of iron-reducing species are capable of reducing Fe(III) to 
Fe(II) in subsurface environments. Some bacteria, such as the sulfate-reducers, are 
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also capable of reducing Fe(III) although there is no evidence that they are able to 
utilise this process for growth (Lloyd, 2003).  
In some cases, microbial reduction leads to the mobilisation of toxic metals, which 
could have potentially harmful effects on flora and fauna (including humans). In other 
cases however, reduction of metals can produce ions that are less harmful or less 
soluble, for example the reduction of Cr(VI) to Cr(III), or the reduction of the soluble 
radionuclide Tc(VII) to an insoluble black precipitate (Lloyd et al., 1997). Microbial 
reduction can therefore be used in the bioremediation of contaminated land, but also 
has potential uses in the reclamation of valuable metals from wastes, such as gold 
(Kashefi et al., 2001) and palladium (Mabbett et al., 2006). 
 
2.2.1 Dissimilatory metal reduction 
Iron reduction 
Iron is the most abundant redox-active metal in the Earth’s crust, followed by 
manganese (Lovley, 2000), and most organisms that reduce one also reduce the other 
(Lovley et al., 2004). The term ‘dissimilatory’ reduction is used as the organisms do not 
accumulate the reduced Fe(II) intracellularly. It is probable that Fe(III) reduction to 
Fe(II) was the first respiratory process to evolve, as Fe(III) is abundant and its 
reduction is thermodynamically driven, not requiring specialist enzymes (Lovley, 1991; 
Lovley, 2000; Richardson, 2000). The Fe(III) acts as the terminal electron acceptor in 
the ETC, whereby electrons flow along a series of membrane-bound proteins towards 
a more positive redox potential with the associated conversion of energy (Lloyd, 2003). 
Fe(III) reduction using hydrogen as the electron donor is highly conserved in 
hyperthermophilic organisms (Lovley et al., 2004), which also points towards an early 
evolutionary development. However, different mechanisms exist amongst Fe(III) 
reducers, indicating that the capacity for Fe(III) reduction evolved more than once. For 
example Geobacter species, which have been isolated from a variety of diverse 
sedimentary environments (Coates et al., 1996), require direct contact with Fe(III) for 
reduction to take place. Shewanella and Geothrix species on the other hand produce 
chelators and electron shuttles to effect Fe(III) reduction at a distance (Lovley et al., 
2004). 
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The dissimilatory reduction of Fe(III) and Mn(IV) has a strong influence on the 
biogeochemical cycles of many other components of sediments, groundwater, and 
aquatic environments, due to the use of these components as electron donors or their 
co-precipitation or dissolution with iron (Lovley, 1991). Competition with sulfate-
reducing bacteria (SRB) and methanogens for organic carbon, for example, interferes 
with the cycling of sulfate and the production of methane (Megonigal et al., 2003). 
However, it is the ability of Fe(III)-reducing organisms to oxidise organic compounds to 
carbon dioxide and reduce a variety of other metals which provides potential 
candidates for bioremediation. 
 
2.2.2 Bioremediation 
Organic contaminants 
Fe(III) is the predominant electron acceptor in anaerobic zones, which are often 
extensive in petroleum-contaminated aquifers. If the aromatic hydrocarbons benzene 
or toluene oxidation were coupled to Fe(III) reduction therefore, this would present a 
useful bioremediation tool for use in contaminated aquifers (Anderson et al., 1998; 
Lovley & Anderson, 2000). The dissimilatory Fe(III)-reducing genus Geobacter is the 
only genus known to degrade aromatic hydrocarbons coupled with Fe(III) reduction, 
and these species may therefore be exploited for their ability to oxidise organic 
contaminants (Anderson et al., 1998; Lovley et al., 1993; Lovley & Anderson, 2000; 
Megonigal et al., 2003). Early work on the oxidation of benzene and toluene in aquifer 
sediments showed that in vitro oxidation only occurred when sediments were 
supplemented with a Fe(III) chelator, such as nitrilotriacetic acid (Lovley et al., 1994), 
ethylenediaminetetraacetic acid (EDTA), N-methyliminodiacetic acid, ethanol diglycine, 
and phosphates (Lovley et al., 1996b). In the latter study, humics were also used, but 
it was later realised that the humics were in fact behaving as electron shuttles 
between the bacterial cells and the insoluble Fe(III) oxides (Lovley et al., 1996a). It was 
subsequently demonstrated that microbial communities consisting predominantly of 
Geothrix spp. were not capable of oxidising [14C]benzene to 14CO2 without a 
considerable lag time, but in sediments containing Geobacteriaceae, the oxidisation of 
benzene was rapid, and did not require the addition of chelators or humics (Anderson 
et al., 1998). 
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Toxic metals 
Many Fe(III) reducing species are capable of substituting other metals as the terminal 
electron acceptor (Lovley & Anderson, 2000), causing the precipitation and 
immobilisation of metals in the subsurface. Examples include the reduction of U(VI) to 
U(IV) by Geobacter metallireducens and Shewanella putrifaciens (Lovley et al., 1991), 
the reduction of Tc(VII) to Tc(IV) by the same two species (Lloyd & Macaskie, 1996), 
and the reduction of Cr(VI) to Cr(III) (Lovley, 1995). The sulfate-reducing bacterium D. 
desulfuricans is capable of reducing Fe(III), U(VI) (Lovley & Phillips, 1992), Cr(VI) 
(Mabbett et al., 2002; Tucker et al., 1998), Tc(VII) (Lloyd et al., 1998b), Mo(VI) (Tucker 
et al., 1998), and Pd(II) (Lloyd et al., 1998a) using hydrogen as the electron donor, 
although without obtaining energy for growth (Lloyd et al., 2001). the formation of 
insoluble precipitates immobilises toxic and radioactive metals in the subsurface, 
limiting their bioavailability and their spread. The reduced forms may also be less toxic, 
as in the case of chromium. Cr(VI) is 1000 times more toxic and mutagenic than Cr(III), 
and in the trivalent form chromium is also less mobile as it precipitates as Cr(III) 
minerals (Lovley, 2000). However, the reverse can also be true, and insoluble metals 
can be reduced to more soluble and toxic forms (Lloyd, 2003). 
 
Different mechanisms are used by D. desulfuricans for the reduction of Tc(VII), Cr(VI), 
Se(IV), and Te(IV), and it is impossible to predict the reduction sequence from the 
redox potentials due to the preferential reduction of some contaminants over others. 
This would need to be taken into account if bioremediation of contaminated land was 
under consideration, and the electron donor would need to be chosen with a 
particular acceptor in mind (Lloyd et al., 2001). 
 
2.2.3 Recovery of metals 
The use of microorganisms in mining for metals has been considered, for example 
whereby Fe(III) is reduced to soluble Fe(II) and leached from ores. However, biomining 
has been rejected as the process is too slow, making it impractical against other 
extraction methods (Lovley, 1991). In the processing of industrial wastes however, 
bioreduction may present a viable method of recovering precious metals. The 
recovery of Pd, Pt and Rh from both industrial wastes (Yong et al., 2002a) and the 
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aqua regia leachates from spent automotive catalysts (Yong et al., 2003) has been 
demonstrated, using a D. desulfuricans biofilm in a flow-through bioreactor. The 
recovered Pd(0) nanoparticles have also been successfully used as catalysts, in the 
liberation of hydrogen from hypophosphite (Yong et al., 2002a), and the continuous 
reduction of Cr(VI) to Cr(III) in a flow-through reactor (Mabbett et al., 2006). 
 
 
2.3 Palladium 
Palladium is a lustrous silvery metal, of the platinum group of metals (PGM), a group 
that also includes platinum and rhodium. Its symbol is Pd, atomic number 46, and its 
relative atomic mass is 106.5. It was first discovered by W. H. Wollaston in 1803, and 
is named after the then recently discovered asteroid Pallas. It resists corrosion, and 
has the unique property that hydrogen gas is able to filter through it. At room 
temperature palladium can absorb up to 900 times its own volume of hydrogen (RSC, 
2008). Finely divided palladium is used as a catalyst in hydrogenation and 
dehydrogenation reactions. Supported palladium nanoparticles demonstrate 
enhanced catalytic properties (Eberhardt, 2002; Grunwaldt et al., 2007; Kim et al., 
2004b); however, growth of the palladium nanoparticles by coalescence or ripening 
would render the catalyst less active, and interventions to prevent this are expensive 
(Creamer et al., 2007b). 
 
Some palladium is used in jewellery and dental amalgams, although the majority is 
used in catalysts.  Demand for palladium grew to 6.84 million ounces in 2007 (Jollie, 
2008), with almost two thirds of this amount (4.45 million ounces) required to replace 
the platinum in autocatalysts due to the rising cost of platinum. However, only 1.00 
million ounces of palladium was recovered from spent autocatalysts (Jollie, 2008), as 
methods for reclaiming palladium are ineffective and expensive (Yong et al., 2002a).  
 
2.3.1 Production of Pd nanoparticles 
For optimal performance, palladium nanoparticles should be well-dispersed and have 
identical properties. The conventional synthesis of nanoparticles involve the reduction 
of salts precipitated onto a support or in a super-saturated solution, using high 
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temperatures or chemical reduction (Burton et al., 2011; Liu et al., 2009). Nucleation 
sites form throughout  the nanoparticle growth stage and metal clusters also form, 
which leads to a broad distribution of particles size and shape, and capping agents are 
required to prevent aggregation (Liu et al., 2009). 
 
Flame spray pyrolysis allows the formation of supported metal catalysts in a single 
step, by the spraying and combusting of a liquid precursor in a flame. Particle size can 
be controlled by altering the experimental conditions, such as precursor concentration 
and feed flow rate (Mekasuwandumrong et al., 2011). The flame used is a 
methanol/oxygen flame in a ~1:2 mixture, and the liquid precursor is dispersed by 
oxygen (Madler et al., 2003). This leads to the synthesis of PdO crystals, which can be 
reduced to Pd(0) using a chemical reductant such as sodium borohydride (Ma et al., 
2011). 
 
In a partially biological process for the production of palladium nanoparticles, the 
antioxidants in an extract from the plant Gardenia jasminoides Ellis have been used to 
reduce palladium chloride (Jia et al., 2009). The nanoparticles produced were 3-5 nm 
in diameter, and were successfully used for the hydrogenation of p-nitrotoluene. The 
same group later used a broth made from the leaves of the tree Cinnamomum 
camphora for the same purpose, although the catalytic activity of the nanoparticles 
produced was not determined (Yang et al., 2010). 
 
 
2.4 Bioreduction of palladium 
Physical and chemical techniques for the production of palladium nanoparticles 
require the use of specialised equipment, which carries a considerable expense. The 
biogenic generation of nanoparticles offers an inexpensive ‘green’ alternative, with a 
narrow range of nanoparticles formed and no additional processing required. 
 
The bioreduction of soluble Pd(II) to insoluble Pd(0) was first performed 
experimentally using the sulfate-reducing bacterium (SRB) D. desulfuricans, with a 
view to the recovery of palladium from waste (Lloyd et al., 1998a). D. desulfuricans 
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was chosen for its high metal reductase activity and broad specificity. Using pyruvate, 
formate, and hydrogen as electron donors, the bacteria were involved in catalysing 
the reduction of Pd(II), which formed clusters of approximately 50 nm on the cell 
surface (detected by electron microscopy). Energy dispersive X-ray microanalysis (EDX) 
showed these electron-dense areas to be composed of palladium, which was further 
identified as elemental palladium, or Pd(0), by X-ray diffraction (XRD). It was 
hypothesised that the enzyme catalysing this reaction was a hydrogenase enzyme, 
possibly also with cytochrome c3 (a component of the electron transport chain), due 
to the use of H2 as an electron donor under aerobic conditions as well as anaerobic, 
the periplasmic location of hydrogenases in SRB, and the inhibition of the reaction by 
Cu3+. H2 was used under both aerobic and anaerobic conditions with equal success, 
but in a later study using formate, the reaction proceeded only under anaerobic 
conditions (Yong et al., 2002c). Use of D. fructosovorans mutants has shown that the 
reduction of Pd(II) by this species is mediated by the periplasmic [NiFe]-hydrogenase 
(Mikheenko et al., 2008). Other bacteria that have been used to produce bioPd are 
shown in Table 2.2 (page 35). In the case of a study using E. coli, the culture was 
grown aerobically, then switched to anaerobic conditions before palladisation of the 
cells (Mabbett et al., 2006). A more recent study has confirmed the role of 
hydrogenases in formate-dependent palladium reduction by anaerobic cultures of E. 
coli, by using mutant strains (Deplanche et al., 2010). 
 
The role of the bacterial cell in the reduction of Pd(II) to Pd(0) is to provide nucleation 
sites where the Pd(II) sorbs onto the cell. A one-hour biosorption step is critical in SRB, 
during which time the metal ions bind to amine groups, on or near a hydrogenase 
enzyme (de Vargas et al., 2004). The cell also provides initial electrons via the enzymes, 
with the concurrent oxidation of H2. The reaction then proceeds autocatalytically, with 
the cell acting as a scaffold for the growth of Pd(0) crystals (Creamer et al., 2007b; 
Yong et al., 2002b). In the case of Gram-negative bacteria, with which most studies 
have been performed, the crystals are located in the periplasm between the 
cytoplasmic and outer membranes, often bursting through the outer membrane 
(Macaskie et al., 2005) (see Figure 2.4.1). In Gram-positive bacteria the enzymes 
involved in the reduction of Pd(II) are unknown, although the nanoparticles formed by 
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B. sphaericus have been observed by electron microscopy to be located between the 
peptidoglycan and the S-layer (Creamer et al., 2007b).  
 
 
Figure 2.4.1: TEM image of Pd(0) nanoparticles located in the periplasm of D. 
desulfuricans (adapted from Macaskie et al., 2005). Scale bar = 500 nm. 
 
The bioreduction of palladium by bacteria allows Pd(0) to be recovered directly from 
waste leachates (Creamer et al., 2006; Mabbett et al., 2006; Yong et al., 2002b; Yong 
et al., 2002c), and the resultant bioPd can be used directly as a palladium catalyst 
without further refining (Yong et al., 2002b). An added advantage of bioPd is that the 
palladised cells settle out of suspension easily, whereas palladium on a carbon matrix 
is difficult to separate from the reaction products (Creamer et al., 2007b). 
 
2.4.1 Uses of bioPd 
A number of studies have investigated the catalytic activity of bioPd and 
demonstrated its use in a variety of reduction reactions as shown in Table 2.2. At 3-10 
nm (Redwood et al., 2008a), the bionanoparticles are around half the size of those 
produced abiotically indicating a likely increase in activity of the palladium catalyst 
due to the increased surface area (Yong et al., 2002b). In most cases where the bioPd 
was compared with an abiotically-produced palladium catalyst (finely-divided or 
supported on a carbon matrix), the bioPd was more active or at least as active as the 
commercially available alternative. When utilised for the dehalogenation of the flame 
retardant material and possible pollutant tris(chloroisopropyl)phosphate (TCPP), 
bioPd was five times more active than the commercially available Pd(0) catalyst 
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(Deplanche et al., 2009). BioPd has also been used in reactions in methanol, in the 
conversion of 4-azidoaniline to 1,4-phenylenediamine (Creamer et al., 2008). 
 
Table 2.2: Microbial cell-supported Pd(0) nanocatalysts and their applications 
(Adapted from Deplanche et al., 2011; and Schröfel & Kratošová, 2011). 
Microorganism Catalytic application References 
Gram-negative bacteria   
Bacteroides vulgatus Dehalogenation of diatrizoate (Hennebel et al., 2011) 
Citrobacter braakii Dehalogenation of diatrizoate (Hennebel et al., 2011) 
Clostridium butyricum Dehalogenation of diatrizoate (Hennebel et al., 2011) 
Cupriavidus necator Suzuki–Miyaura and Mizoroki–
Heck reactions. 
Evolution of H2 from 
hypophosphite 
(Gauthier et al., 2010; 
Sobjerg et al., 2009; 2011) 
(Bunge et al., 2010) 
Cupriavidus metallidurans Mizoroki–Heck reaction of  
n-butylacrylate with  
4-iodoanisole 
(Gauthier et al., 2010) 
Desulfovibrio desulfuricans Evolution of H2 from 
hypophosphite. 
Dehalogenation reactions. 
 
 
Reduction of Cr(VI) to Cr(III). 
 
 
Fuel cell. 
 
Hydrogenation of 2-pentyne. 
(Yong et al., 2002a; Yong 
et al., 2002b) 
(Baxter-Plant et al., 2003; 
2004; Harrad et al., 2007; 
Redwood et al., 2008a) 
(Humphries et al., 2006; 
Mabbett et al., 2004; 
2006) 
(Orozco et al., 2010; Yong 
et al., 2007; 2010) 
(Bennett et al., 2010) 
Desulfovibrio 
fructosovorans 
None (Mikheenko et al., 2008) 
Desulfovibrio vulgaris Dehalogenation of chlorophenol 
and polychlorinated biphenyls. 
Reduction of Cr(VI) to Cr(III). 
(Baxter-Plant et al., 2003; 
2004) 
(Humphries et al., 2006) 
Escherichia coli Fuel cell. (Orozco et al., 2010; Yong 
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Dehalogenation of diatrizoate. 
et al., 2010) 
(Hennebel et al., 2011) 
Klebsiella pneumoniae Dehalogenation of diatrizoate (Hennebel et al., 2011) 
Paracoccus denitrificans Evolution of H2 from 
hypophosphite 
(Bunge et al., 2010) 
Plectonema boryanum None (Lengke et al., 2007) 
Pseudomonas putida Suzuki–Miyaura and Mizoroki–
Heck reactions. 
Evolution of H2 from 
hypophosphite. 
(Sobjerg et al., 2009) 
 
(Bunge et al., 2010) 
Rhodobacter capsulatus Partial hydrogenation of 2-butyne-
1,4-diol to 2-butene-1,4-diol. 
(Wood et al., 2010) 
Rhodobacter sphaeroides Dehalogenation of polychlorinated 
biphenyls and pentachlorophenol. 
(Redwood et al., 2008a) 
Serratia sp. Reduction of Cr(VI) to Cr(III). (Beauregard et al., 2010) 
Shewanella oneidensis Dehalogenation reactions. 
 
 
 
Fuel cell. 
(De Windt et al., 2005; 
2006; Hennebel et al., 
2011; Mertens et al., 
2007) 
(Ogi et al., 2011) 
   
Gram-positive bacteria   
Arthrobacter oxydans Partial hydrogenation of 2-butyne-
1,4-diol to 2-butene-1,4-diol. 
(Wood et al., 2010) 
Bacillus sphaericus Hydrogenation of itaconic acid. (Creamer et al., 2007a) 
Enterococcus faecium Dehalogenation of diatrizoate in a 
membrane bioreactor. 
(Hennebel et al., 2011) 
Clostridium pasteurianum Reduction of Cr(VI) to Cr(III). (Chidambaram et al., 
2010) 
Staphylococcus sciuri Suzuki–Miyaura cross coupling 
reaction and hydrogenation 
reactions. 
(Sobjerg et al., 2011) 
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2.5 Hydrogenases and formate dehydrogenases in Escherichia coli 
Formate and molecular hydrogen are both important energy sources for anaerobic 
bacteria. Formate is a highly reducing, high-energy compound, produced in 
anaerobically growing E. coli by the cleavage of pyruvate, catalysed by pyruvate 
formate lyase (PFL) (Sawers, 2005). At neutral pH, formate is excreted from the cell 
into the periplasm, the area between the cytoplasmic and outer membranes in Gram-
negative bacteria where the peptidoglycan cell wall is situated. Here, the formate is 
made available to formate dehydrogenases (Sawers, 1994). 
 
E. coli synthesises three formate dehydrogenase isoenzymes and four hydrogenase 
isoenzymes, all of which are membrane-bound (see Figure 2.5.1). The three formate 
dehydrogenases (FDH) consist of α, β, and γ subunits (Abaibou et al., 1995; Sawers, 
1994), and catalyse the oxidation of formate. All three FDH are dependent on 
molybdenum cofactors, derived from molybdopterin complexed with molybdenum 
and selenium (Sawers, 1994). They have more specific designations based on the 
growth conditions which lead to their optimal expression, i.e. FDH-O (also known as 
formate oxidase) is synthesised aerobically or anaerobically in the presence of nitrate 
(Sawers et al., 1991), FDH-N is synthesised during anaerobic growth in the presence of 
nitrate, and the synthesis of FDH-H is optimal when E. coli grows fermentatively 
(Sawers, 1994). FDH-O is always present in the cell in small amounts and is very active 
(Sawers, 1994). A possible role for FDH-O is to allow bacteria to adapt rapidly to a 
sudden shift from aerobic respiration to anaerobiosis, before FDH-N has been 
produced in sufficient amounts to continue formate metabolism (Abaibou et al., 1995). 
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Figure 2.5.1: Locations and orientations of the formate dehydrogenases and 
hydrogenases 1-3 within the cytoplasmic  membrane. Adapted from Sawers (1994), 
and Forzi & Sawers (2007). 
 
The four hydrogenase enzymes are [NiFe]-hydrogenases, as they have both a nickel 
and an iron atom at their active site, and they are named in the order of their 
discovery. Hyd-1 and Hyd-2 are uptake hydrogenases, and catalyse the reversible 
oxidation of H2 linked to the reduction of electron acceptors such as nitrate or 
fumarate (during anaerobic growth), or oxygen (during aerobic growth). Hyd-1 and 
Hyd-2 consist of αβ heterodimers, with the large α-subunit containing the bimetallic 
active site (Vignais, 2008). They are linked to the quinone pool of the respiratory chain 
by cytochrome b, which anchors the dimeric proteins to the cytoplasmic membrane 
(Vignais & Billoud, 2007). Hyd-1 is the most abundant hydrogenase in E. coli, and its 
role may be to recycle H2 produced under fermentative conditions by the FHL complex 
(Sawers et al., 1985). Hyd-2 is synthesised at high levels when cells are grown with 
glycerol and fumarate or H2 and fumarate (Forzi & Sawers, 2007). Expressed only 
under strictly anaerobic conditions (Vignais et al., 2001), the multimeric Hyd-3 forms 
part of the formate hydrogenlyase (FHL) complex, which also includes two electron 
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carriers and FDH-H, and is involved in the evolution of H2 and CO2 from the 
metabolism of formate (Sawers, 1994). Hyd-3 has already been shown to catalyse the 
reduction of Tc(VII), using formate or H2 as electron donors (Lloyd et al., 1997). One 
group has reported that H2 uptake decreases with FHL- or Hyd-3-deficient mutants 
(Maeda et al., 2007), although another group has reported that there is no significant 
uptake activity with Hyd-2-deficient mutants (Redwood et al., 2008b). There is also a 
putative hydrogenase-4, although little is known about this enzyme as yet (Vignais & 
Billoud, 2007). It is possible that Hyd-4 is part of a second FHL complex, which is active 
at higher pH than FHL complex I (Mnatsakanyan et al., 2002). 
 
All the isoenzymes have abundant iron-sulfur clusters, which are involved in the 
transfer of electrons between the enzyme and the donors or acceptors (Vignais, 2008). 
There are also numerous ancillary proteins involved in the maturation and assembly 
of these enzymes, about the majority of which little is known (Sawers, 1994). 
 
The genes responsible for the encoding of the isoenzymes are shown in Table 2.3 
below. 
 
Table 2.3: Operons encoding the formate dehydrogenase and hydrogenase 
isoenzymes. 
Isoenzyme Operon Reference 
FDH-O fdo (Plunkett et al., 1993) 
FDH-N fdn (Berg et al., 1991) 
FDH-H fdhF gene (Zinoni et al., 1986) 
Hyd-1 hya (Menon et al., 1990) 
Hyd-2 hyb (Menon et al., 1994) 
Hyd-3 hyc (Bohm et al., 1990) 
Hyd-4 hyf (Andrews et al., 1997) 
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2.6 Biocatalysis 
Biocatalysis is the use of enzymes , or whole cells containing enzymes, for the 
chemical modification of organic compounds. Enzymes are used in the manufacture of 
foods, detergents, textiles, diagnostic assays (Demain & Adrio, 2008; Kirk et al., 2002), 
and in the production of agrochemicals, pharmaceuticals, and fine chemicals (Panke et 
al., 2004; Straathof et al., 2002). There are a number of advantages to using enzymes 
in organic synthesis, as the mild conditions under which enzymes are active (typically 
ambient temperatures, atmospheric pressure, ca. pH 7.0) are easy to achieve; they are 
naturally produced and so are compatible with requirements for ‘green’ technology; 
reactions performed by enzymes may otherwise be difficult or impossible to achieve 
chemically; and they usually exhibit high selectivity. Attributes of particular interest 
are chemoselectivity (a preferential reaction with one functional group over others), 
regioselectivity (one direction or site of bond making or breaking occurs preferentially, 
forming an excess of one structural isomer), and stereoselectivity (preferential 
formation of one stereoisomer over another). The production of optically pure 
compounds by means of enantioselective enzymes is of particular interest, as this is 
difficult to achieve by chemical means. These compounds are often used as building 
blocks, and are combined with other molecules to obtain the final product (Turner, 
2009). 
 
Microbial cells are usually used in the production of biocatalysts as they are easier to 
cultivate than animal or plant cells, grow more quickly and are less nutritionally 
demanding. Biocatalysts may be used as whole cells, or as purified enzymes. With 
purified enzymes there is no interference from other enzymes that are present in the 
cell, and the enzymes may also be more tolerant to solvents and the formation of 
toxic products. However, the purification of enzymes is an expensive process during 
which the target enzyme may be exposed to cellular proteases, the yield is typically 
low, enzyme co-factors must be added to the reaction mix or recycled, and the long-
term stability of the enzyme is reduced; also, the conformation of the enzyme may 
change once outside the cell, rendering it inactive (Ishige et al., 2005; Roberts et al., 
1995). 
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Enzymes are classified according to the Enzyme Commission (EC) classification system, 
which divides enzymes into one of six classes. The choice of enzymes for 
biotransformations is vast, although some classes of enzyme have proved more useful 
than others. 
 
EC 1 Oxidoreductases 
Oxidoreductases catalyse oxidation and reduction reactions, such as the 
interconversions of ketones and alcohols, the reduction of double bonds, and the 
oxidation of amines to imines. Examples include alcohol dehydrogenase, lactate 
dehydrogenase, and amine oxidases. As oxidoreductases are usually dependent on a 
co-factor, this must be supplied in excess or recycled during the biotransformation, 
which can be expensive. 
 
EC 2 Transferases 
The transfer of groups between molecules is catalysed by transferases, such as 
transaminases (transfer of amino groups), kinases (transfer of phosphate groups), and 
glucosyl transferases (transfer of sugars). The transfer of sugars can be problematic, as 
the donors for these groups are nucleotides, which are expensive. An enantioselective 
transaminase has also been used in the manufacture of sitagliptin, an antidiabetic 
drug, to catalyse the amination of the prositagliptin ketone to form sitagliptin 
phosphate (Mutti et al., 2011; Savile et al., 2010). 
 
The generation of 2-amino-1,3-diols, which are a component of the broad-spectrum 
antimicrobial compound chloramphenicol, may be achieved by the transfer of an 
amino group from an donor molecule to α,α’-dihydroxy ketone, as demonstrated in 
Figure 2.6.1 (Hailes et al., 2010). 
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EC 3 Hydrolases 
A hydrolysis reaction is one in which bonds are cleaved with the addition of water. 
Examples of hydrolases include lipases, esterases, proteinases, phosphatases, and 
glycosidases. Lipases and proteinases are the two most commonly used hydrolases in 
biotransformations (Grogan, 2009). A benefit of using lipase is that it is possible to 
catalyse the reverse reaction, e.g. transesterfication using Candida antarctica lipase B. 
Figure 1.7.4 shows an example of such a lipase-catalysed biotransformation. 
Hydrolysis of racemic N-acetylbenzylamine to generate (S)-1-methylbenzylamine has 
been performed using whole-cell preparations of the microorganisms Nocardia 
erythropofis and Cellulomonas fimi (Ogawa et al., 1994). 
 
EC 4 Lyases 
Lyases catalyse the addition of water or ammonia across a double bond. Examples 
include aldolases, aspartase, and fumarase. Phenylalanine ammonia lyase is used in 
the synthesis of chiral amines (Gloge et al., 2000). 
 
EC 5 Isomerases 
Isomerases and racemases catalyse isomerisation reactions. Alanine racemase, 
produced by Salmonella typhimurium, has been used in a multi-step process for the 
production of D-amino acids (Fotheringham, 2000). During this process, alanine 
racemase catalyses the conversion of L-alanine to D-alanine, which is then used as the 
Figure 2.6.1: Transfer of an amino group from a donor molecule to α,α’-dihydroxy 
ketone via the enzyme co-factor pyridoxal 5’-phosphate (PLP), producing 2-amino-1,3-
diol. 
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amino donor in the transaminase-catalysed conversion of an α-keto acid to a D-amino 
acid (see Figure 2.6.2). 
 
NH
2
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O NH2
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O
R
COOHO
R
COOHH
2
N
alanine
racemase
D-amino acid
transaminase
L-alanine D-alanine D-amino acid
-keto acid  
 
Figure 2.6.2: The multi-step production of D-amino acids. 
 
EC 6 Ligases 
Ligases catalyse the formation of bonds between molecules, and whilst they are very 
useful in molecular biology, they are of limited use in biotransformations.  
 
 
2.7 Synthesis of optically pure compounds 
2.7.1 Chirality 
When stereoisomers are chiral molecules, i.e. non-superimposable mirror images of 
each other, they are also known as enantiomers. Enantiomers may be distinguished 
from one another by their ability to rotate plane-polarised light – light is rotated in 
opposite directions by each enantiomer. A racemic mixture therefore shows a net 
rotation of zero. A compound composed of only one enantiomer is optically pure. 
 
Enantiomers are classified as R or S according to the Cahn, Ingold and Prelog (CIP) 
system (1966). Using this system, groups around the chiral centre of a molecule are 
numbered in order of priority, as determined by the atomic number of the immediate 
substituent atoms followed by the adjacent atoms, e.g. H < C < N < O and CH3 < C2H5 < 
CH3O. The lowest priority group is then put to the back, and a curve drawn through 
+ 
pyruvate 
+ 
NH3 
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the groups from the highest downwards. If the curve goes in a clockwise direction, the 
enantiomer is designated R, after the Latin rectus, meaning right. If the curve goes to 
the left, the enantiomer is designated S, after the Latin sinister, meaning left (see 
Figure 2.7.1). 
 
 
Figure 2.7.1: Classification of chiral molecules by assigning priority to groups around 
the chiral centre (chiral centre identified by *). 
 
Enantiomerically pure compounds are of importance in the pharmaceutical industry 
when only one enantiomer is biologically active. The other enantiomer may be either 
inactive, or may have adverse side-effects. If an enantiomerically pure compound is 
obtained, the dosage may be halved which would decrease costs and the risk of 
adverse reactions. Chiral pharmaceuticals manufactured using enantioselective 
enzymes include anti-anxiety drugs, antiviral and antiretroviral agents, anti-
hypertensive drugs, cholesterol-lowering drugs, anti-cancer agents, anti-Alzheimer's 
drugs, and drugs for the treatment of diabetes (Patel, 2001; 2006; 2008). The anti-
Alzheimer’s drug rivastigmine is more active in its (S) form, intermediates for which 
can be manufactured by lipase-catalysed reactions (Mangas-Sanchez et al., 2009). The 
anti-hypertensive drug Omapatrilat has four chiral centres, and can be manufactured 
using multi-enzyme systems that include enzymes for both chiral resolution and co-
factor recycling (Panke & Wubbolts, 2005).  
 
The first methods to be developed for the resolution of racemates were capable of 
effectively separating the enantiomers, but if only one enantiomer is required the 
productivity is low as the maximum yield is 50% (Faber, 2001). The goal therefore is 
the production of an optically pure compound via a method which uses all of the 
starting material, giving a theoretical yield of 100%.  
* * 
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2.7.1.1 Stereoselective synthesis 
Traditionally known as asymmetric synthesis, this describes any process in which an 
element of chirality is introduced to a molecule, and the two enantiomers are 
generated in unequal amounts. Kinetic resolution and dynamic kinetic resolution are 
both examples of stereoselective processes. 
 
2.7.1.2 Kinetic resolution 
Kinetic resolution describes a process in which one enantiomer in a racemic mixture 
has a higher reaction rate than that of the other with a particular enzyme (Figure 
2.7.2). This produces an excess of one enantiomer which reaches a maximum, then 
decreases until the reaction reaches completion. The maximum yield from kinetic 
resolution techniques is 50%. 
 
 
Figure 2.7.2: Kinetic resolution of a racemate. SR and SS: substrate enantiomers; PR and 
PS: product enantiomers; kR and kS: rate constants. 
 
2.7.1.3 Dynamic kinetic resolution 
The problem of the maximum yield of 50% with kinetic resolution is solved by using 
dynamic kinetic resolution (DKR). In addition to a kinetic resolution step, the 
enantiomers are equilibrated simultaneously via a racemisation step, as shown in 
Figure 2.7.3. 
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Figure 2.7.3: Dynamic kinetic resolution of a racemate. SR and SS: substrate 
enantiomers; PR and PS: product enantiomers; kR and kS: rate constants. 
 
In order for DKR to be successful, a number of criteria should be fulfilled. The 
resolution step should be irreversible, and product should not be involved in the 
racemisation step. The selectivity of the resolution step should be high, and the rate 
constant for the racemisation step should be higher than that of the resolution step 
(Pellissier, 2011). DKR techniques that have been particularly successful have 
combined a chemocatalytic racemisation step with a biocatalytic enantioselective 
transformation (Faber, 2001; Pàmies & Bäckvall, 2003). Kim et al (2004a) have 
developed techniques using a pair of complimentary enzyme-metal combinations for 
the DKR of racemic secondary alcohols. (R)-selective DKR is performed using a lipase-
Ru complex combination, and (S)-selective DKR is performed using a subtilisin-Ru 
combination. 
 
2.7.1.4 Enantioconvergent reactions 
During enantioconvergent reactions, both enantiomers of a racemate are converted 
via kinetic resolution to a single enantiomer of product (Figure 2.7.4). The two 
pathways taken by each enantiomer are completely independent, and show opposing 
enantiopreference, with both pathways proceeding via separate enantioselective 
steps. The kSR pathway must also proceed with a stereoinversion step.  
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Figure 2.7.4: Enantioconvergent deracemisation. SR and SS: substrate enantiomers; PR: 
product; kR and kSR: rate constants. 
 
In practice, enantioconvergent deracemisations are difficult to achieve (Faber, 2001), 
although a process has been described for the successful resolution of  racemic sec-
alkyl sulfate esters using an alkylsulfatase from Rhodococcus ruber (Pogorevc et al., 
2002). 
 
2.7.1.5 Cyclic deracemisation 
Deracemisation is the interconversion of enantiomers via a stereoinversion process, 
for example cyclic oxidation and reduction reactions (Turner, 2003). In cyclic 
deracemisation, an initial enantioselective oxidation step converts one enantiomer to 
an achiral intermediate, followed by a non-selective reduction step which regenerates 
both enantiomers of the substrate (see Figure 2.7.5). 
 
 
Figure 2.7.5: Cyclic deracemisation of a racemate. An enantioselective oxidation step 
is followed by a non-selective reduction step. SR and SS: substrate enantiomers; I: 
achiral intermediate. 
 
Oikawa et al (2001) successfully used cyclic deracemisation for the generation of pure 
D-lactate, using an L-selective lactate oxidase from Aerococcus viridans, and sodium 
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borohydride for the non-selective reduction step (see Figure 2.7.6). Shortly afterwards, 
cyclic deracemisation of the primary amine α-methylbenzylamine was performed 
using an (S)-selective monoamine oxidase from Aspergillus niger, and ammonia-
borane as the non-selective reductant (Alexeeva et al., 2002). 
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Figure 2.7.6: Cyclic deracemisation of a DL-lactate. An L-selective oxidation step is 
followed by a non-selective reduction step. 
 
 
2.8 Amines 
Amines are an important class of molecules, and are widely used in their 
enantiomerically pure forms in pharmaceutical preparations. Amines are derivatives 
of ammonia, NH3, and are further classified according to the number of hydrogens 
that have been replaced by alkyl or aryl groups. Primary amines have one hydrogen 
replaced, secondary amines have two hydrogens replaced, and tertiary amines have 
all three hydrogens replaced. 
 
Some examples of amines are shown in Figure 2.8.1. 
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Figure 2.8.1: a) α-methylbenzylamine, a primary amine; b) (S)-1-methyltetrahydro-
isoquinoline, a secondary amine; c) (S)-N-methyl-2-phenylpyrrolidine, a tertiary amine. 
 
2.8.1 Enzymes used in the generation of optically pure amines 
2.8.1.1 Transaminases 
Transaminases, also known as aminotransferases, catalyse the biotransformation of 
amines by transferring an amino group from a donor molecule to a ketone, and have 
attracted attention as biocatalysts for either direct asymmetric synthesis from 
prochiral ketones or by kinetic resolution of racemic amines. The α-transaminases 
usually transfer amino groups from biologically-produced α-amino acids to α-keto 
acids, whereas ω-transaminases are usually unable to aminate α-keto acids, but are 
able to aminate aldehydes or ketones. Hailes et al (2010) investigated a ω-
transaminase from Chromobacterium violaceum which is able to convert a range of 
aldehydes and ketones, and successfully used it in the conversion of ketodiols to 2-
amino-1,3-diols (Hailes et al., 2010; Kaulmann et al., 2007; Smith et al., 2010; Smithies 
et al., 2009). The enzyme was also found to be particularly useful in that it could 
accept either the (R)- or (S)-1,3-dihydroxy ketone, but generated the (2S)-amine 
product in >99% ee (Smithies et al., 2009).  
 
Koszelewski et al. (2008) tested various commercially available ω-transaminases with 
ketones as the starting materials for the generation of enantiomerically pure amines. 
Alanine was used as the amino donor, which was converted to pyruvate, and 
presented the problem that the equilibrium lay on the side of the starting material. 
Lactate dehydrogenase was used to reduce pyruvate to lactate, shifting the 
equilibrium to the product. The group was successful in creating both amine 
enantiomers in pure form, depending on which ω-transaminase was used.  The same 
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enzymes were later used with a variety of racemic amines as the starting material, in a 
two-step reaction. Firstly, one ω-transaminase was used in the kinetic resolution of 
one enantiomer to a ketone; and secondly, a ω-transaminase with the opposite 
stereopreference was used to convert the ketone to the remaining amine enantiomer 
(Koszelewski et al., 2009). The enantiomer produced depended on the order in which 
the two ω-transaminases were used. Recombinant transaminases from the soil 
bacterium Bacillus megaterium have also been used for the deracemisation of amines 
(Hanson et al., 2008; Koszelewski et al., 2010). 
 
2.8.1.2 Lipases 
The most commonly used enzyme in DKR processes for the generation of chiral 
amines is C. antarctica lipase B immobilised in an acrylic resin (Parvulescu et al., 2010), 
usually with a metal racemisation catalyst, such as ruthenium, iridium, or palladium 
(Thalén et al., 2009). Selective acylation in a BASF patented process produces an (S)-
enantiomer and an (R)-amide, which can be separated by distillation. The (R)-
enantiomer is then released through basic hydrolysis of the amide (Breuer et al., 
2004). A DKR technique using an (R)-selective lipase and palladium nanoparticles for 
the resolution of primary amines is shown in Figure 2.8.2, which improved on the 
reaction time and yield of earlier techniques (Kim et al., 2007; 2011). 
      
Figure 2.8.2: Dynamic kinetic resolution of primary amines, using an (R)-selective 
lipase and palladium nanoparticles (Kim et al., 2007). 
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2.8.1.3 Lyases 
Phenylalanine ammonia lyase is synthesised by plants to catalyse the reversible 
conversion of L-phenylalanine to trans-cinnamic acid, a precursor of lignin, flavonoids 
and coumarins (Ward & Wohlgemuth, 2010). Phenylalanine ammonia lyase can also 
be used in the synthesis of L-phenylalanine derivatives, by supplying high 
concentrations of ammonia in order that the reverse reaction is catalysed (Gloge et al., 
2000). 
 
 
2.9 Amine oxidases 
2.9.1 Classification of amine oxidases 
Amine oxidases are oxidoreductases, enzyme class EC 1, which catalyse reactions via 
the transfer of electrons. Most amine oxidases are in the subclass EC 1.4.3.X, which is 
comprised of enzymes that act on the CH-NH2 group of donors (EC 1.4), and use 
oxygen as the electron acceptor (EC 1.4.3). Some others are in the subclass EC 1.5.3.X, 
which act on the CH-NH group of donors (EC 1.5), and also use oxygen as the electron 
acceptor (EC 1.5.3). As oxygen is reduced, the process of oxidative deamination also 
produces hydrogen peroxide (see Figure 2.9.1 ). There are four main types of amine 
oxidase: 
1. monoamine oxidases (MAO), EC 1.4.3.4. MAO oxidise primary amines, and also 
some secondary and tertiary amines. These enzymes are flavoproteins. 
2. polyamine oxidases (PAO), EC 1.5.3.13-17. PAO oxidise secondary and tertiary 
amines, and are also flavoproteins. 
3. primary amine oxidases (PrAO), EC 1.4.3.21. PrAO oxidise primary amines only, 
and contain copper. 
4. diamine oxidases, EC 1.4.3.22. These enzymes oxidise diamines, such as 
histamine, as well as some primary amines. They contain copper, and along 
with PrAO were previously known as semicarbazide-sensitive oxidases (EC 
1.4.3.6, now deleted). 
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Figure 2.9.1: Oxidative deamination catalysed by amine oxidase. The amine is 
converted to an imine with the reduction of oxygen, and hydrogen peroxide is 
produced. 
 
The copper-containing amine oxidases catalyse the deamination of biogenic amines, 
and have diverse biological roles. They are responsible for nutrient metabolism in 
prokaryotes, and cell signalling and adhesion in eukaryotes (Kurtis et al., 2011). 
Polyamines are important in the metabolism of prokaryotes and plants; and 
monoamine oxidases enable the assimilation of nitrogen as ammonia in fungi 
(Schilling & Lerch, 1995a), and the regulation of neurotransmitters and deamination of 
dietary amines in higher eukaryotes (Edmondson et al., 2004).  
 
2.9.2 Monoamine oxidases 
The monoamine oxidases of mammals exist in two isoforms, MAO-A and MAO-B, with 
different but overlapping functions. The two forms are distinguished by differences in 
substrate specificity, sensitivity to inhibitors, and hormone regulation (Shih et al., 
2011; Tipton et al., 2004). The proteins share 70% sequence identity and are encoded 
by two distinct genes, although identical intron/exons structures indicate a probable 
origin for both of ancestral gene duplication (Shih et al., 2011). Both isoforms of the 
enzyme are located in the outer mitochondrial membrane, and contain a covalently-
bound flavin adenine dinucleotide (FAD) molecule. FAD is a redox cofactor, which 
accepts two electrons to become reduced to FADH2. The cofactor consists of riboflavin 
(vitamin B2) linked to adenosine diphosphate, and is itself linked by the riboflavin 
moiety to a cysteine residue in the active site of the enzyme (Schilling & Lerch, 1995a). 
 
MAO-B was the first of the two isoenzymes to have its 3-dimensional structure 
studied, using Pichia pastoris as the expression system (Edmondson et al., 2004). The 
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enzyme is a heterodimer, and each subunit has a molecular mass of 58.8 kDa (Schilling 
& Lerch, 1995a) and is 520 amino acids long. The subunits each consist of three 
domains – the membrane-binding domain, the flavin-binding domain, and the 
substrate-binding domain. The membrane-binding domain is an α-helix made up of 27 
residues at the carboxyl terminus of the protein, with an apolar surface to aid 
membrane insertion. The substrate-binding domain consists of two cavities, an 
entrance cavity and the active site, entry to which is controlled by a flexible protein 
loop at the membrane surface. The two cavities connect the opening to the flavin, and 
may be separate or fused, depending on the conformation of the residue Ile99 which 
connects the two (Edmondson et al., 2004). 
 
MAO-A was studied the following year and found to be a monomer (De Colibus et al., 
2005), with a molecular mass of 59.7 kDa (Schilling & Lerch, 1995a). The enzyme has 
only one cavity for the active site. 
 
Pathologies linked to MAO in humans include neurological and psychological illnesses, 
such as anxiety disorders and depression (Riederer et al., 2004). In Alzheimer’s disease, 
levels of prefrontal cortex MAO-B increase by 16%, and prefrontal cortex MAO-A 
decreases by 17%. These changes occur early in the disease onset, and persist at 
similar levels throughout its course (Kennedy et al., 2003). A connection has also been 
made with Parkinson’s disease (Youdim & Bakhle, 2006), as MAO inhibitors for the 
treatment of depressive illness have been found to alleviate the symptoms. 
 
2.9.3 MAO-N 
MAO-N is a soluble, tetrameric flavoprotein, each subunit of which has a molecular 
mass of 55 kDa. FAD is non-covalently bound, and the enzyme itself is not membrane-
bound, but located in peroxisomes. Prior to the discovery of the expression of MAO-N 
by A. niger in 1995, the only amine oxidases found in non-vertebrates had been 
diamine oxidases and polyamine oxidases (Schilling & Lerch, 1995a). 
 
MAO-N is active towards substrates of both MAO-A and MAO-B, and is sensitive to the 
same inhibitory compounds. It is likely therefore that there are structural similarities 
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between the proteins. Differences include the FAD cofactor attachment, which is 
covalently bound in MAO-A and MAO-B, and the location within the cell. However, it 
is probable that MAO-N is an evolutionary precursor of MAO-A and MAO-B, due to the 
similarities in sequence and subunit size, which is 59.7 kDa and 58.8 kDa in MAO-A 
and MAO-B respectively (Schilling & Lerch, 1995a; 1995b). 
 
 
2.10 The laboratory evolution of enzymes 
As biocatalysis has proved useful in many fields, new enzymes are continually being 
sought that can replace traditional methods of synthesis. New enzymes are initially 
identified due to some activity towards the substrate of interest, and can be either 
constructed or homologous genes might be found (Turner, 2009). However, it is likely 
that there will be a need to enhance one or more of the properties of the enzyme, 
such as the catalytic activity, substrate specificity, stability (tolerances to organic 
solvents, temperature, and pH), or selectivity (e.g. enantioselectivity for the synthesis 
of chiral molecules). Methods used to improve the properties of enzymes are 
described below, and can be generally assigned to one of the two broad categories of 
directed evolution and rational design. 
 
2.10.1 Directed evolution 
Directed evolution is the process by which an enzyme undergoes repeated cycles of 
mutagenesis, forming potentially vast libraries from which variants displaying 
enhanced properties are selected for further work. The advantage of directed 
evolution as a method for improving enzymes for specific applications is that no prior 
knowledge of enzyme structure is required, as selection is purely on the basis of 
enhanced properties. Directed evolution can be applied to a wide range of enzymes, 
usually with a high success rate. 
 
The first step in directed evolution is to create a library of genetic variants, for which a 
number of techniques exist. These methods are based either upon the random 
mutagenesis of DNA, or the recombination of genes. Of the former, the error-prone 
polymerase chain reaction (epPCR) is commonly employed due to its ease of use. This 
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method was first used for the evolution of enzymes in 1997, when Reetz and 
colleagues used epPCR for the random mutagenesis of Pseudomonas aeruginosa 
PAO1 lipase (Reetz et al., 1997). The wild-type enzyme was only very slightly 
enantioselective for the (S)-enantiomer of product in the hydrolysis of racemic p-
nitrophenyl 2-methyldecanoate, with an ee of 2%. The group altered the conditions of 
the PCR reaction, for example the Mg2+ ion concentration, in order to introduce 1-2 
errors per lipase gene. Within only four generations, the enantioselectivity had risen 
from 2% ee to 81% ee, using epPCR only. A later group used epPCR to improve the 
specific activity of an Arthrobacter citreus aminotransferase, as well as the 
thermostability of the enzyme, by introducing 17 alterations in amino acid sequence 
over five generations (Martin et al., 2007). Mutations may also be introduced using 
the E. coli XL1-Red mutator strain for gene cloning. Three independent DNA repair 
pathways have been inactivated in this strain by the mutations mutS, which causes 
error-prone mismatch repair (Radman et al., 1980); mutD, whereby DNA polymerase 
III lacks the subunit responsible for 3´-5´ exonuclease activity (Scheuermann et al., 
1983); and mutT, causing an inability to hydrolyse 8-oxo-dGTP (Cox, 1976). The lack of 
these three repair pathways gives a spontaneous mutation rate of around 5000-fold 
greater than the wild-type parent (Greener et al., 1997). Another method to induce 
mutations has been recently developed, known as phage-assisted continuous 
evolution (PACE), by which genes inserted into the M13 bacteriophage are mutated 
when incorporated into the host bacterial cell (Esvelt et al., 2011). Potentially rapid 
and low cost, this method could be applied to enzymes involved in DNA and RNA 
binding, protein binding, and bond-forming catalysis. 
 
The two most common gene recombination methods are DNA shuffling (Stemmer, 
1994), and the staggered extension process (StEP) (Nair et al., 2010; Zhao et al., 1998). 
In DNA shuffling, copies of the gene of choice are randomly fragmented and then 
reassembled using a PCR-like process, leading to the incorporation of point mutations 
in the recombinant genes. The point mutation rate by DNA shuffling is around 0.7%, 
similar to epPCR. The technique was first demonstrated for the evolution of enzymes 
by inducing cefotaxime resistance in E. coli, achieved by introducing six mutations 
over two cycles of recombination (Stemmer, 1994). StEP is a process similar to PCR, 
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but with a very short annealing/extension step, leading to shortened complementary 
strand fragments. With each cycle, the fragments anneal to a different template and 
are further extended. The end result is full-length fragments that consist of sequences 
from numerous different parent templates. When first developed, StEP was used to 
generate thermostable subtilisin E variants from heat-labile wild-type enzymes. An 
initial cycle of epPCR identified five variants with enhanced thermostability, which 
when recombined using StEP lead to the discovery of three mutants with a half-life at 
65°C of 25-50 times that of the wild-type (Zhao et al., 1998). In theory, gene 
recombination methods should be more successful at selecting for advantageous 
mutations, as wild-type genes are used as templates and natural selection has already 
removed any mutations that are deleterious (Tobin et al., 2000). 
 
Following random mutagenesis, semi-rational processes may be employed whereby 
large numbers of mutations in one area are induced by saturation mutagenesis. Site-
directed mutagenesis can then be used to optimise individual amino acid residues, for 
example in the active site, although this does require some knowledge of the 
structure of the enzyme. The first coordination sphere of the active site, which is in 
contact with the substrate, is made up of around 10-15 amino acid residues; the 
second coordination sphere has around 20-30 residues (Turner, 2009). Focussing on 
these residues can help to further improve the properties of an enzyme that has 
already been selected via screening for favourable characteristics (Park et al., 2005). A 
technique known as iterative CASTing (combinatorial active site saturation testing) can 
help to minimise screening by selecting 2-3 amino acid residues in the active site, and 
randomising to form small libraries of mutants (Reetz et al., 2006). However, it is 
possible that by focussing on the active site instead of using further cycles of random 
mutagenesis, opportunities may be lost for greatly enhancing the required 
characteristics. Structurally and functionally important amino acid clusters (mutational 
‘hot spots’) have been identified that exert their influence over a considerable 
distance, which would be difficult to predict using site-specific techniques (Spiller et 
al., 1999). Others have found similar effects, although it appears that targeting the 
active site may often be the most successful strategy (Morley & Kazlauskas, 2005). 
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Screening methods 
On possible disadvantage of directed evolution is the requirement for a high 
throughput screening process following random mutagenesis in order to identify 
variants with enhanced properties. As there are potentially a large numbers of 
variants, a rapid and simple method is preferred, for example the use of a pH indicator 
as a measure of the extent and rate of reaction (Turner, 2009). Approaches include 
fluorogenic and chromogenic assays (Wahler & Reymond, 2001), genetic selection 
methods (Reetz et al., 2008), and agar-based selective methods (Leemhuis et al., 
2009). 
 
2.10.2 Rational design 
In contrast to the random nature of mutations by directed evolution, rational design is 
the insertion of specific mutations at designated sites with the intentional of altering 
function in a predetermined manner. As such, knowledge of the structure and 
mechanisms of the protein in question is required. If the primary sequence of a 
protein is not precisely known, homology modelling may be used (Cho et al., 2008), or 
techniques such as iterative saturation mutagenesis (Reetz & Carballeira, 2007), 
whereby repeated cycles of random mutagenesis are targeted at a specific area. 
 
Lipases are a common target for rational design, as they are popular enzymes for use 
in biocatalysis. By comparing C. antarctica lipase B with two other hydrolases for 
catalysing the transacylation of acrylates, Syrén et al (2010) were able to engineer a 
mutant with three times the activity of the wild-type enzyme. In another study, the 
redesign of the stereoselectivity pocket of C. antarctica lipase B created a general 
esterification catalyst, which had previously been hampered by the slow conversion of 
the (S)-enantiomer of the secondary alcohol substrate (Liu et al., 2010). 
 
Rational design of enzymes is commonly used in conjunction with computational 
design, whereby mutations are modelled in silico before being confirmed 
experimentally. Röthlisberger et al (2008) created eight novel kemp elimination 
catalysts using computer modelling, using random mutagenesis to increase catalytic 
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efficiency 200-fold. Later improvements to correct features missing from these 
enzymes increased catalytic efficiency 400-fold (Khersonsky et al., 2011).  
 
 
The most common reasons for using directed evolution and rational design are to 
increase the promiscuity of the biocatalyst, to improve enantioselectivity, or to 
increase its specificity towards minor substrates. A biocatalyst may acquire the ability 
to catalyse alternative reactions by neutral drift, whilst maintaining its original 
function. Combined rational design and directed evolution approaches have been 
employed to first redesign sections of a protein scaffold, then activity is fine-tuned 
using random mutagenesis and screening. Such approaches have generated enzymes 
that have switched catalytic function from glyoxalase II to β-lactamase activity (Park et 
al., 2006), and from esterase to epoxide hydrolase activity (Jochens et al., 2009). 
 
Increased enantioselectivity is a valuable property in a biocatalyst, particularly if the 
reaction cannot be catalysed in any other way. The rational design of phenylacetone 
monooxygenase led to the discovery of mutants which showed unusually high activity 
and enantioselectivity in the oxidative kinetic resolution of a variety of substrates 
which are not accepted by the wild-type enzyme. The group used bioinformatics data 
and a knowledge of the enzyme structure to identify sites suitable for mutagenesis 
(Reetz & Wu, 2009). The same group has also completely reversed the 
enantioselectivity of P. aeruginosa lipase, by using high error rate epPCR and DNA 
shuffling (Zha et al., 2001). 
 
Increasing the specificity of a biocatalyst can enable the enzyme to accept alternative 
substrates whilst maintaining its original function, although this may be at the 
expense of the activity towards the original substrate. One such example is the 
directed evolution of the phenylalanine dehydrogenase of B. sphaericus, an enzyme 
which normally catalyses the oxidative deamination of phenylalanine to the 
corresponding keto acid. The switching of specificity to the non-natural amino acid 
propargylglycine led to a modest activity for the new substrate, and a reduction for 
the original (Chen & Engel, 2009). Cho et al (2008) however were able to rationally 
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redesign an ω-aminotransferase obtained from Vibrio fluvialis, increasing the 
specificity of two mutants which showed catalytic activity towards a broad range of 
aliphatic amines without losing the original enantioselectivity and activities toward 
aromatic amines. 
 
 
2.11 Directed evolution of MAO-N for the deracemisation of amines 
In 2002, the Turner group at the University of Edinburgh reported a conceptually 
novel method for the preparation of enantiomerically pure chiral amines (Alexeeva et 
al., 2002). Using the monoamine oxidase of A. niger, MAO-N (Schilling & Lerch, 1995a), 
the group used directed evolution to create a biocatalyst capable of catalysing the 
enantioselective oxidation of amines to the corresponding imine, which is then non-
selectively reduced back to the amine using a chemocatalyst. With further cycles, 
complete deracemisation is achieved (Figure 2.11.1). 
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Figure 2.11.1: The cyclic deracemisation of the primary amine α-methylbenzylamine, 
using the (S)-selective biocatalyst MAO-N variant and the non-selective chemocatalyst 
ammonia borane. 
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MAO-N first attracted interest due to reports of its high catalytic activity towards 
simple aliphatic amines, such as benzylamine (kcat ~500 min
–1) (Sablin et al., 1998). In 
order to engineer a biocatalyst with high activity towards primary amines, α-
methylbenzylamine was chosen as a model substrate for screening. As the activity of 
the enzyme was higher towards the (S)-enantiomer, it was decided to engineer a 
biocatalyst with both improved activity and enantioselectivity. The mao-N gene was 
first ligated into the pET16-b plasmid, and the E. coli XL1-Red mutator strain used to 
create a library of variants.  Three independent DNA repair pathways have been 
inactivated in this strain of E. coli, giving a spontaneous mutation rate of around 5000-
fold greater than the wild-type parent (Greener et al., 1997). Screening of the library 
was initially by the development of a colorimetric assay applied directly to the 
colonies. The colonies were transferred to a nitrocellulose filter, and treated with 
either the (S)- or (R)-enantiomer and 3,3’-diaminobenzidine (DAB). After incubation at 
37°C, any MAO-N activity showed up as pink colonies. 
 
After several rounds of random mutagenesis, a clone was selected for its superior 
activity (47-fold higher than WT) and enantioselectivity (~6-fold higher than WT). 
Sequencing showed one mutation, Asn336Ser. The later introduction of a second 
mutation, Met348Lys, produced higher activity and expression levels, with some 
activity towards the secondary amine 1-methyltetrahydroisoquinoline (MTQ) (Carr et 
al., 2003). An additional two mutations, Arg259Lys and Arg260Lys, further improved 
expression levels, and the fifth mutation Ile246Met improved the kcat towards (S)-MTQ 
5.5-fold (Carr et al., 2005). A later variant known as MAO-N-D5 which also had five 
mutations (Ile246Met/Asn336Ser/Met348Lys/Thr384Asn/ Asp385Ser) was examined 
towards tertiary amines, and out of 10 different substrates good activity towards four 
was found, with excellent activity towards N-methyl-2-phenylpyrrolidine (Dunsmore 
et al., 2006). 
 
The random mutagenesis of MAO-N had been carried out without prior knowledge of 
the structure of the protein. However, in order to determine why the random 
mutations had had the observed effects and to identify possible future improvements, 
it was necessary to solve the 3-dimensional structure of MAO-N-D5. X-ray 
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crystallography indicated that the MAO-N-D5 enzyme crystallises as a dimer (Atkin et 
al., 2008b), and the 3-dimensional structure showed the presence of two channels 
from the surface of the protein which intersected at the active site. These channels, 
part of the second coordination sphere of the active site, proved to be the location of 
four of the mutations (Atkin et al., 2008a). It is thought that these mutations have 
some effect on the access of the substrate, or the release of the product. 
The results of this final study demonstrate the ability of directed evolution to generate 
superior biocatalysts, without prior knowledge of enzyme structure. Using rational 
design, it is unlikely that the same residues would have been chosen, as their success 
in improving activity and enantioselectivity could not be predicted (Turner, 2009). 
 
 
2.12 Immobilisation of biocatalysts 
Biocatalysts are immobilised in order to confine the enzymes or cells to one or more 
defined zones, whilst maintaining prolonged catalytic activity and if appropriate the 
viability of the cell. When used in this way, biocatalysts can be more easily removed 
from the reaction vessel, and may be reused or used in a continuous flow reactor. The 
biocatalyst is concentrated in one area which may help to improve activity, and as the 
cells are usually not growing there are fewer secondary reactions which might 
otherwise cause interference.  
 
The different methodologies used for cell immobilisation include adsorption or 
bonding to a solid surface, entrapment in a matrix, or physical separation by means of 
a permeable membrane. A common method is matrix entrapment due to its ease of 
use, although there may however be problems with mass transfer of the substrate 
and product. The different types of matrix available include hydrogels, such as calcium 
alginate and chitosan; thermogels, such as agar or agarose; and synthetic polymers, 
such as polyacrylamide and sol-gel.  
 
2.12.1 Alginate 
Alginate is a biopolymer, produced by many algal species, and is made up of varying 
proportions of β-D-mannuronic and α-L-guluronic acids. Its popularity as an 
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immobilisation matrix stems from its ease of use, mild conditions, and general 
applicability. Cells are mixed with a sodium alginate solution, which is then added 
drop-wise to a solution of polyvalent cations, usually Ca2+. Ionic crosslinks form 
between carboxylic acid moieties and the divalent cations, and the droplets 
immediately solidify, entrapping the cells in a gel lattice. The high porosity of the 
beads reduces the problems of mass transfer limitations, although it does make the 
method unsuitable for purified enzymes (Smidsrod & Skjak-Braek, 1990). 
 
Due to its structure of ionic crosslinking, alginate is susceptible to destabilisation by 
cation scavengers, such as phosphate, sodium citrate, and EDTA (Smeds & Grinstaff, 
2001; Smidsrod & Skjak-Braek, 1990), although stability is improved with higher levels 
of guluronate (Smidsrod & Skjak-Braek, 1990). One advantage of its ease of 
dissolution is the release of entrapped cells if required.  
 
In a recent study, it was demonstrated that cells encapsulated in alginate could be 
stored at 4°C for three months without a decrease in enzyme activity (Dey & Roy, 
2011). The entrapped cells also showed a higher tolerance to temperature and pH 
than the free cells. 
 
2.12.2 Chitosan 
Chitosan is a nontoxic natural polymer, obtained by extensive deacetylation of chitin, 
which is found in the shells of crustaceans, molluscs, the cell walls of fungi, and the 
cuticle of insects (Peniche et al., 2003). It is a weak cationic polysaccharide composed 
of glucosamine and N-acetylglucosamine units, and is a suitable entrapment matrix if 
alginate cannot be used, for example if a phosphate buffer is to be used during 
biocatalysis. The method for producing chitosan beads is similar to that used for 
alginate, whereby a solution of chitosan adjusted to pH 5.5 with acetic acid is mixed 
with cells and dropped into a crosslinking solution of polyvalent ions. Ionic crosslinking 
occurs if the chitosan-acetate solution is dropped into a solution of pH <6, as the 
majority of the NH2 groups of chitosan are protonated. If dropped into a solution of 
pH 7.5, crosslinking still takes place but the chitosan is mainly precipitated. The latter 
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method is suitable if the beads are to be used in reactions taking place at pH >7.5, but 
these beads will be unstable at lower pH (Vorlop & Klein, 1981). 
 
In a study comparing alginate and chitosan as immobilisation matrices for 
Pseudomonas spp., the latter had greater mechanical stability. With both matrices the 
enzyme activity was reduced due to mass transfer limitations, but this was 
compensated for by the long-term viability of the cells (Stocklein et al., 1983). 
 
2.12.3 Polyacrylamide 
Polyacrylamide gels attract interest as immobilisation matrices due to their improved 
mechanical properties, although the neurotoxicity of the acrylamide monomer 
precursor should be taken into consideration. The acrylamide monomer is cross-linked 
using bis-acrylamide, at a ratio of 29:1, a reaction which is initiated using ammonium 
persulfate. Once the gel has set, it can be cut shredded or cut into cubes before use. 
Studies have demonstrated the ability of polyacrylamide-immobilised bacterial cells to 
remove toxic metals from waste water (Macaskie, 1990; Tucker et al., 1998). 
 
2.12.4 Sol-gel 
Silica sol-gels are created by the polymerisation of two silica sources, one of which is a 
colloidal silica (sol), triggered by adjusting the pH to form a gel. Following drying, an 
inert ceramic matrix is formed which is mechanically very strong and protects cells 
from external stresses. However, a high osmotic pressure due to sodium ions and 
drying effects during sol-gel formation can be detrimental to cell viability, although 
the addition of glycerol or gelatin can protect against these effects (Nassif et al., 2002; 
2003). The use of aqueous instead of alkoxide precursors is also preferable for the 
encapsulation of bacteria, as this route does not release alcohol. The leakage of the 
cytoplasmic enzyme β-galactosidase when alkoxides are used indicates membrane 
damage, probably from dissolution of the membrane phospholipids (Coiffier et al., 
2001; Nassif et al., 2003). Bacteria can be encapsulated in a combination of sol-gel and 
alginate, combining the advantages of alginate (ease of use and mild conditions) with 
the mechanical strength of silica (Livage & Coradin, 2006). 
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Chapter 3: Materials and Methods 
Methods 
3.1 Bioreduction of palladium 
3.1.1 Bioreduction of Pd(II) by E. coli K12 
The bioreduction of Pd(II) by E. coli was first performed using the standard laboratory 
strain K12, which is a useful model organism since it is facultatively anaerobic and has 
well-defined molecular tools to elucidate reaction mechanisms under aerobic and 
anaerobic conditions. The following method used to generate the palladium 
bionanoparticles (‘palladisation’) was adapted from that used by Lloyd & Macaskie 
(1998a). 
 
Starter cultures: Bacterial stocks maintained at -80C were plated onto LB (Luria-
Bertani) agar and incubated at 37C overnight. 50 ml LB broth in a 500 ml Erlenmeyer 
flask was inoculated with a single isolated colony of E. coli K12 and incubated for 18 
hours at 37C, shaking at 180 rpm. 
 
Aerobic cultures: An 11 ml starter culture was added to 99 ml LB broth in a 1 L 
Erlenmeyer flask. Flasks were incubated for 24 hours at 37C, shaking at 180 rpm. The 
oxygen saturation of a 5 ml aliquot of the broth culture was measured after 24 hours 
of incubation using an Oakton D06 Acorn Series dissolved oxygen meter. 
 
Anaerobic cultures: An 11 ml starter culture was added to 97.9 ml LB broth containing 
20 mM sodium fumarate and supplemented with 1.1 ml 50% vol/vol glycerol in a 120 
ml bottle, sealed with a butyl rubber stopper. Bottles were incubated for 24 hours at 
37C, shaking at 180 rpm. The oxygen saturation of a 5 ml aliquot of the broth culture 
after 24 hours of incubation was measured under anaerobic conditions using an 
Oakton D06 Acorn Series dissolved oxygen meter. 
 
Although a popular method for the aerobic cultivation of bacteria, flask cultures can 
become oxygen limiting within a few hours, and the generation of acidic by-products 
as a result of overflow metabolism can reduce the pH to below optimum growth 
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conditions. The dissolved oxygen content also decreases rapidly once shaking is 
stopped, which can reduce the stability of plasmids. However, after 9 hours of 
incubation the oxygen level rises again and remains high, possibly due to decreased 
respiration as a result of cell death (Vasala et al., 2006). The flask-grown shaking 
culture had a dissolved oxygen content of 76% (based on two identical readings on 
two separate occasions), indicating that the culture was growing aerobically. The pH 
of the aerobic cultures had increased from 7.2 (uninoculated broth) to 7.7-7.9 at 24 
hours of incubation. The anaerobic culture had a dissolved oxygen content of only 
2.8%, which is below the level required for anaerobic growth conditions (Vasala et al., 
2006). However, the aerobic culture did undergo a period of anaerobiosis, based on 
dissolved oxygen content readings of 2.5% at two hours incubation, and 2.4% at three 
hours incubation. 
 
The optical density of cultures were measured using a biochrom WPA Spectrowave 
S1200 Diode Array Spectrophotometer.  Aerobically-grown starter cultures reached an 
OD600 of around 5 after 18 hours of shaking incubation at 37°C. Aerobic broth cultures 
typically reached an OD600 of 5-6 at 24 hours of shaking (180 rpm) incubation at 37°C, 
yielding a biomass of around 0.7 g ml–1 (mass of the wet pellet) from 100 ml liquid 
culture. This corresponded to a dry weight of 0.12 g. Anaerobic cultures reached an 
OD600 of ~2 following 24 hours of static incubation at 37°C, with a biomass yield of 
~0.25 g ml–1. 
 
Palladisation using hydrogen as the electron donor: Each broth culture was divided 
between two 50 ml Falcon tubes and washed three times in 20 ml MOPS-NaOH 
(morpholinepropanesulfonic acid) buffer, 20 mM at pH7.6 after centrifugation for 20 
minutes at 2500 g in a Boeco C-28 A centrifuge. Cell pellets were adjusted to a mass of 
250 mg, based on the wet cell pellet, and resuspended MOPS-NaOH to a volume of 1 
ml. Each cell pellet was resuspended in 25 ml buffer with 1 mM sodium 
tetrachloropalladate in 30 ml bottles sealed with butyl rubber stoppers. Bottles were 
incubated at 30C for 1 hour for the Pd(II) to biosorb to the cells (Baxter-Plant et al., 
2003), then purged with H2 for 5 minutes, with H2 allowed to fill the headspace. 
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Palladisation using formate as the electron donor: The broth cultures were prepared 
in the same way, and each cell pellet was resuspended in 22.5 ml MOPS-NaOH buffer 
with 1 mM sodium tetrachloropalladate. Following incubation at 30C for 1 hour, 2.5 
ml 10 mM sodium formate was then added to the bottle to initiate bioreduction of 
the Pd(II). Bottles were incubated at 30C until Pd(II) reduction occurred. 
 
3.1.2 X-ray diffraction (XRD) analysis 
The cells were coated in a black precipitate forming bioPd within a few minutes in 
bottles purged with H2, and in less than 30 minutes in bottles containing formate. The 
palladised cells settled out leaving a clear colorless supernatant. In order to confirm 
the presence of palladium in the black precipitate, XRD analysis was performed. The 
black precipitate was washed once in acetone and air-dried before investigation. The 
measurements were performed on a Bruker D8 Advance diffractometer, using Cu K 
alpha1 radiation. The samples were scanned from 5-70 degrees 2theta in steps of 0.2 
degrees, with a count time of 2 seconds per step. 
 
3.1.3 Characterisation of palladium nanoparticles by extended X-ray absorption fine 
structure (EXAFS) 
The palladium nanoparticles were analysed using extended X-ray absorption fine 
structure (EXAFS). Cell/Pd/formate suspensions were prepared as above using E. coli 
BL21(DE3), as this was the strain of choice for later transformation with the mao-N-D5 
gene. Aliquots of the cell/Pd/formate suspension were taken at times 0 and 30 
minutes, and 1, 3 and 4 hours from the addition of formate, and frozen immediately in 
liquid nitrogen. The reduction of Pd(II) to Pd(0) was demonstrated using EXAFS, 
performed at the European Synchrotron Radiation Facility (ESRF), in Grenoble, France. 
The samples were transported to the synchrotron at ESRF on dry ice, where they were 
thawed and injected immediately into sample holders, before freezing once more in 
liquid nitrogen and placing into the beam. X-ray absorption data were collected on 
beamline BM29 at the Pd K–edge in the energy range 24,200 – 24,900 eV. Data were 
recorded at low temperature (77 K) and under vacuum to reduce the thermal Debye-
Waller factor and prevent oxidation. A Si(111) double crystal monochromator was 
used, calibrated with a Pd foil, and the spectra were collected in fluorescence mode 
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using a 13-element solid-state detector. A reference spectrum of a palladium foil was 
recorded in transmission mode on station 9.3 at the SRS Daresbury. The data were 
background subtracted and the EXAFS spectra fitted in DL_Excurv 
(http://www.cse.scitech.ac.uk/cmg/EXCURV/) using full curved wave theory (Gurman 
et al., 1984). 
 
3.1.4 Use of transmission electron microscopy (TEM) with energy dispersive X-ray 
spectroscopy (EDX) to determine location of palladium nanoparticles 
TEM was performed on E. coli BL21(DE3) cells which had been palladised using both 
hydrogen and formate, in order to determine the location of the nanoparticles. It was 
hoped that the location of the nanoparticles would give some indication as to the 
enzymes involved in their bioreduction, as following the bioreduction of Pd(II) by D. 
fructosovorans, nanoparticles were seen in the periplasm of the cell wall. This is the 
location of membrane-bound hydrogenases in D. fructosovorans, which were later 
demonstrated to be involved in bioreduction by the use of hydrogenase-negative 
mutants (Mikheenko et al., 2008). As Pd(II) was reduced by aerobically-grown cultures 
of E. coli, it was expected that the nanoparticles would be deposited in the periplasm, 
which is the location of the aerobic formate dehydrogenase, FDH-O. However, the 
reduced palladium was precipitated predominantly in the extracellular matrix of the 
cultures, which gave no clues as to the biological involvement of the cell in Pd(II) 
bioreduction. 
 
Preparation of the cell pellets for TEM was performed at the University of Birmingham, 
School of Biosciences. Following metal challenge, cell pellets were rinsed twice with 
deionised water, fixed in 2.5% (wt/vol) glutaraldehyde, centrifuged for 5 minutes at 
15,996 g, resuspended in 1.5 ml of 0.1 M cacodylate buffer (pH 7) and stained in 1% 
osmium tetroxide in 0.1 M phosphate buffer, pH 7 (60 min). Cells were dehydrated 
using an ethanol series (70, 90, 100, 100, 100% dried ethanol, 15 min each) and 
washed twice in propylene oxide (15 min, 9500 g). Cells were embedded in epoxy 
resin and the mixture was left to polymerise (24 h; 60°C). Sections (100-150 nm thick) 
were cut from the resin block, placed onto a copper grid and viewed with a JEOL 
1200CX2 TEM, accelerating voltage 80 keV. Energy dispersive X-ray spectroscopy (EDX) 
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was performed on electron-dark areas, to confirm the presence of palladium. The EDX 
trace and the peaks seen are shown in Figure 3.1. 
 
 
 
Figure 3.1: EDX trace showing the presence of palladium in the electron-dense 
precipitates seen by TEM. Peaks are also seen for carbon (far left of trace, >500 
counts), copper (composition of the grids used), and osmium (osmium tetroxide was 
used to stain the sections). The unlabelled peak at around 14 keV does not correspond 
to any elements and is not recognised by the detector. It is therefore most likely a 
false peak, and may represent a sum peak (where two X-rays have reached the 
detector at the same time), or an escape peak (where an X-ray has knocked an 
electron out of the detector material). 
 
3.1.5 Formate-dependent bioreduction of Pd(II) by different strains of E. coli 
The bioreduction of Pd(II) by aerobically-grown cultures of E. coli indicates the 
possible involvement of the aerobic formate dehydrogenase, FDH-O. In order to 
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investigate the possible role of FDH-O and other hydrogenase and formate 
dehydrogenase enzymes, the rates of reduction by six additional different E. coli 
strains (Table 3.2, page 79) and a series of controls – killed (autoclaved) cells 
(MC4100), cell-free suspension, and live cells (MC4100) unsupplemented with formate 
– were compared. The strains were ‘palladised’ as above using aerobically-grown 
cultures, using 50 μg ml–1 kanamycin as the selective agent for JW2682 and JW3865, 
and 50 μg ml–1 apramycin as the selective agent for MC4100 ΔmoaA. Aliquots were 
taken at timed intervals, and centrifuged for 5 minutes at 15,996 g to clarify the 
supernatant. 100 μl supernatant was added to 100 μl 70% nitric acid, and 3.1 ml 
deionised water was added to give a final concentration of ~2% nitric acid. The 
samples were filtered and the Pd(II) remaining in solution was measured using 
inductively coupled plasma mass spectrometry (ICP-MS) with the Agilent 7500cx. 
 
All strains except BL21(DE3) were from the culture collection of Professor Frank 
Sargent at the College of Life Sciences, University of Dundee. Strain BL21(DE3) was 
obtained from Invitrogen, Paisley, UK. Strain FTD128 has an in-frame deletion of the 
fdhE gene, which expresses an accessory protein required to locate the FDH-O and 
FDH-N enzymes to the cytoplasmic membrane. Strains JW2682 and JW3865 were 
created as part of the Keio collection (Baba et al., 2006) by the in-frame deletion of 
the hypF and fdoG genes respectively. The hypF gene encodes a hydrogenase 
maturation protein and the fdoG gene encodes α-subunit of FDH-O. Strain MC4100 
ΔmoaA was created by disruption of the moaA gene which encodes the molybdenum 
cofactor biosynthesis protein A, using the method of Datsenko and Wanner (2000) 
whereby PCR products are used to disrupt the gene of choice by recombination using 
the plasmid-borne phage λ Red recombinase. 
 
As ICP-MS can be used to measure palladium removal from solution, but not Pd(II) 
reduction to Pd(0), the precipitation of Pd(II) in the control without formate gave a 
false-positive result. Also, in two of the experiments the nanoparticles formed were so 
small as to be impossible to remove from the supernatant by centrifugation or 
filtration. As a result, the ICP-MS analysis was unable to distinguish between Pd(II) in 
solution and Pd(0), wrongly giving the impression that bioreduction had not taken 
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place. A more accurate method of determining Pd(II) reduction would be to use 
synchrotron radiation, but this method is not practical due to the time taken to secure 
a beamline allocation. 
 
3.1.6 Investigation of palladium reduction using QEXAFS 
In order to determine whether Pd(II) was reduced directly to Pd(0) or if intermediate 
species were formed, the reduction of Pd(II) to Pd(0) was analyzed by quick-scanning 
extended X-ray absorption fine structure (QEXAFS) in an in situ reduction experiment 
on beamline BL21 at the Swiss Light Source (SLS) synchrotron facility. E. coli strains 
BL21(DE3), MC4100, and FTD128 were grown aerobically as described previously, 
frozen and transported to the SLS on dry ice. After thawing, the cells were 
resuspended in 25 ml 20mM MOPS-NaOH buffer (pH 7.6) and challenged with 1 mM 
Pd(II), in a 5 cm tube placed longitudinally in the beam (see Figure 3.2). The tube was 
purged with hydrogen for 30 seconds at 10 minute intervals, until the sample had 
turned completely black. The reduction of the Pd(II) was slower than under normal 
laboratory conditions, as hydrogen could not be continuously supplied due to the 
necessity of vacating the experimental area during use of synchrotron radiation on the 
beamline. Hydrogen was therefore supplied for only 30 seconds between 
measurements. The experiment could not be repeated using formate as there was no 
possibility of incubating the samples whilst in the beam. 
 
 
Figure 3.2: Cells challenged with palladium on beamline BL21, Swiss Light Source. 
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Scans were performed at a rate of 4 scans per minute, for 10 minutes at a time. X-ray 
absorption data were collected in the energy range 23,970 – 25,727 eV. Data were 
recorded in transmission, in fast-scanning mode, each run accumulating 118 spectra 
over 10 minutes. The spectra were isolated, the data range cut to 22,210 – 24,900 eV, 
and the number of points in each spectrum reduced (and signal-to-noise improved) by 
averaging adjacent groups of points to a grid finely spaced over the Pd K-edge and 
after the edge evenly spaced in k-space. The individual spectra were summed into ten 
groups of ten and one group of eight for each run. This was repeated until all spectra 
had been processed. 
 
The summed data were background subtracted in the Daresbury program EXBACK. 
The X-ray absorption near-edge spectroscopy (XANES) spectra were generated by 
adding back in the E0 defined in the subtraction routine. 
 
3.1.7 Transmission electron microscopy (TEM) of mutant E. coli strains 
TEM of the different strains of E. coli was performed to determine whether the 
missing enzymes had any influence on the site of Pd(0) nanoparticle deposition. 
Sections of the metal-loaded cells of strains MC4100 and FTD128 (formate-dependent 
Pd(II) bioreduction) were provided by EM facility in the Faculty of Life Sciences, 
University of Manchester. The bacteria were fixed in primary fixative (2.5% 
glutaraldehyde and 4% formaldehyde in 0.1M sodium cacodylate buffer at pH7.4) and 
secondary fixative (1% osmium tetroxide and 1.5% potassium ferrocyanide in 0.1M 
sodium cacodylate buffer at pH7.4) and dehydrated in a graded acetone series (30 
minutes each in 50%, 70%, 90% and three changes at 100%) before embedding in 
TAAB LV medium epoxy resin. Sections were imaged using a FEI Tecnai12 Twin 
transmission electron microscope. Other bacterial strains were prepared and imaged 
by the University of Birmingham, as described previously. 
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3.2 Engineering a whole cell biometallic catalyst 
3.2.1 Transformation of E. coli BL21(DE3) with pET-16b plasmid containing mao-N-
D5 insert 
Strains and plasmid: E. coli BL21(DE3) and E. coli TOP10/P3 cells were obtained from 
Invitrogen. The pET16-b plasmid containing the mao-N-D5 insert and an ampicillin 
resistance gene was obtained from Dr Andrew Ellis at the Manchester Interdisciplinary 
Biocentre. Bacterial isolates were stored at -80C, and the plasmid was stored at -20C. 
 
Transformation: E. coli BL21(DE3) chemically competent cells were transformed 
according to the supplier’s instructions, using approximately 100 ng (2 μl) of plasmid. 
Transformed BL21(DE3) cells were subcultured onto LB-ampicillin agar, and incubated 
overnight at 37C before storage at 4C for a maximum of 1 week. 
 
3.2.2 Preparation of biocatalyst 
Starter culture: 50 ml LB-ampicillin broth in a 500 ml Erlenmeyer flask was inoculated 
with a single isolated colony of transformed E. coli BL21(DE3) and incubated for 18 
hours at 37C, shaking at 180 rpm. 
 
Aerobic cultures: An 11 ml starter culture was added to 99 ml LB-ampicillin broth in a 
1 L Erlenmeyer flask. Flasks were incubated for 24 hours at 37C, shaking at 180 rpm. 
Each broth culture was then divided between two 50 ml Falcon tubes and washed 
three times in 20 ml MOPS-NaOH buffer, 20 mM at pH7.6 after centrifugation for 20 
minutes at 2500 g. Cell pellets were adjusted to a mass of 250 mg based on the wet 
cell pellet, and resuspended in MOPS-NaOH to a volume of 1 ml. Aliquots were stored 
at -20°C. 
 
3.2.3 Catalytic activity of biocatalyst 
Frozen transformed cells were thawed and added to 8 ml 12.5 mM racemic MTQ, 
from a stock solution made up in 0.1 M potassium phosphate buffer at pH 7.6. 
Additional potassium phosphate buffer (1 ml) was added to bring the volume of the 
reaction mixture to 10 ml. The vessel used was a 120 ml gas bottle sealed with a butyl 
rubber stopper, and the reaction was allowed to proceed in air at 37°C, with shaking 
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at 225 rpm. Samples were taken as required, by removing 550 μl in triplicate, 
centrifuging for 20 minutes at 2500 g and storing 500 μl of the supernatant at -20°C in 
a 2 ml centrifuge tube before extraction with methyl-tert-butyl ether (MTBE).  
Solvent extraction: The pH of the samples was first increased to >12 by the addition 
of 20 μl 10N sodium hydroxide, in order to make the substrate and product more 
soluble in MTBE. 1 ml MTBE was then added, and the samples vortexed for 30 seconds 
before centrifuging for 5 minutes at 15,996 g to ensure complete separation of the 
phases, with the MTBE layer on the top. This layer was removed using a glass pipette, 
and transferred to an eppendorf tube containing ~50 mg anhydrous sodium sulfate, to 
ensure complete removal of water from the sample. The samples were centrifuged for 
a few seconds, and the supernatant transferred to an HPLC vial and the MTBE allowed 
to evaporate under a flow of nitrogen, leaving behind a clear colourless oil.  
HPLC analysis: The samples were resuspended in 200 μl isohexane prior to testing by 
normal phase chiral HPLC on an Agilent 1200 chromatograph, using a Daicel Chiralpak 
AD-H 4.6 mm x 250 mm column, at a flow rate of 1 ml min-1 for 20 minutes at 40°C 
with a mobile phase of 88% isohexane, 2% ethanol, and 10% isohexane containing 
0.5% diethylamine. The analytes were detected by UV-Vis spectroscopy, at 
wavelengths of 220 nm (MTQ), and 254 nm (MDQ).  
 
Relative standard deviation: The relative standard deviation (RSD) of the data was 
2.8%, calculated from three separate measurements using the following equation: 
 
 
(Equation 3.1) 
 
3.2.4 Catalytic activity of Pd(0) nanoparticles 
Pd-loaded untransformed E. coli BL21(DE3) cells were prepared as previously (section 
3.1.1), using hydrogen as the electron donor. Cells were washed once in MOPS-NaOH 
buffer and cell pellets were adjusted to a mass of 250 mg based on the wet cell pellet 
before resuspending in MOPS-NaOH buffer to a volume of 1 ml. Aliquots were stored 
at -20°C. 
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Reduction of MDQ using formate as the electron donor: Frozen transformed cells 
were thawed and added to 8 ml 12.5 mM MDQ, from a stock solution made up in  
0.1 M potassium phosphate buffer at pH 7.6, and 1 ml 70 mM sodium formate in 
buffer. The vessel used was a 120 ml gas bottle sealed with a butyl rubber stopper, 
and the reaction was allowed to proceed in air at 37°C, with shaking at 225 rpm. 
Samples were taken as required, by removing 550 μl in triplicate, centrifuging for 20 
minutes at 2500 g and storing 500 μl of the supernatant at -20°C before extraction 
with MTBE and analysis by HPLC. Reduction of MDQ was complete within one hour. 
 
Reduction of MDQ using hydrogen gas as the electron donor: Frozen transformed 
cells were thawed and added to 8 ml 12.5 mM MDQ, from a stock solution made up in 
0.1 M potassium phosphate buffer at pH 7.6, in a 120 ml gas bottle. Additional 
potassium phosphate buffer (1 ml) was added to bring the volume of the reaction 
mixture to 10 ml, and the bottle was sealed with a butyl rubber stopper. The bottle 
was sparged with H2 for 90 seconds, before incubation at 37°C with shaking at 225 
rpm. Samples were taken as required, by removing 550 μl in triplicate, centrifuging for 
20 minutes at 2500 g and storing 500 μl of the supernatant at -20°C before extraction 
with MTBE and analysis by HPLC. Reduction of MDQ was complete within 30-40 
minutes. 
 
3.2.5 Integration of processes for deracemisation 
Deracemisation with sodium formate as the electron donor: The two reactions were 
combined by using palladised transformed cells in the reaction mixture, and with the 
addition of 70 mM sodium formate (final concentration). The bottles were incubated 
as above. 
 
Despite the rapid conversion of the starting materials in both the oxidation and 
reduction experiments, when initially combined into one system and incubated for 24 
hours, deracemisation did not proceed beyond the initial oxidation step. This was due 
to the unexpected formation of another product from MDQ by further chemical 
oxidation (Figure 3.3). This molecule was identified as 1-methylisoquinoline (MIQ) 
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using reverse-phase LC-MS. The sample was dissolved in 200 μl acetonitrile and water 
in a 1:1 ratio, and run on an Agilent 1100 LC / MSD SC using a Phenomenex Luna C18 
(2) 150 x 4.60 mm 3 μm column, at a flow rate of 1 ml min-1 with a mobile phase of 2% 
acetonitrile and 98% water, ramping to 98% acetonitrile over 30 minutes. 
 
 
Figure 3.3: HPLC traces, showing trace soon after start of oxidation (blue trace) with 
large peaks for (S)-MTQ (retention time 10.35 minutes) and (R)-MTQ (12.03 minutes) 
and small peaks for MDQ (8.95 minutes) and MIQ (10.1 minutes); and after 3 hours of 
incubation at 37°C (red trace), showing large peaks for MDQ and MIQ, no peak for (S)-
MTQ, and no change to the peak for (R)-MTQ. 
 
Deracemisation with hydrogen as the electron donor: The two reactions were 
combined by using palladised transformed cells in the reaction mixture. Oxidation and 
reduction steps were performed as separate cycles, by flushing the vessel alternately 
with air or hydrogen. The reaction vessel was a 120 ml gas bottle with a 10 ml reaction 
volume, providing a 110 ml headspace. The vessel was first flushed with nitrogen to 
avoid the mixing of air and hydrogen. Based on the initial separate oxidation and 
reduction experiments, each oxidation step was two hours long, and each reduction 
step was 45 minutes. Samples were taken at the end of each reduction step, for 4 
cycles. The pH of the reaction supernatant following the biotransformation was 7.5, 
indicating that it was still in the range of activity for the MAO-N-D5 enzyme which has 
an optimum activity at pH 7.5-8.1 (Reiss, 2008), and not detrimental to the viability of 
the biocatalyst. Production of MIQ was not observed when hydrogen gas was used 
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instead of formate as the electron donor for the reduction step, possibly as hydrogen 
drives the reduction of MDQ at a faster rate than formate (see section 3.2.4). 
 
3.2.6 Re-use of cells 
Palladised transformed cells were used in a 5-cycle biotransformation as described in 
section 3.2.5, using hydrogen as the electron donor. The used cells were then 
recovered by centrifuging for 20 minutes at 2500 g, and resuspended to 1 ml in 20 
mM potassium phosphate buffer, pH 7.6. The cells were frozen in liquid nitrogen and 
stored at -20°C until used in an oxidation experiment, as described in section 3.2.3. 
 
3.2.7 Comparison with commercially available palladium on a carbon support (Pd/C). 
The activity of the biometallic catalyst was compared with non-palladised cells and 
0.0221 g commercially available 10% palladium on carbon (Pd/C). The 
biotransformation was carried out over 5 cycles of alternating air and hydrogen. 
 
Measuring loss of palladium into the reaction supernatant: In order to determine 
whether palladium was leached into the reaction supernatant, contaminating the 
products, the supernatant was obtained by centrifugation of 1 ml at 15,996 g for 5 
minutes, before digestion with an equal volume of 70% nitric acid for 24 hours. 
Samples were then diluted to 2% nitric acid, and filtered before analysis for the 
presence of palladium using ICP-MS. 
 
3.2.8 Immobilisation of biocatalyst in alginate 
The method used for the immobilisation of palladised transformed cells in alginate 
beads was adapted from that of Hartmeier (1988). 1.2 g sodium alginate was dissolved 
in 42 ml deionised water, and 6 ml of palladised transformed E. coli cells (250 mg ml-1 
in 20 mM MOPS-NaOH buffer at pH 7.6) were added to 350 ml dissolved alginate 
solution. The alginate-cell suspension was then dropped into 200 ml of a 2% w/v 
calcium chloride solution using a plastic Pasteur pipette, whilst gently stirring to 
prevent bead aggregation. Alginate beads were left stirring for 1 hour to harden, after 
which time the CaCl2 solution was diluted to 0.5% w/v with the addition of a further 
600 ml deionised water. Beads were stored in the 0.5% w/v CaCl2 solution at 10°C 
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until use. The beads were approximately 3-4 mm in diameter (Figure 3.4), and each 
250 mg aliquot of biocatalyst produced around 110 beads. 
 
 
Figure 3.4: Alginate beads containing immobilised palladised E. coli. 
 
Before use in oxidation, reduction, or deracemisation experiments, the beads were 
rinsed in MOPS-NaOH buffer at pH 7.6. All experiments were carried out using 
reagents made up in MOPS-NaOH buffer rather than potassium phosphate buffer, as 
phosphate would destabilise the beads and release the biocatalyst (Smidsrod & Skjak-
Braek, 1990). Otherwise, the experiments were carried out as for planktonic cells, in 
120 ml gas bottles (see Figure 3.5). Culture of the reaction supernatant following 
biotransformation revealed no viable cells had been released from the beads. 
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Figure 3.5: Alginate beads in reaction vessel, showing 10 ml substrate and 110 ml 
headspace. 
 
3.2.9 Environmental scanning electron microscopy (ESEM) 
Biocatalyst-containing beads were examined using a Philips XL30 ESEM-FEG using 
ionised water vapour to disperse the charge from the sample surface, thus avoiding 
the need to carbon coat. The beads were imaged both before and after use in a 
deracemisation reaction, in order to determine any possible effects on the integrity of 
the beads. 
 
3.2.10 Use of freeze-dried beads in oxidation and reduction reactions 
To assess the suitability of freeze-drying for the long-term storage of the biocatalyst, 
beads were frozen in liquid nitrogen and dried for 24 hours. The beads were stored at 
10°C under vacuum until use, and were used in oxidation experiments on day one, 
after two weeks, and after six weeks. 
 
 
3.3 Materials 
Most of the culture media, buffers, enzymes and chemicals used in this study were 
obtained from Fisher Scientific or Sigma Aldrich. Any materials not obtained from 
these sources are listed in Table 3.1. 
 
Table 3.1: Materials used in this study. 
Material Source 
Culture media:  
SOC medium In 200 ml deionised water: 
Tryptone 4 g 
Yeast extract 1 g 
NaCl 0.1 g 
Buffers:  
MOPS buffer Acros Organics 
Chemicals:  
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Material Source 
Acrylamide:bis-acrylamide (29:1) BioRad 
Diethylamine Fluka 
Hydrogen gas BOC Gases 
Isohexane Romil 
MDQ Acros Organics 
MTQ GSK 
Nitrogen gas BOC Gases 
Oxygen gas BOC Gases 
Pyrogallol red dye Acros Organics 
Sodium sulfate BDH 
Sodium tetrachloropalladate Alfa Aesar 
HPLC columns:  
Daicel Chiralpak AD-H 4.6 mm x 250 
mm column 
Chiral Technologies Europe 
Phenomenex Luna C18 (2) 150 x 4.60 
mm 3 μm column 
Phenomenex 
 
 
3.3.1 Bacterial strains and plasmid 
The bacterial strains and plasmid used in this study are listed in Table 3.2, which 
includes the genotypes and source of the strains. 
 
Table 3.2: E. coli strains and plasmid used in this study. 
Strain Genotype Phenotype Reference Source 
K12 JM109 F´ traD36 proA+B+ lacIq 
Δ(lacZ)M15/ Δ(lac-
proAB) glnV44 e14- 
gyrA96 recA1 relA1 
endA1 thi hsdR17 
Strain commonly 
used for 
recombinant protein 
expression. 
(Yanisch-
Perron et al., 
1985) 
New England 
BioLabs 
TOP10/P3 F- mcrA Δ(mrr-hsdRMS-
mcrBC) φ80lacZΔM15 
ΔlacX74 recA1 araΔ139 
Strain commonly 
used for plasmid 
amplification. 
Invitrogen Invitrogen 
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Δ(ara-leu)7697 galU 
galK rpsL (StrR) endA1 
nupG. 
BL21(DE3) F2 ompT gal dcm lon 
hsdSB(rB
– mB
–) λ(DE3 
[lacI lacUV5-T7 gene 1 
ind1 sam7 nin5]) 
Strain commonly 
used for 
recombinant protein 
expression. 
(Studier & 
Moffatt, 
1986) 
Invitrogen 
MC4100 F- ΔlacU169 araD139 
rpsL150 relA1 ptsF rbs 
flbB5301 
Parental strain for 
FTD128 and MC4100 
ΔmoaA. 
(Casadaban 
& Cohen, 
1979) 
From the 
collection of 
Professor F. 
Sargent, 
University of 
Dundee. 
BW25113 laclq rrbBT14 ΔlacZWJ16 
hsdR514 ΔaraBADAH33 
ΔrhaBADLD78 
Parental strain for 
JW2682 and 
JW3865. 
(Datsenko & 
Wanner, 
2000) 
As above 
FTD128 As MC4100, with in-
frame deletion in the 
fdhE gene. 
FDH-O & FDH-N 
negative. 
(Luke et al., 
2008) 
As above 
JW2682 As BW25113, with in-
frame deletion of the 
hypF gene. 
Deficient in all 
hydrogenases. 
(Baba et al., 
2006) 
As above 
JW3865 As BW25113, with in-
frame deletion of the 
fdoG gene. 
FDH-O negative. (Baba et al., 
2006) 
As above 
MC4100 
ΔmoaA 
As MC4100, disruption 
of the moaA gene. 
Deficient in all 
molybdoenzymes. 
This study. As above 
pET 16-b 
plasmid 
T7 promoter, T7 
transcription start, 
His•Tag sequence, MCS 
(Nde I -BamH I), T7 
terminator, lacI coding 
sequence, pBR322 ori, 
bla coding sequence. 
High-level expression 
plasmid. 
Novagen Novagen 
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ABSTRACT The ability of microbial cells to synthesize highly reactive nano-scale 
functional materials provides the basis for a novel synthetic biology tool for developing 
the next generation of multifunctional industrial biocatalysts. Here we demonstrate that 
aerobic cultures of Escherichia coli, genetically engineered to overproduce a 
recombinant monoamine oxidase (MAO-N) possessing high enantioselectivity against 
chiral amines, can be augmented with nano-scale Pd(0) precipitated via bioreduction 
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reactions. The result is a novel biometallic catalyst for the deracemization of racemic 
amines. This deracemization process is normally achieved by discrete sequential 
oxidation/reduction steps using a separate enantiomer-specific biocatalyst and metal 
catalyst respectively. Here, use of E. coli cultures carrying the cloned monoamine 
oxidase gene and nano-scale bioreduced Pd(0) particles was used successfully for the 
conversion of racemic 1-methyltetrahydroisoquinoline (MTQ) to (R)-MTQ, via the 
intermediate 1-methyl-3,4-dihydroisoquinoline (MDQ), with an enantiomeric excess of 
up to 96%. There was no loss of catalyst activity following the five rounds of oxidation 
and reduction, and importantly there was minimal loss of palladium into the reaction 
supernatant. This first demonstration of a whole cell biometallic catalyst mixture for 
“single-pot”, multi-step reactions opens up the way for a wide range of integrated 
processes, offering a scalable and highly flexible platform technology. 
 
 
Keywords: palladium catalyst, Escherichia coli, biocatalysis, biotransformation, 
deracemization.
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The fabrication of functional biominerals by microbial cells offers the potential to 
revolutionize the synthesis of nanomaterials. These biosynthetic routes are potentially 
highly scalable, work at ambient pressures and temperatures in the absence of toxic 
compounds such as capping agents, and their properties can be fine-tuned using genetic 
or physiological manipulations.
1
 In several examples, waste materials can be used as 
the feedstock for biomineral synthesis, offering a green chemistry solution to 
nanomaterial synthesis.
2
 Functional biominerals produced recently by microbial routes 
include precious metal catalysts,
2, 3
 nanomagnets for hyperthermic cancer treatment,
4
 
quantum dots,
5
 bioremediation agents,
6
 silver-based antimicrobials,
7
 and SERS probes.
8
 
The model organisms used for these processes are all amenable to manipulations using 
the rapidly advancing tools of synthetic biology. Thus, they have the potential to form 
the basis of complex multifunctional systems, when integrated with the microbial 
host’s cellular physiology.  
 
A particularly promising area for this type of approach is the development of 
multifunctional biocatalysts. The application of recombinant whole cell biocatalysts is 
an established technology for a broad range of industrial conversions including notable 
examples such as the reduction of ketones to alcohols using ketoreductases
9
 and also 
the asymmetric synthesis of chiral amines using transaminases.
10
 
 
The requirement for enantiomerically pure chiral amines in the pharmaceutical and 
agrochemicals industries has led to the development of asymmetric transformations, 
dynamic kinetic resolutions (DKR) and deracemization reactions using biocatalysts that 
can efficiently generate products in up to 100% yield and 100% e.e.
11
 Previous work 
has reported the use of lipases with a carbon-supported palladium catalyst for the DKR 
of racemic amines.
12
 However, this method takes up to five days at 60C to give 
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moderate yields, and generates unwanted by-products. Lipases are suitable for use with 
primary amines and some secondary amines, but cannot be applied to tertiary amines.
13
 
By contrast, monoamine oxidase-N (MAO-N), has attracted attention as a result of its 
enantioselectivity towards the (S)-form of the primary amine -methyl-benzylamine.
14
 
MAO-N is a tetrameric flavoprotein that catalyzes the oxidative deamination of 
terminal amine groups.
15
 The use of this enzyme for the deracemization of racemic 
chiral amines is based on the creation of imine intermediates by oxidation of the (S)-
enantiomer. The addition of a chemical reductant, such as ammonia-borane or 
palladium-formate/hydrogen, results in the non-selective conversion of the imine back 
to the racemic amine. After several oxidation/reduction cycles, a very high 
enantiomeric excess and yield of the (R)-enantiomer is achieved. 
 
The directed evolution of mao-N from Aspergillus niger has led to the generation of 
enzymes with enhanced activity and specificity towards primary,
11
 secondary
16
 and 
tertiary amines.
13
 The advantage of directed evolution as a method for improving 
enzymes for specific applications is that no prior knowledge of enzyme structure is 
required, as screening is carried out purely on the basis of the desired functional 
properties.
17
 After several cycles of mutagenesis and screening, a variant enzyme was 
identified with activity towards the secondary amine 1-methyltetrahydroisoquinoline 
(MTQ)
16
 and the tertiary amine N-methyl-2-phenylpyrrolidine.
13
 The latter variant has 
five point mutations in the gene, giving rise to the alterations 
Ile246Met/Asn336Ser/Met348Lys/Thr384Asn/Asp385Ser in the product. This enzyme 
is designated MAO-N-D5.
13, 18
 
 
It has been known for more than a century that a range of specialist prokaryotes can 
reduce metals by using them as the terminal electron acceptor during anaerobic 
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respiration.
19
 These microbial activities can be used in the bioremediation of land 
contaminated with toxic metals and also in the reclamation of potentially valuable 
precious metals.
1
 For example, the obligately anaerobic sulfate-reducing bacterium 
Desulfovibrio desulfuricans has been shown to reduce soluble Pd(II) to insoluble Pd(0), 
which is precipitated in the periplasm as nanoparticles.
20
 This property has allowed the 
use of the palladized organism (known as Bio-Pd) directly in a broad range of 
reactions, showing good activity compared with a commercially available carbon-
supported palladium catalyst for the dehalogenation of chlorophenol, polychlorinated 
biphenyls, and polybrominated diphenyl ethers. 
21, 22
 Here we outline how Bio-Pd can 
be produced without the use of strict anaerobic culture, or complicated washing steps to 
remove sulfide formed by the sulfate-reducing bacterium (which can poison palladium 
catalysts) by using the facultative anaerobe Escherichia coli grown under aerobic 
conditions. E. coli is also easily transformed with plasmid DNA, and hence can be used 
to express foreign genes, making this organism ideal for use as a biocatalyst in a one-
pot reaction utilizing recombinant enzymes such as MAO-N-D5 in combination with 
Bio-Pd . The aim of this study was to demonstrate for the first time the coupled activity 
of a functional biomineral catalyst and enzyme in a novel engineered catalyst, in this 
case for the deracemization of racemic amines, providing a prototype for multi-step 
transformations and other hybrid biometallic systems (Figure 1). 
 
Figure 1: The cyclic deracemization of 1-methyltetrahydroisoquinoline (MTQ) via the 
imine 1-methyl-3,4-dihydroisoquinoline (MDQ) using palladized biocatalyst with the 
mao-N-D5 insert. 
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RESULTS AND DISCUSSION 
PALLADIZATION OF E. COLI BL21 
In order to develop a multifunctional biometallic whole-cell catalyst for deracemization 
reactions, washed aerobically-grown E. coli BL21 cells containing the cloned gene 
expressing the enzyme MAO-N-D5 were palladized by challenging with 1 mM Pd(II) 
and hydrogen gas as an electron donor. The cells were coated in a black precipitate 
within a few minutes (Figure 2a), indicating the reduction of Pd(II) to insoluble 
particles of Pd(0).
20
 Pd(II) did not reduce to Pd(0) in bottles that were not purged with 
H2. The black precipitate was analyzed by X-ray diffraction to confirm the presence of 
elemental palladium (Figure 2b), although the signal was weak due the nanoparticulate 
nature of the sample. The size of the particles was calculated to be approximately 1 nm 
in diameter, as measured using the Scherrer equation. 
 
Figure 2: a) Biomass with palladium (II) (left), and reduced palladium (right); b) XRD 
showing presence of palladium on in the microbial cultures supplied with Pd(II) and 
hydrogen as the electron donor; c) TEM of thin sections of aerobically grown cells 
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showing extracellular palladium (scale bar = 1 µm); d) TEM of a cell showing 
intracellular nanoparticles associated with the inner surface of the plasma membrane 
(scale bar = 50 nm). 
 
 
TEM images of thin sections of cells showed that the reduced palladium was 
precipitated predominantly in the extracellular matrix of the cultures (Figure 2c). 
Occasionally, larger nanoparticles (~10 nm) were seen inside the cell, possibly located 
on the inner surface of the plasma membrane (Figure 2d). Energy dispersive X-ray 
spectroscopy (EDS) confirmed the presence of palladium in these electron dense nano-
scale precipitates. 
 
QEXAFS analysis at the Swiss Light Source showed that the Pd(II) is reduced to Pd(0) 
with no evidence of intermediate species (Figure 3). However, the reduction of the 
Pd(II) was slower than under normal laboratory conditions, as hydrogen could not be 
continuously supplied due to the necessity of vacating the experimental area during use 
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of synchrotron radiation on the beamline. Hydrogen was therefore supplied for only 30 
seconds between measurements. 
 
Figure 3: EXAFS spectra showing reduction of Pd(II) to Pd(0) within 1 hour (in situ 
experiment). Times shown are in minutes. 
 
 
SUBSTRATE OXIDATION AND REDUCTION  
When E. coli transformed with the mao-N-D5 gene insert was added to 10 mM racemic 
MTQ and incubated at 37°C, all of the (S)-enantiomer of the MTQ was oxidized to 
MDQ within two hours (Figure 4). 
 
Figure 4: The oxidation of (S)-MTQ to MDQ within 2 hours at 37°C, by E. coli 
transformed with the mao-N-D5 gene insert. 
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When palladized untransformed E. coli was added to 10 mM MDQ and 70 mM sodium 
formate and incubated at 37°C, all of the MDQ was reduced to racemic MTQ within 1 
hour. Subsequent experiments using hydrogen gas showed complete reduction of MDQ 
within 30 minutes (Figure 5). Thus both the oxidative and reductive steps required for 
the deracemization of chiral amines such as MTQ were active in the same culture of 
recombinant, palladized E. coli developed in this study. 
 
Figure 5: The reduction of MDQ to racemic MTQ within 30 minutes at 37°C, by 
palladized E. coli using hydrogen gas as the electron donor. 
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INTEGRATION OF PROCESSES FOR DERACEMIZATION  
Despite the rapid conversion of the starting materials in both the oxidation and 
reduction experiments, when initially combined into one system and incubated for 24 
hours, deracemization did not proceed beyond the initial oxidation step. This was due 
to the unexpected formation of 1-methylisoquinoline (MIQ) from MDQ by further 
chemical oxidation. However, production of MIQ was not observed when hydrogen gas 
was used instead of formate as the electron donor for the reduction step, possibly 
indicating that hydrogen drives the bioreduction of MDQ at a faster rate than formate. 
To avoid the potentially hazardous mixing of air and hydrogen in the reaction vessel, 
oxidation and reduction steps were performed as separate cycles. Based on the results 
from the separate oxidation and reduction reactions, each oxidation step was 
maintained for two hours, and each reduction step was 45 minutes, to allow each 
reaction to proceed to completion. After four cycles of oxidation and reduction, the (R)-
enantiomer was present in an enantiomeric excess (e.e.) of 89%. The hypothetical value 
at this stage after 4 cycles of oxidation and reduction is a 96.875% e.e. Increasing the 
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experiment from 4 cycles to 5 cycles increased the e.e. to 96% (Figure 6), which would 
be the standard required for commercial application. 
 
Figure 6: The deracemization of MTQ, giving an e.e. of 96% (R)-MTQ (5 cycles of air 
alternated with 5 cycles of hydrogen). 
 
 
When cells used in a 5-cycle biotransformation were collected by centrifugation and 
washed with potassium phosphate buffer and used in further oxidation-only and 
reduction-only experiments, it was found that the activity of both the MAO-N-D5 
enzyme and the palladium was the same as that prior to the biotransformation. Thus 
both the recombinant enzyme and Bio-Pd were stable for multiple rounds of 
biotransformation. 
 
COMPARISON OF ACTIVITY WITH COMMERCIALLY AVAILABLE PALLADIUM. 
When the performance of the palladized cells was compared to that of recombinant  
non-palladized cells with an equivalent amount of conventional-Pd (carbon with 10% 
palladium) in a biotransformation of 5 cycles of oxidation and reduction, there was a 
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97% conversion to (R)-MTQ by both the Bio-Pd and the conventional-Pd. However, 
the total mass of the final product (R)-MTQ was low at 85% of the expected total 
produced for the Bio-Pd and 75% for the conventional-Pd. Washing the cell pellets 
three times with methyl-tert-butyl ether recovered the (R)-MTQ from the Bio-Pd cell 
pellet, however 10% of the missing (R)-MTQ was still not recoverable at this stage 
from the conventional-Pd cell pellet. The third wash for the conventional-Pd samples 
continued to yield (R)-MTQ, indicating retention of the amine through adsorption onto 
the carbon support, which was difficult to recover through washing. The recovery of 
product from the Bio-Pd was 100%, with no further (R)-MTQ recovered after the 
second wash. With the additional material taken into account from the washing of the 
cell pellets, both the Bio-Pd and the conventional-Pd showed a 92% conversion to (R)-
MTQ. However, the yield was 10% lower than expected for the conventional-Pd. In 
this respect, Bio-Pd is superior to conventional-Pd for use in deracemization reactions 
due to the comparative ease of product recovery.  
 
MEASURING LOSS OF PALLADIUM INTO THE REACTION SUPERNATANT 
Although centrifugation was sufficient to remove all Bio-Pd nanoparticles from the 
reaction supernatant, visible particles of conventional-Pd remained in the supernatant 
after centrifugation and required filtering to remove. The ICP-MS results also showed 
that more palladium was lost to the supernatant when using conventional-Pd than with 
Bio-Pd. The Bio-Pd reaction supernatant contained 0.17 mg l
-1
 palladium, whereas the 
conventional-Pd reaction supernatant contained 0.24 mg l
-1
. 
 
CONCLUSIONS 
Recent advances in the field of synthetic biology allow us to anticipate the possibility 
of creating a “designer” biometallic catalyst, engineered precisely to the requirements 
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of the desired chemical transformation. This study has shown that it is already possible 
to engineer a biometallic catalyst mixture capable of one-pot deracemization reactions. 
 
Although previous studies investigating the bioreduction of palladium have used 
anaerobic cultures, this study has demonstrated that palladium reduction is possible 
with aerobic cultures of E. coli, using hydrogen as the electron donor. Although Pd(II) 
is reduced by hydrogen without the presence of bacteria, there is likely to be a 
biological mechanism for Pd(II) reduction in this cultures, due to the significantly  
increased time taken for reduction to complete in cell-free controls and killed 
(autoclaved) cell controls (based on visual interpretation), as also seen by others.
23
  The 
aerobic expression of hydrogenases known to mediate Pd(II) reduction in anaerobic 
cultures,
24
 is one possibility that is being investigated in our laboratory, or the 
expression of another macromolecular system with the capability to catalyze hydrogen 
oxidation and Pd(II) reduction. The use of aerobic cultures for the production of 
biometallic catalysts is preferable, due to increased cell yield, higher yields of 
recombinant proteins
25
 and in the case of SRB no production of H2S which can poison 
metallic catalysts.
26
 TEM images show the presence of elemental palladium as 
extracellular nanoparticles, associated with the cell surface and possibly with 
exopolysaccharides. It may be this association which prevents the removal of the 
palladium nanoparticles during washing of the biocatalyst. Occasionally nanoparticles 
were seen inside the cell, possibly located on the inner surface of the plasma 
membrane. QEXAFS data confirms the reduction of Pd(II) directly to Pd(0), without 
the production of intermediate species.  
 
Palladized E. coli transformed with the mao-N-D5 plasmid is capable of performing 
both oxidation and reduction reactions required for the deracemization reactions 
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studied here. However, it was not possible to perform both reactions simultaneously, 
with aerobic cells supplied with formate as an electron donor for the Pd-catalyzed 
reaction, due to the formation of the unwanted product MIQ under these conditions. 
However, this product was not seen when hydrogen was used instead of formate as the 
electron donor in the reduction reaction. The use of hydrogen required the two 
reactions to be performed separately but in the same reaction vessel, in a cyclical 
manner. This simple approach should be amenable for use in a broad range of reactor 
configurations, including those using high densities of cells immobilized on a suitable 
support for easy re-use. As the two reactions are not run simultaneously, each discrete 
reaction step can be optimized fully, with prolonged activity for the catalyst 
demonstrated in this study.  
 
When the performance of enzymatically produced Bio-Pd was compared to that of 
commercially available “conventional-Pd” in a biotransformation of 5 cycles of 
oxidation and reduction, both were found to adsorb the reactants and products of the 
biotransformation. However, the conventional-Pd adsorbed around 10% more than the 
Bio-Pd (1 mM of the potential 10 mM final product in our study), indicating that the 
amine could not be desorbed from the catalyst even with multiple washing steps. It was 
also found that the conventional-Pd was present in the reaction supernatant at higher 
levels than the Bio-Pd, and had to be removed by an additional filtration step 
complicating downstream processing. The ease of removal of Bio-Pd from the reaction 
mixture indicates both reduced contamination of the products with palladium, and 
improved recyclability of the catalyst. The re-use of Bio-Pd cells following a 5-cycle 
biotransformation confirmed that the activity of these cells was the same as in previous 
experiments. 
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 In conclusion, we have demonstrated that it is possible to create a biometallic catalyst 
that expresses MAO-N as a model oxidase enzyme in palladized cells, and can perform 
both oxidation and reduction reactions leading to a 96% deracemization of a secondary 
amine, without the addition of a separate chemical reductant and with limited 
contamination or adsorption of the reaction products by the catalyst. This method has a 
broad potential for simplifying or improving other enzyme/inorganic catalyst 
combinations, not being specific to either E. coli or palladium, and could be potentially 
useful for a range of industrial and biotechnological applications. This study, therefore, 
illustrates the exciting potential of applying the rapidly evolving synthetic biology 
toolkit available to biotechnologists to engineer biocatalysts and novel nano-scale 
biomineral precipitates in a single organism for multi-step catalysis. 
 
EXPERIMENTAL SECTION 
TRANSFORMATION OF E. COLI BL21 WITH PET-16B PLASMID CONTAINING THE MAO-
N-D5 INSERT 
Strains and plasmid: E. coli BL21 cells were obtained from Invitrogen. The pET16-b 
plasmid containing the mao-N-D5 insert and an ampicillin resistance gene was obtained 
from Dr Andrew Ellis at the Manchester Interdisciplinary Biocentre. Bacterial isolates 
were stored at -80C, and the plasmid was stored at -20C. 
Transformation: Cells were transformed according to the supplier’s instructions, 
using approximately 100 ng of plasmid. Transformed BL21 cells were subcultured onto 
LB agar plates containing 100 g ml-1 ampicillin, and incubated overnight at 37C 
before storage at 4C for a maximum of 1 week. 
 
PALLADIZATION OF E. COLI BL21 
The method used was adapted from that used by Lloyd & Macaskie.
20
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Starter cultures: 50 ml LB broth in a 500 ml Erlenmeyer flask was inoculated with a 
single isolated colony of the transformed E. coli and incubated overnight at 37C, 
shaking at 180 rpm. 
Aerobic cultures: An 11 ml starter culture was added to 99 ml LB broth containing 
100 g ml-1 ampicillin, in a 1 L Erlenmeyer flask. Flasks were incubated for 24 hours at 
37C, shaking at 180 rpm. An oxygen saturation of 72% was measured using an 
Oakton D06 Acorn Series dissolved oxygen meter. 
Palladization: Each culture was divided between two 50 ml Falcon tubes (supplied by 
Fisher) and washed three times in 20 ml MOPS-NaOH (morpholinepropanesulfonic 
acid) buffer, 20 mM at pH7.6 after centrifugation for 20 minutes at 2500 g. Cell pellets 
were adjusted to a mass of 250 mg, based on the wet cell pellet, and resuspended 
MOPS-NaOH to a volume of 1 ml. Two tubes of each culture were resuspended in 25 
ml buffer with 1 mM sodium tetrachloropalladate (supplied by Alfa Aesar) in 30 ml 
bottles sealed with butyl rubber stoppers (two bottles per culture). Bottles were 
incubated in the dark at 30C for 1 hour for the Pd(II) to biosorb to the cells.21 One of 
each of the two different cultures was then purged with H2 for 5 minutes, with H2 
allowed to fill the headspace to promote the enzymatic reduction of the Pd(II). The 
final loading of bioreduced, elemental Pd(0) in the biomass was approximately 1% by 
mass.  The remaining two bottles were H2-negative controls. 
 
X-RAY DIFFRACTION (XRD) ANALYSIS 
The cells were coated in a black precipitate within a few minutes in bottles containing 
cells as Pd(II) purged with H2. The palladized cells settled out leaving a clear colorless 
supernatant. The black precipitate was washed once in acetone and air-dried, before 
investigation by XRD. The measurements were performed on a Bruker D8 Advance 
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diffractometer, using Cu Kalpha1 radiation. The samples were scanned from 5-70 
degrees 2theta in steps of 0.2 degrees, with a count time of 2 seconds per step. 
 
TRANSMISSION ELECTRON MICROSCOPY (TEM) AND ENERGY DISPERSIVE X-RAY 
SPECTROSCOPY (EDS) 
Sections of the palladized cells were provided by EM facility in the Faculty of Life 
Sciences, University of Manchester. The bacteria were fixed in primary fixative (2.5% 
glutaraldehyde and 4% formaldehyde in 0.1M sodium cacodylate buffer at pH7.4) and 
secondary fixative (1% osmium tetroxide and 1.5% potassium ferrocyanide in 0.1M 
sodium cacodylate buffer at pH7.4) and dehydrated in a graded acetone series (30 
minutes each in 50%, 70%, 90% and three changes at 100%) before embedding in 
TAAB LV medium epoxy resin. EDS was performed on electron-dark areas, to confirm 
the presence of palladium. 
 
QUICK-SCANNING EXTENDED X-RAY ABSORPTION FINE STRUCTURE (QEXAFS) 
The reduction of Pd(II) to Pd(0) was analyzed by QEXAFS in an in situ reduction 
experiment on beamline BL21 at the Swiss Light Source (SLS) synchrotron facility. 
Cells were grown aerobically as described previously, frozen and transported to the 
SLS on dry ice. After thawing, the cells were resuspended in 25 ml 20mM MOPS-
NaOH buffer (pH 7.6) and challenged with 1 mM Pd(II), in a 5 cm tube placed 
longitudinally in the beam. The tube was purged with hydrogen for 30 seconds at 10 
minute intervals, until the sample had turned completely black. Scans were performed 
at a rate of 4 scans per minute, for 10 minutes at a time. X-ray absorption data were 
collected in the energy range 23,970 – 25,727 eV. Data were recorded in transmission, 
in fast-scanning mode, each run accumulating 118 spectra over 10 minutes. The spectra 
were isolated, the data range cut to 22,210 – 24,900 eV, and the number of points in 
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each spectrum reduced (and signal-to-noise improved) by averaging adjacent groups of 
points to a grid finely spaced over the Pd K-edge and after the edge evenly spaced in k-
space. The individual spectra were summed into ten groups of ten and one group of 
eight for each run. This was repeated until all spectra had been processed. 
 
The summed data were background subtracted in the Daresbury program EXBACK.  
 
SUBSTRATE OXIDATION AND REDUCTION 
Oxidation: Frozen transformed cells (250 mg ml
-1
 in 20 mM MOPS-NaOH buffer at 
pH 7.6) were thawed and added to 8 ml 12.5 mM racemic MTQ, from a stock solution 
made up in 0.1 M potassium phosphate buffer at pH 7.6. Potassium phosphate buffer (1 
ml) was added to bring the volume of the reaction mixture to 10 ml. The vessel used 
was a 120 ml gas bottle sealed with a butyl rubber stopper, and the reaction was 
allowed to proceed in air at 37°C, with shaking at 225 rpm. Samples were taken as 
required, by removing 550 l in triplicate, centrifuging for 20 minutes at 2500 g and 
storing 500 l of the supernatant at 20°C before extraction with methyl-tert-butyl ether 
(MTBE).  
Reduction with sodium formate as the electron donor: Frozen palladized 
untransformed cells (250 mg ml
-1
 in 20 mM MOPS-NaOH buffer at pH 7.6, with 1% 
Pd loading by mass) were thawed and added to 8 ml 12.5 mM MDQ (1-methyl-3,4-
dihydroisoquinoline, supplied by Acros Organics), from a stock solution made up in 0.1 
M potassium phosphate buffer at pH 7.6. Sodium formate (1 ml) was added to a final 
concentration of 70 mM, giving a total reaction volume of 10 ml. The conditions of 
incubation and MTBE extraction were the same as for the oxidation step. 
Reduction with hydrogen as the electron donor: The procedure was carried out as 
above, with 1 ml 0.1 M potassium phosphate buffer replacing the sodium formate in the 
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reaction mixture. The reaction volume was 10 ml, in a 120 ml gas bottle, providing a 
110 ml headspace. The bottle was sparged with hydrogen for 2 minutes before 
incubating and extracting as previously. 
HPLC analysis: The samples were resuspended in 200 l isohexane prior to testing by 
normal phase chiral HPLC on an Agilent 1200 chromatograph, using a Daicel 
Chiralpak AD-H 4.6 mm x 250 mm column, at a flow rate of 1 ml min
-1
 for 20 minutes 
at 40°C with a mobile phase of 88% isohexane, 2% ethanol, and 10% isohexane 
containing 0.5% diethylamine. The analytes were detected by UV-Vis spectroscopy, at 
wavelengths of 220 nm (MTQ), and 254 nm (MDQ) (see Supplementary Fig. 1 online). 
The error (RSD) was 2.8%. 
 
INTEGRATION OF PROCESSES FOR DERACEMIZATION 
Deracemization with sodium formate as the electron donor: The two reactions were 
combined by using palladized transformed cells in the reaction mixture, and with the 
addition of 70 mM sodium formate (final concentration). The bottles were incubated as 
above. 
Deracemization with hydrogen as the electron donor: The two reactions were 
combined by using palladized transformed cells in the reaction mixture. Oxidation and 
reduction steps were performed as separate cycles, by flushing the vessel alternately 
with air or hydrogen. The reaction vessel was a 120 ml gas bottle with a 10 ml reaction 
volume, providing a 110 ml headspace. The vessel was first flushed with nitrogen to 
avoid the mixing of air and hydrogen. Each oxidation step was two hours long, and 
each reduction step was 45 minutes. Samples were taken at the end of each reduction 
step, for 4 cycles. The deracemisation took a total of 11 hours, with intervention for the 
flushing of gases at the end of each oxidation and each reduction step (8 interventions 
in total). Increasing the deracemisation step from 4 cycles to 5 cycles required an 
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additional 2 interventions for the flushing of gases, over a total of 13 hours and 45 
minutes. 
 
COMPARISON OF ACTIVITY WITH COMMERCIALLY AVAILABLE PALLADIUM 
The activity of the biometallic catalyst was compared with non-palladized cells and 
commercially available 10% palladium on carbon (conventional-Pd), supplied by 
Sigma Aldrich. The biotransformation was carried out over 5 cycles of air and 
hydrogen. 
 
MEASURING LOSS OF PALLADIUM INTO THE REACTION SUPERNATANT 
In order to determine whether palladium was leached into the reaction supernatant, 
contaminating the products, the supernatant was obtained by centrifugation of 1 ml at 
15,682 g for 5 minutes, before digestion with an equal volume of 70% nitric acid for 24 
hours. Samples were then diluted to 2% nitric acid, and filtered before analysis for the 
presence of palladium using the ICP-MS Agilent 7500cx. 
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HPLC analysis 
Supplementary Figure 1: HPLC traces, showing trace soon after start of oxidation 
(blue trace) with large peaks for (S)-MTQ (retention time 10.35 minutes) and (R)-MTQ 
(12.03 minutes) and small peaks for MDQ (8.95 minutes) and MIQ (10.1 minutes), and 
after 3 hours of incubation at 37°C (red trace), showing large peaks for MDQ and MIQ, 
no peak for (S)-MTQ, and no change to the peak for (R)-MTQ. 
 
 
Enantiomeric excess (e.e.) of (R)-MTQ 
Supplementary Table 1: Expected and actual percentages of (S)-MTQ and (R)-MTQ 
after repeated cycles of oxidation and reduction. 
 
 
 Percentage after 
0 cycles 1 cycle 2 cycles 3 cycles 4 cycles 5 cycles 
(S)-MTQ 
(expected) 
50 25 12.5 6.25 3.125 1.563 
(R)-MTQ 
(expected) 
50 75 87.5 93.75 96.875 98.438 
       
(S)-MTQ  
(actual) 
49 29 16 9 6 2 
(R)-MTQ  
(actual) 
51 71 84 91 94 98 
S3 
 
Pd(II) reduction rates using hydrogen 
Supplementary Figure 2: Removal of soluble Pd(II) from solution during reduction 
by E. coli MC4100, with hydrogen as the electron donor. Palladium in the supernatant 
was measured using the Perkin-Elmer Optima 5300 dual view ICP-AES. 
 
 
 
 
 
Oxidation and reduction experiments using cells previously used in a 5 cycle 
biotransformation 
Supplementary Figure 3: cells used in a 5-cycle biotransformation were collected by 
centrifugation and washed with potassium phosphate buffer and used in further 
oxidation-only experiments. The activity of the MAO-N-D5 enzyme in the whole cells 
after the 5-cycle biotransformation remained the same as that prior to the 
biotransformation steps. All data points represent mean values from triplicate 
measurements, with standard error bars. 
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Supplementary Figure 4: cells used in a 5-cycle biotransformation were collected by 
centrifugation and washed with potassium phosphate buffer and used in further 
reduction-only experiments. The activity of the palladium after the 5-cycle 
biotransformation remained the same as that prior to the biotransformation steps. All 
data points represent mean values from triplicate measurements, with standard error 
bars. 
 
S5 
 
Comparison of activity with commercially available palladium 
Supplementary Figure 5: A comparison of loss of palladium into the reaction 
supernatant from Bio-Pd and commercial Pd. After standing overnight, the Bio-Pd 
nanoparticles settled to the bottom of the experimental vessel (left), whereas the 
commercial Pd (right) could not be fully removed from the supernatant without 
filtering. 
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Escherichia coli is a Gram-negative bacterium with a flexible respiratory metabolism. 
E. coli grows optimally aerobically while utilising molecular oxygen (O2) as terminal 
electron acceptor. In the absence of O2, E. coli continues to survive by switching to 
either a fermentative growth or by utilising alternative compounds, e.g. nitrate, as 
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terminal electron acceptors. The respiratory activity of E. coli can also be harnessed to 
drive biotechnologically-important activities, for example on in the bio-reduction of 
precious metal ions to recover the metal. In this work, aerobically-grown whole cells of 
E. coli were shown to reduce Pd(II) and precipitate Pd(0) nanoparticles via a novel 
mechanism using formate as the electron donor. The reductive transformation of 
palladium was monitored in real-time using extended X-ray absorption fine structure 
(EXAFS), and subsequent TEM analysis showed that the Pd(0) nanoparticles, 
confirmed by XRD, were precipitated outside the cells. The rate of reduction of Pd(II) 
was measured using  E. coli mutants deficient in a range of oxidoreductases, including 
the [NiFe] hydrogenases and the molybdenum-dependent formate dehydrogenases.  
Results from these aerobic experiments suggested a novel, molybdoprotein-mediated 
mechanism is at play, which is completely distinct from the hydrogenase-mediated 
Pd(II) reduction previously described for anaerobically-grown E. coli cultures.  The 
potential implications for Pd(II) recovery and bioPd  catalyst fabrication are discussed. 
 
INTRODUCTION 
The microbial reduction of metals and radionuclides has attracted much recent interest, 
as it can be potentially harnessed for bioremediation, metal recovery, the fabrication of 
novel nanobiominerals and even energy generation in biobatteries (Lloyd, 2003; Lloyd 
et al., 2008; Lovley, 2006). For example, the sulfate-reducing bacterium (SRB) 
Desulfovibrio desulfuricans has been shown to use a periplasmic hydrogenase supplied 
with hydrogen to reduce soluble Pd(II), resulting in the precipitation of Pd(0) 
nanoparticles in the periplasm of the cell, however SRB produce H2S, a potent catalyst 
poison that must be removed before making the bioPd. Other organisms capable of this 
metal bioreduction include the Gram-negative bacteria Shewanella oneidensis (De 
Windt et al., 2005), Escherichia coli (Mabbett et al., 2006), Pseudomonas putida, 
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Cupriavidus necator (Sobjerg et al., 2009), C. metallidurans (Gauthier et al., 2010), 
Paracoccus denitrificans (Bunge et al., 2010),  Rhodobacter sphaeroides (Redwood et 
al., 2008) and R. capsulatus (Wood et al., 2010), and the Gram-positive bacteria 
Bacillus sphaericus (Creamer et al., 2007a; Creamer et al., 2007b), Arthrobacter 
oxidans (Wood et al., 2010), Staphylococcus sciuri (Sobjerg et al., 2009) and 
Clostridium pasteurianum (Chidambaram et al., 2010; Deplanche et al., 2011). This 
property has allowed the use of the palladised whole cell or processed biomineral 
(“bioPd”) directly in industrially important reactions, often showing superior activity 
compared with a commercially available carbon-supported palladium catalyst. A 
number of studies have investigated the catalytic activity of bioPd, demonstrating its 
use in the evolution of H2 from sodium hypophosphite (Yong et al., 2002), the 
reduction of Cr(VI) to Cr(III) (Mabbett et al., 2002; Mabbett et al., 2004), the 
dehalogenation of chlorophenol, polychlorinated biphenyls, polybrominated diphenyl 
ethers (Baxter-Plant et al., 2003; De Windt et al., 2005; Harrad et al., 2007), 
trichloroethylene (Hennebel et al., 2009a; Hennebel et al., 2009b), and the pesticide γ- 
hexachlorocyclohexane (Mertens et al., 2007), the hydrogenation of itaconic acid 
(Creamer et al., 2007a; Creamer et al., 2007b) and 2-pentyne (Bennett et al., 2010), and 
the application of bioPd as a fuel cell electrocatalyst to produce electricity from 
hydrogen (Yong et al., 2007). In each case where the bioPd was compared with an 
abiotically-produced palladium catalyst (finely-divided or supported on a carbon 
matrix), the bioPd was more active or at least as active as the commercially available 
alternative.  
 
Of the organisms shown to produce bioPd to date, E. coli provides a very useful model 
organism since it is facultatively anaerobic and has well-defined molecular tools to 
elucidate reaction mechanisms under aerobic and anaerobic conditions. The enzymes 
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thought to be involved in the bioreduction of palladium by E. coli under the latter 
conditions are the nickel-dependent hydrogenase enzymes Hyd-1, Hyd-2, and Hyd-3, 
and the formate dehydrogenase molybdoenzymes FDH-N, and FDH-H. Another 
molybdoenzyme, FDH-O, is expressed under both aerobic and anaerobic conditions. A 
possible role for FDH-O is to allow bacteria to adapt rapidly to a sudden shift from 
aerobic respiration to anaerobiosis, before FDH-N has been produced in sufficient 
amounts to continue formate metabolism (Abaibou et al., 1995). Hyd-1, Hyd-2, FDH-O, 
and FDH-N are membrane-bound and periplasmically oriented, whereas Hyd-3 and 
FDH-H are subunits of the formate hydrogenlyase (FHL) complex, an intracellular 
enzyme complex that is also membrane-bound but which faces into the cytoplasm.  The 
mechanisms responsible for the formate-dependent bioreduction by anaerobically-
grown cultures of E. coli have been studied, and it has been shown that the hydrogenase 
enzymes Hyd-1 and Hyd-2 are mainly responsible for Pd(II) bioreduction (Deplanche 
et al., 2010). In a study of formate-dependent Pd(II) bioreduction by D. fructosovorans, 
the deletion of the periplasmic hydrogenases caused the Pd(0) nanoparticles to be 
relocated to the cytoplasmic membrane site of the remaining hydrogenases, indicating 
that the periplasmic hydrogenases are at least partially involved (Mikheenko et al., 
2008).  
 
The growth yield of anaerobic cultures is also lower than that of aerobic cultures, and 
for economic production at scale a method of growth of high biomass density is 
required. When using anaerobic cultures there is also the cost of supplementing with 
sodium fumarate and glycerol. For production of hydrogen by E. coli aerobic pre-
growth to high cell density followed by anaerobiosis yielded cells capable of making 
bioPd catalytically active in the hydrogenation of soybean oil (Zhu et al., 2011). 
However the catalytic activity of bioPd made by cells which were used for hydrogen 
 5 
fermentation and then transferred into anaerobic conditions to ‘prime’ the hydrogenases 
was lower than for cells grown anaerobically throughout (Zhu et al., 2011). Since the 
catalytic activity of bioPd relates to the specific enzyme responsible for its manufacture 
(Deplanche et al., 2010; Rousset et al., 2006) and it is not known to what extent 
‘aerobic’ enzymes cease to be active under anaerobic conditions, the purpose of this 
study was to investigate the role of enzymes in aerobically-grown cells in the reduction 
of Pd(II). It is possible that such enzymes may ‘dilute out’ anaerobic enzymes 
responsible for the manufacture of the highest quality bioPd and such a nuisance effect 
may need to be removed for industrial bionanocatalyst production. 
 
The dual aims of this study are to establish whether E. coli cells grown aerobically are 
capable of manufacturing bioPd and to identify the enzyme(s) responsible for such 
metal reduction. A move away from the need for anaerobic growth would simplify the 
preparation of catalyst at industrial scale. 
 
METHODS 
Bacterial growth 
Starter cultures: 50 ml LB broth in a 500 ml Erlenmeyer flask was inoculated with a 
single isolated colony of the E. coli strain under investigation and incubated aerobically 
(37°C, shaking at 180 rpm for 18 hours). 
 
Aerobic cultures: An 11 ml starter culture was added to 99 ml LB broth in a 1 L 
Erlenmeyer flask. Flasks were incubated for 24 hours (37°C, 180 rpm) to produce 
stationary phase “resting” cells. The pH of the cells after 24 hours incubation was 
measured to determine that organic acids had not been produced that would lower the 
pH considerably (Vasala et al., 2006). Oxygen saturation of a 5 ml aliquot of the broth 
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culture was measured immediately after 24 hours of incubation using an Oakton D06 
Acorn Series dissolved oxygen meter. 
 
Reduction of Pd(II) to produce bioPd on bacteria 
The aerobically grown liquid culture was divided between two 50 ml Falcon tubes and 
washed three times in 20 ml MOPS-NaOH (morpholinepropanesulfonic acid) buffer, 
20 mM at pH7.6 after centrifugation for 20 minutes at 2500 g. Cell pellets were 
adjusted to a mass of 250 mg wet pellet weight, and resuspended in the MOPS-NaOH 
buffer to a volume of 1 ml. One tube of 250 mg wet weight cells was resuspended in 
22.5 ml MOPS-NaOH buffer with 1 mM sodium tetrachloropalladate in a 30 ml bottle 
sealed with a butyl rubber stopper. The bottle was incubated in the dark at 30°C for 1 
hour for the Pd(II) to biosorb to the cells (Baxter-Plant et al., 2003). 2.5 ml 10 mM 
sodium formate was then added to the bottle to initiate bioreduction of the Pd(II).  
 
Extended X-ray absorption fine structure (EXAFS) 
Aliquots of the cell/Pd/formate suspension were taken at times 0 and 30 minutes, and 1, 
3 and 4 hours from the addition of formate, and frozen immediately in liquid nitrogen. 
The direct reduction of Pd(II) to Pd(0) was demonstrated using EXAFS, performed at 
the European Synchrotron Radiation Facility (ESRF), in Grenoble, France. The 
samples were transported to the synchrotron at ESRF on dry ice, where they were 
thawed and injected immediately into sample holders, before freezing once more in 
liquid nitrogen and placing into the beam. X-ray absorption data were collected on 
beamline BM29 at the Pd K–edge in the energy range 24,200 – 24,900 eV. Data were 
recorded at low temperature (77 K) and under vacuum to reduce the thermal Debye-
Waller factor and prevent oxidation. A Si(111) double crystal monochromator was used, 
calibrated with a Pd foil, and the spectra were collected in fluorescence mode using a 
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13-element solid-state detector. A reference spectrum of a palladium foil was recorded 
in transmission mode on station 9.3 at the SRS Daresbury. The data were background 
subtracted and the EXAFS spectra fitted in DL_Excurv 
(http://www.cse.scitech.ac.uk/cmg/EXCURV/) using full curved wave theory (Gurman 
et al., 1984).  
 
Use of mutants to determine electron transfer pathway to Pd(II) 
In order to investigate the possible role of the aerobic formate dehydrogenase (FDH-O)  
and other hydrogenase/formate dehydrogenase enzymes in the reduction of Pd(II) by 
aerobically-grown cells of E. coli, the rates of reduction by six additional different 
strains (Table 1) were compared by measuring the Pd(II) remaining in solution by ICP-
MS. The strains were ‘palladised’ as above, and rates of reduction/removal compared 
to that in a series of controls – killed cells (MC4100), cell-free suspension, and live 
cells (MC4100) unsupplemented with formate. 
 
All strains except BL21(DE3) were from the culture collection of Professor Frank 
Sargent at the College of Life Sciences, University of Dundee. Strain BL21(DE3) was 
obtained from Invitrogen, Paisley, UK. Strain MC4100 ΔmoaA was created by 
disruption of the moaA gene which encodes the molybdenum cofactor biosynthesis 
protein A, using the method of Datsenko and Wanner (2000) whereby PCR products 
are used to disrupt the gene of choice by recombination using the plasmid-borne phage 
λ Red recombinase. 
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Table 1: E. coli strains used to determine biological involvement in the reduction of 
palladium (II) using formate as the electron donor. 
Strain Genotype Phenotype Reference 
BL21(DE3) F2 ompT gal dcm lon 
hsdSB(rB
–
 mB
–) λ(DE3 
[lacI lacUV5-T7 gene 1 
ind1 sam7 nin5]) 
Wild type strain 
commonly used for 
recombinant protein 
expression. 
(Studier & 
Moffatt, 1986) 
MC4100 F- ΔlacU169 araD139 
rpsL150 relA1 ptsF rbs 
flbB5301 
Parental strain for 
FTD128 and 
ΔmoaA. 
(Casadaban & 
Cohen, 1979) 
BW25113 lacl
q
 rrbBT14 ΔlacZWJ16 
hsdR514 ΔaraBADAH33 
ΔrhaBADLD78 
Parental strain for 
JW2682 and 
JW3865. 
(Datsenko & 
Wanner, 2000) 
FTD128 As MC4100, with in-
frame deletion in the 
fdhE gene. 
FDH-O & FDH-N 
negative. 
(Luke et al., 
2008) 
JW2682 As BW25113, with in-
frame deletion of the 
hypF gene. 
Deficient in all 
hydrogenases. 
(Baba et al., 
2006) 
JW3865 As BW25113, with in-
frame deletion of the 
fdoG gene. 
FDH-O negative. (Baba et al., 
2006) 
MC4100 ΔmoaA As MC4100, disruption 
of the moaA gene. 
Deficient in all 
molybdoenzymes 
This study. 
 
 
X-ray diffraction (XRD) analysis 
The black precipitates were washed once in acetone and air dried, before analysis by X-
ray diffraction (XRD). The measurements were performed on a Bruker D8 Advance 
diffractometer, using Cu K alpha1 radiation. The samples were scanned from 5-70 
degrees 2theta in steps of 0.2 degrees, with a count time of 2 seconds per step. 
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Transmission electron microscopy (TEM) and energy dispersive X-ray 
spectroscopy (EDS) 
Following Pd(II) reduction, cells were stored at 10°C. After 24 hours, the cell pellets 
were rinsed twice with deionised water, fixed in 2.5% (wt/vol) glutaraldehyde, 
centrifuged for 5 minutes at 15,996 g, resuspended in 1.5 ml of 0.1 M cacodylate buffer 
(pH 7) and stained in 1% osmium tetroxide in 0.1 M phosphate buffer, pH 7 (60 min). 
Cells were dehydrated using an ethanol series (70, 90, 100, 100, 100% dried ethanol, 15 
min each) and washed twice in propylene oxide (15 min, 9500 g). Cells were embedded 
in epoxy resin and the mixture was left to polymerise (24 h; 60°C). Sections (100-150 
nm thick) were cut from the resin block, placed onto a copper grid and viewed with a 
JEOL 1200CX2 TEM, accelerating voltage 80 keV. EDS was performed on electron-
dark areas, to confirm the presence of palladium. 
 
RESULTS 
Palladisation of E. coli BL21(DE3) 
The pH of the aerobically-grown liquid culture was between 7.7-7.9, indicating that 
there was no considerable production of organic acids due to overflow metabolism. 
Oxygen saturation measurements showed that the liquid culture was 72% saturated 
following 24 hours of incubation, indicating that it was not oxygen-limited. The 
palladium was seen to be completely removed from solution within 45 minutes (Fig. 1a) 
as confirmed by ICP-MS, and the presence of crystalline Pd(0) was confirmed using 
XRD. 
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Figure 1:  a) complete reduction of Pd(II) to Pd(0) by an aerobically-grown culture of E. 
coli. Both bottles contain cells resuspended in 20 mM MOPS buffer at pH7.6, and 1 
mM sodium tetrachloropalladate (total volume 25 ml). This image was taken 45 
minutes after the addition of formate to the bottle on the right. b) controls showing no 
abiotic reduction of Pd(II). Time is in hours from the addition of formate. Controls used 
were killed (autoclaved) cells, cell-free suspension, and a positive control containing 
MC4100. Soluble Pd(II) in the supernatant was measured using ICP-MS. ▲= MC4100; 
■ = no cells; ♦ = killed cells. 
 
Extended X-ray absorption fine structure (EXAFS) 
The features in EXAFS are due to the wave-like nature of the photoelectron, which is 
released from the atom with increasing energy and scattered from surrounding atoms 
with new waves being emitted. With increasing photon energy, the interference 
between the waves alternates between constructive and destructive, which leads to 
oscillations in the spectrum. Examining these oscillations gives information on the 
number, species and distance of the surrounding atoms. As seen in Figure 4.3, the 
samples taken at times 0 and 30 minutes, which contain Pd(II), have identical EXAFS 
spectra. The samples taken at 60 minutes onwards are identical to the Pd(0) foil control, 
which indicates that only Pd(0) was present. Reduction of the Pd(II) to Pd(0) was 
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therefore complete in less than 30 minutes, which was later confirmed by ICP-MS 
analysis.  
 
Figure 2: EXAFS data showing the presence of Pd(II) at 0 and 30 minutes (bottom two 
traces), and Pd(0) at 1, 3 and 4 hours. The top trace is palladium foil. 
 
Use of mutants to determine electron transfer pathway to Pd(II) 
Controls: The controls showed no abiotic reduction of Pd(II) using formate (Fig. 1b), 
although a brown precipitate was seen in the no-formate control. The X-ray diffraction 
pattern did not show the presence of any peaks characteristic of Pd(0) in this 
precipitate, indicating that it was probably amorphous and non-crystalline. Time 0 on 
Fig. 3 is the point at which formate was added, following one hour of incubation to 
allow biosorption of the Pd(II) to the cells. As the killed cell control has less than 20% 
of the original Pd(II) remaining, this indicates that an increased amount of sorption has 
taken place, possibly due to the increased surface area of the biomass. 
 
Mutants: The parental strains MC4100 and BW25113 and the strain which lacked all 
hydrogenases (JW2682) removed Pd(II) identically with no residual Pd(II) detected 
after 30 minutes (Fig. 3). Removal of the hydrogenase enzymes had no effect of the 
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rate of palladium removal from solution, indicating that hydrogenases have no role in 
the aerobic reduction of Pd(II). The FDH-O-negative strain JW3865 reduced Pd(II) 
within 1 hour, and the FDH-O/FDH-N-negative strain FTD128 within 2 hours. Strain 
MC4100 moaA, lacking all molybdoenzymes, reduced the palladium within 7 hours. 
These results indicate the likely involvement of the FDH-O enzyme in the reduction of 
Pd(II) by aerobically-grown E. coli using formate, although other Mo-containing 
enzymes must also be involved given the impaired metal reduction noted with the 
moa mutant.  
 
 
Figure 3: Pd(II) reduction by six different strains of E. coli, using formate as the 
electron donor. Soluble Pd(II) in the supernatant was measured using ICP-MS. ♦ = 
BW25113; □ = JW2682; ▲= JW3865; Δ = MC4100 ΔmoaA; ■ = MC4100; ◊ = 
FTD128. Data points for BW25113, JW2682 and JW3865 are mean values of triplicate 
readings, with standard error shown. 
 
Transmission electron microscopy (TEM) 
TEM images of thin sections of cells showed that with all strains the reduced palladium 
was precipitated predominantly in the extracellular matrix of the cultures (Fig. 4), 
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although it appears that the nanoparticles may be associated with the outer membrane 
of the cells. Energy dispersive X-ray spectroscopy (EDS) confirmed the presence of 
palladium in these precipitates.  
 
 
 14 
Figure 4: TEM of thin sections of aerobically grown cells showing extracellular 
palladium; a) MC4100, inset BL21(DE3); b) BW25113, inset BL21(DE3) (no Pd); c) 
FTD128; d) JW2682; e) MC4100 moaA; f) JW3865. Scale bar a) = 100 nm; b)-f) = 
500 nm; insets = 1μm. 
 
DISCUSSION 
The results above demonstrate that it is possible for aerobically-grown cultures of E. 
coli to enzymatically reduce Pd(II), with no need to de-aerate the experimental system 
during the bioreduction step. The only known aerobically-expressed molybdoenzyme 
(FDH-O) is involved, but it is not the only enzyme implicated. Autoclaved control 
experiments indicate that Pd(II) bioreduction in these cultures is enzymatic, with 
reduction of palladium not occurring in the absence of viable cells irrespective of the 
length of incubation. The major enzymes shown to be involved include the formate 
dehydrogenases FDH-O and FDH-N, although bioreduction still occurs in strains 
without these enzymes albeit at a much lower rate. Other molybdoenzymes must 
therefore be involved. The strain that lacked all molybdoenzymes however did still 
reduce the palladium, although this took 7 hours, compared with less than 30 minutes 
by the wild-type strains. Hydrogenases, implicated as the dominant Pd(II) reductases in 
other experimental systems (Deplanche et al., 2010; Mikheenko et al., 2008) are not 
expressed in aerobically grown cultures, and their lack of involvement was evident as 
the strain lacking any hydrogenase enzymes reduced palladium at the same rate as the 
wild-type strains.  
 
Furthermore, whichever biological system is responsible for the aerobic bioreduction 
system, there seems to be little impact on the site of Pd(0) deposition. The location of 
the bioreduced Pd(0) in our experiments is almost always extracellular, although often 
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associated with the outer membrane of the cells. This is particularly the case with the 
MC4100 moaA strain (which lacks all molybdoenzymes), in which the majority of the 
Pd(0) nanoparticles are closely associated with the outer membrane (Figure 4e). One 
conclusion that may be drawn from this is that whilst cells that lack the formate 
dehydrogenases are still capable of reducing Pd(II), when all of these enzymes are 
missing a cellular component associated with the outer membrane may be responsible. 
Furthermore, this formate oxidation activity is much weaker than that seen with the 
strains containing formate dehydrogenases, where Pd(II) reduction is more rapid. It is 
possible however that following the initial enzymatic reduction of a small percentage of 
the Pd(II), the Pd(0) nanoparticles formed may themselves be responsible for catalysing 
the reduction of the remainder of the Pd(II) (Yong et al., 2002), which would mean that 
only a minor, initial biological input is required.  
 
Although the formate dehydrogenase enzyme systems implicated in Pd(II) bioreduction 
by E. coli are periplasmic, the majority of the reduced Pd(0) precipitates outside the 
cell. It is possible that an electron shuttle system exists similar to that found in 
Geobacter sulfurreducens and Shewanella oneidensis (Lloyd et al., 2003) that is as yet 
undiscovered in E. coli. It is also possible that the first Pd(0) nanoparticles to form 
breach the outer membrane, and themselves form an electron conduit for further Pd(II) 
reduction outside the cell. The pH of these experiments is also higher than others where 
Pd(0) nanoparticles accumulated in the periplasm (Redwood et al., 2008), which could 
indicate the higher biosorption of cationic metals to the outer membrane and 
extracellular polymeric substances, which are then not able to enter the periplasm. The 
influence of a higher pH in the location of the Pd(0) may be confirmed by the 
observation that Pd(0) nanoparticles were located on the cell surface of D. 
desulfuricans when the bioreduction was performed at pH 7 (Yong et al., 2002). 
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One limitation of using ICP-MS for the measurement of Pd(II) in solution is that 
palladium removal is measured rather than palladium reduction. This meant that the 
formation of a brown precipitate in the cell control lacking formate, and from 3-7 hours 
following formate addition in the MC4100 ΔmoaA strain, implied Pd(II) reduction to 
Pd(0) where none had occurred. This precipitate may be formed due to increased 
biosorption of the Pd(II) to viable cells over time. There is also removal of  soluble 
Pd(II) when using autoclaved cells, possibly indicating that the increased surface area 
of the lysed cells leads to increased sorption of the Pd(II) to the biomass. In some cases, 
such as with the strains MC4100 and FTD128, the reduced palladium particles were so 
small that they could not be removed from the reaction supernatant, and gave a false 
impression of the amount of Pd(II) remaining in solution. Synchrotron radiation 
techniques such as X-ray absorption would be better to measure bioreduction, as it 
provides the oxidation state of the palladium. However, the time constraints involved in 
securing beam time made this approach unfeasible. 
 
This study has demonstrated the presence of a novel biological mechanism responsible 
for the bioreduction of Pd(II) in aerobically-grown cultures of E. coli, catalysed mainly 
by molybdenum-containing enzyme systems. Subsequent studies will investigate the 
catalytic activity of the Pd(0) nanoparticles produced under aerobic conditions in a 
range of industrially important reactions. If active, this new form of bioPd has the 
advantage over that produced by anaerobic culture as it is easier to produce and 
perform and provides increased biomass. There is also no requirement for additional 
processing steps to remove H2S (produced by SRB systems), and the use of formate 
instead of hydrogen gas means that the procedure is less hazardous and more 
controllable. 
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ABSTRACT 
We have previously developed a biometallic catalyst for the cyclic deracemisation of 
amines, using Escherichia coli transformed with a variant monoamine oxidase gene 
(mao-N-D5), and loaded with bioreduced Pd(0) nanoparticles. Here, this new 
biocatalyst is immobilised in alginate beads, to facilitate  re-use, and through freeze-
drying to increase its stability during storage. Encapsulation had no effect on the 
activity of either the enzyme or the biogenic Pd(0) catalyst, as the amine substrate was 
deracemised to give the (R)-enantiomer in up to 91% enantiomeric excess following 
 2 
five cycles of oxidation and reduction reactions using either immobilised or planktonic 
cells. Loss of palladium from the immobilised biometallic catalyst was minimised, with 
ICP-MS data showing that only 9.8 μg l–1 palladium was lost into the reaction 
supernatant following deracemisation using the immobilised biocatalyst, compared 
with 63.4 μg l–1 without immobilisation in alginate. The storage time of the beads was 
successfully increased to up to six weeks (the time limit of this experiment) by freeze-
drying the beads and storing under vacuum. 
 
Keywords: palladium catalyst, Escherichia coli, biocatalysis, biotransformation, 
deracemisation, immobilisation, alginate. 
 
INTRODUCTION 
The production of functional biominerals by microbial routes presents a green 
technology capable of leading to a permanent shift towards the biosynthesis of 
nanomaterials. Recent developments in the production of biominerals include precious 
metal catalysts (Coker et al., 2010; Macaskie et al., 2010), nanomagnets for 
hyperthermic cancer treatment (Coker et al., 2009), quantum dots (Pearce et al., 2008), 
bioremediation agents (Cutting et al., 2009), silver-based antimicrobials (Suresh et al., 
2010), and SERS probes (Jarvis et al., 2008). We have previously also engineered a 
recombinant whole cell biocatalyst, exploiting the ease with which Escherichia coli can 
be genetically manipulated, as well as its ability to reduce soluble palladium (II) to 
nanoparticulate Pd(0) suitable for use in reduction reactions (Foulkes et al., 2011). 
 
The bioreduction of soluble Pd(II) to insoluble Pd(0) was first reported in anaerobic 
cultures of the sulphate-reducing bacterium (SRB) Desulfovibrio desulfuricans (Lloyd 
et al., 1998), with the aim of recovering of palladium from industrial wastewaters. D. 
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desulfuricans was chosen for its high metal reductase activity and broad specificity. 
Using pyruvate, formate, and hydrogen as electron donors, the bacteria catalysed the 
reduction of Pd(II) to form nano-scale clusters of Pd(0) in the periplasm (detected by 
electron microscopy), via a process referred to as palladisation. A number of studies 
have investigated the catalytic activity of this material (“Bio-Pd”), demonstrating its 
use in processes including the evolution of H2 from sodium hypophosphite (Yong et al., 
2002), the dehalogenation of chlorophenol, polychlorinated biphenyls, polybrominated 
diphenyl ethers (Baxter-Plant et al., 2003; De Windt et al., 2005; Harrad et al., 2007), 
trichloroethylene (Hennebel et al., 2009a; Hennebel et al., 2009b), and the pesticide γ- 
hexachlorocyclohexane (Mertens et al., 2007), the hydrogenation of itaconic acid 
(Creamer et al., 2007a; Creamer et al., 2007b), and the reduction of Cr(VI) to Cr(III) 
(Mabbett et al., 2002; Mabbett et al., 2004). In each case where the Bio-Pd was 
compared with an abiotically-produced palladium catalyst (finely-divided or supported 
on a carbon matrix), the Bio-Pd was more active or at least as active as the 
commercially available alternative. The mechanisms responsible for the formate-
dependent bioreduction of Pd(II) by anaerobic cultures of E. coli have been studied, 
and have implicated the involvement of the hydrogenase enzymes Hyd-1 and Hyd-2 
(Deplanche et al., 2010). 
 
The requirement for enantiomerically pure chiral amines in the pharmaceutical and 
agrochemicals industries has led to the requirement for biocatalysts that can generate 
up to 100% yield of products, with up to 100% e.e. (enantiomeric excess) (Alexeeva et 
al., 2002). Previously published work has investigated the use of lipases and 
transaminases, using lipases for hydrolysis reactions and transaminases for the 
conversion of ketones to chiral amines. Lipases are also suitable for use with primary 
amines and some secondary amines only, with no activity towards tertiary amines 
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(Dunsmore et al., 2006). Using a conceptually different approach, we have used the 
monoamine oxidase enzyme MAO-N-D5, a variant of the MAO-N enzyme of 
Aspergillus niger produced by directed evolution of the mao-N gene as an alternative 
enzyme in deracemisation reactions (Atkin et al., 2008; Dunsmore et al., 2006). E. coli 
cells transformed with the mao-N-D5 gene can then be palladised to produce a 
multifunctional biocatalyst which generates imine intermediates by oxidation of the 
(S)-enantiomer of the amine, which are then non-selectively reduced back to the 
racemic amine by the Pd(0) catalyst (Figure 1). After several cycles of oxidation and 
reduction, a high yield and e.e. of the (R)-enantiomer is achieved (Foulkes et al., 2011). 
 
 
Figure 1: The cyclic deracemisation of 1-methyltetrahydroisoquinoline (MTQ) via the 
imine 1-methyl-3,4-dihydroisoquinoline (MDQ) using palladised E. coli cells with the 
mao-N-D5 gene expressed, immobilised in an alginate bead. 
 
Immobilisation matrices for biocatalysts are being used increasingly as they extend the 
viability of the cells, increase recyclability of the biocatalyst, and facilitate the 
separation of the biocatalyst from their products. Matrices used for the entrapment of 
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whole cells include hydrogels, such as calcium alginate and chitosan; thermogels, such 
as agar or agarose; and synthetic polymers, such as polyacrylamide and sol-gel. 
 
The aim of this study was to demonstrate that palladised transformed E. coli cells that 
can be used for the deracemisation of amines can be immobilised successfully in a 
suitable polymeric matrix, in this case alginate, providing a superior biometallic 
catalyst for industrial use. The advantage of immobilisation is that the cells are kept 
separate from the substrate facilitating removal when the reaction is complete. Alginate 
was used in this study as it is non-toxic, and the method used for cell immobilisation 
avoids the use of toxic reagents or harsh processing steps (Hartmeier, 1988). 
 
METHODS 
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Figure 2: Schematic of methods. 1) transformation of E. coli with pET-16b plasmid 
containing mao-N-D5 gene insert; 2) palladisation of transformed E. coli; 3) 
immobilisation of palladised cells in alginate beads; 4) oxidation of (S)-MTQ via 
expressed MAO-N-D5 enzyme; 5) reduction of MDQ via Pd(0) nanoparticles and 
hydrogen. 
 
TRANSFORMATION OF E. COLI BL21 WITH PET-16B PLASMID CONTAINING THE MAO-
N-D5 INSERT 
Strains and plasmid: E. coli BL21 cells were obtained from Invitrogen. The pET16-b 
plasmid containing the mao-N-D5 insert and an ampicillin resistance gene was obtained 
from Dr Andrew Ellis at the Manchester Interdisciplinary Biocentre. Bacterial isolates 
were stored at -80C, and the plasmid was stored at -20C. 
Transformation: Cells were transformed according to the supplier’s instructions, 
using approximately 100 ng of plasmid. Transformed BL21 cells were subcultured onto 
LB agar plates containing 100 g ml
-1
 ampicillin, and incubated overnight at 37C 
before storage at 4C for a maximum of 1 week. 
 
PALLADISATION OF E. COLI BL21 
The method used was that used previously, as adapted from that used by Lloyd and 
Macaskie (1998), as follows. 
Starter cultures: 50 ml LB broth in a 500 ml Erlenmeyer flask was inoculated with a 
single isolated colony of the transformed E. coli and incubated overnight at 37C, 
shaking at 180 rpm. 
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Flask cultures: An 11 ml starter culture was added to 99 ml LB broth containing 100 
g ml-1 ampicillin, in a 1 L Erlenmeyer flask. Flasks were incubated for 24 hours at 
37C, shaking at 180 rpm. 
Palladisation: Each culture was divided between two 50 ml Falcon tubes (supplied by 
Fisher) and washed three times in 20 ml MOPS-NaOH (morpholinepropanesulfonic 
acid) buffer, 20 mM at pH7.6 after centrifugation for 20 minutes at 2500 g. Cell pellets 
were adjusted to a mass of 250 mg, based on the wet cell pellet, and resuspended 
MOPS-NaOH to a volume of 1 ml. Two tubes of each culture were resuspended in 25 
ml buffer with 1 mM sodium tetrachloropalladate (supplied by Alfa Aesar) in 30 ml 
bottles sealed with butyl rubber stoppers (two bottles per culture). Bottles were 
incubated in the dark at 30C for 1 hour for the Pd(II) to biosorb to the cells 
(Humphries et al., 2006). One of each of the two different cultures was then purged 
with H2 for 5 minutes, with H2 allowed to fill the headspace. The remaining two bottles 
were H2-negative controls. 
 
X-RAY DIFFRACTION (XRD) ANALYSIS 
The cells were coated in a black precipitate within a few minutes in bottles containing 
cells as Pd(II) purged with H2. The palladised cells settled out leaving a clear colourless 
supernatant. The black precipitate was washed once in acetone and air-dried, before 
investigation by XRD. The measurements were performed on a Bruker D8 Advance 
diffractometer, using Cu Kalpha1 radiation. The samples were scanned from 5-70 
degrees 2theta in steps of 0.2 degrees, with a count time of 2 seconds per step. 
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TRANSMISSION ELECTRON MICROSCOPY (TEM) AND ENERGY DISPERSIVE X-RAY 
SPECTROSCOPY (EDX) 
Sections of the palladised cells were provided by EM facility in the Faculty of Life 
Sciences, University of Manchester. The bacteria were fixed in primary fixative (2.5% 
glutaraldehyde and 4% formaldehyde in 0.1M sodium cacodylate buffer at pH7.4) and 
secondary fixative (1% osmium tetroxide and 1.5% potassium ferrocyanide in 0.1M 
sodium cacodylate buffer at pH7.4) and dehydrated in a graded acetone series (30 
minutes each in 50%, 70%, 90% and three changes at 100%) before embedding in 
TAAB LV medium epoxy resin. EDX was performed on electron-dark areas, to 
confirm the presence of palladium. 
 
IMMOBILISATION OF PALLADISED TRANSFORMED CELLS IN ALGINATE 
The method used for the immobilisation of palladised transformed cells in alginate 
beads was adapted from that of Hartmeier (1988). 1.2 g sodium alginate was dissolved 
in 42 ml distilled water, and 6 ml of palladised transformed E. coli cells (250 mg ml
-1
 in 
20 mM MOPS-NaOH buffer at pH 7.6) were added to 350 ml dissolved alginate 
solution. The alginate-cell suspension was then dropped into 200 ml of a 2% w/v CaCl2 
solution using a plastic Pasteur pipette, whilst gently stirring to prevent bead 
aggregation. Alginate beads were left stirring for 1 hour to harden, after which time the 
CaCl2 solution was diluted to 0.5% w/v with the addition of a further 600 ml distilled 
water. Beads were stored in the 0.5% w/v CaCl2 solution and refrigerated until use 
(Figure 3c).  
 
KINETICS OF SUBSTRATE OXIDATION AND REDUCTION 
Oxidation: 5.35 g beads (equivalent to 250 mg ml
-1
 cells in 20 mM MOPS-NaOH 
buffer at pH 7.6) were rinsed in 0.1 M MOPS, and added to 10 ml 10 mM racemic 
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MTQ (obtained from GSK), made up in 0.1 M MOPS buffer at pH 7.6. The vessel used 
was a 120 ml gas bottle sealed with a butyl rubber stopper, providing a 110 ml 
headspace (Figure 3d). The reaction was allowed to proceed in air at 37°C, with 
shaking at 225 rpm. Samples were taken as required, by removing 500 µl supernatant in 
triplicate, and storing at -20°C before extraction with methyl-tert-butyl ether (MTBE). 
Beads were tested on day one, after one week, and after two weeks, in order to 
determine the loss of activity following storage at 10°C. 
Reduction of MDQ with hydrogen as the electron donor: 5.35 g beads (equivalent 
to 250 mg ml
-1
 cells in 20 mM MOPS-NaOH buffer at pH 7.6) were rinsed in 0.1 M 
MOPS, and added to 10 ml 10 mM MDQ (1-methyl-3,4-dihydroisoquinoline, supplied 
by Acros Organics), made up in 0.1 M MOPS buffer at pH 7.6. The reaction volume 
was 10 ml, in a 120 ml gas bottle, providing a 110 ml headspace. The bottle was 
sparged with hydrogen for 90 seconds before incubating and extracting as previously. 
Beads were tested on day one, after one week, and after two weeks, in order to 
determine the loss of activity following storage. 
HPLC analysis: The MTBE phase of the sample extract was dried with Na2SO4 and 
concentrated in vacuo to yield the MTQ as a colourless oil. The samples were 
resuspended in 200 µl isohexane prior to testing by normal phase chiral HPLC on an 
Agilent 1200 chromatograph, using a Daicel Chiralpak AD-H 4.6 mm x 250 mm 
column, at a flow rate of 1 ml min
-1
 for 20 minutes at 40°C with a mobile phase of 88% 
isohexane, 2% ethanol, and 10% isohexane containing 0.5% diethylamine. The analytes 
were detected by UV-Vis spectroscopy, at wavelengths of 220 nm (MTQ), and 254 nm 
(MDQ). The error (RSD) was 2.8%. 
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INTEGRATION OF PROCESSES FOR DERACEMISATION 
Oxidation and reduction steps were performed as separate cycles, by flushing the vessel 
alternately with air or hydrogen. The reaction vessel was a 120 ml gas bottle with a 10 
ml reaction volume, providing a 110 ml headspace. The vessel was first flushed with 
nitrogen to avoid the mixing of air and hydrogen. Each oxidation step was two hours 
long, and each reduction step was 45 minutes. Samples were taken at the end of each 
reduction step, for 5 cycles. The same beads were used in three consecutive 
deracemisation reactions over three days, with storage in the reaction mixture at 10°C 
overnight between reactions. Beads were rinsed briefly with 0.1 M MOPS buffer before 
addition to the substrate. 
 
MEASURING THE LOSS OF PALLADIUM INTO THE REACTION SUPERNATANT 
Aliquots of reaction supernatant were analysed following a biotransformation, in order 
to measure the amount of palladium lost from the biocatalyst. The supernatant was 
digested with an equal volume of 70% nitric acid for 24 hours, diluted to 2% nitric 
acid, and filtered before analysis for the presence of palladium using an Agilent 7500cx 
ICP-MS. 
 
ENVIRONMENTAL SCANNING ELECTRON MICROSCOPY (ESEM) 
Biocatalyst-containing beads were examined using a Philips XL30 ESEM-FEG using 
ionised water vapour to disperse the charge from the sample surface, thus avoiding the 
need to carbon coat. The beads were imaged both before and after use in a 
deracemisation reaction, in order to determine any possible effects on the integrity of 
the beads. 
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USE OF FREEZE-DRIED BEADS IN OXIDATION AND REDUCTION REACTIONS 
To assess the suitability of freeze-drying for the long-term storage of the biocatalyst, 
beads were frozen in liquid nitrogen and dried for 24 hours. The beads were stored at 
10°C under vacuum until use. 
 
RESULTS 
PALLADISATION OF E. COLI BL21 
Washed aerobically-grown E. coli BL21 cells containing the cloned gene expressing 
the enzyme MAO-N-D5 were palladised by challenging with 1 mM Pd(II) and 
hydrogen gas as an electron donor. The cells were coated in a black precipitate within a 
few minutes, indicating the reduction of Pd(II) to insoluble particles of Pd(0) (Lloyd et 
al., 1998). Pd(II) did not reduce to Pd(0) in bottles that were not purged with H2, or in 
the absence of cells. The black precipitate was analysed by X-ray diffraction to confirm 
the presence of elemental palladium (Figure 3a), although the signal was weak due the 
nanoparticulate nature of the sample. The size of the particles was calculated to be 
approximately 1 nm in diameter using the Scherrer equation. 
 
TEM images of thin sections of cells showed that the reduced palladium was 
precipitated predominantly in the extracellular matrix of the cultures (Figure 3b). 
Energy dispersive X-ray spectroscopy (EDX) confirmed the presence of palladium in 
these electron dense nano-scale precipitates. 
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Figure 3: a) XRD showing presence of palladium on in the microbial cultures supplied 
with Pd(II) and hydrogen as the electron donor; b) TEM of thin sections of aerobically 
grown cells showing extracellular palladium; c) Alginate beads containing immobilised 
palladised E. coli; d) Alginate beads in reaction vessel, showing 10 ml substrate and 
110 ml headspace. 
 
KINETICS OF SUBSTRATE OXIDATION AND REDUCTION  
When palladised transformed cells of E. coli immobilised in alginate beads were added 
to 10 mM racemic MTQ and incubated at 37°C, less than 7% (S)-enantiomer (0.7 mM) 
of the MTQ remained after two and a half hours (Figure 4a). The remainder was 
oxidised to MDQ, which made up 48% of the total product (4.8 mM). On consecutive 
oxidation reactions however, there was a loss of activity.  By the third oxidation, 18% 
(S)-enantiomer (1.8 mM) still remained after 2.5 hours. 
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Figure 4: a) Three consecutive oxidations of (S)-MTQ to MDQ at 37°C, by cells of E. 
coli transformed with the mao-N-D5 gene insert and immobilised in alginate beads; b) 
Three consecutive reductions of MDQ to racemic MTQ at 37°C, by palladised E. coli 
immobilised in alginate beads, using hydrogen gas as the electron donor. Triplicates of 
each time point were tested, and the error bars show the standard error. 
 
When the immobilised cells were added to 10 mM MDQ, sparged with hydrogen gas 
for 90 seconds and incubated at 37°C, all of the MDQ was reduced to racemic MTQ 
within 45 minutes (Figure 4b). Re-use of the biocatalyst (three consecutive oxidation 
reactions followed by three consecutive reduction reactions) had no effect on the 
activity of the Pd(0) nanoparticles. 
 
INTEGRATION OF PROCESSES FOR DERACEMISATION  
To avoid the potentially hazardous mixing of air and hydrogen in the reaction vessel, 
oxidation and reduction steps for deracemisation were performed as separate cycles. 
Based on the results from the separate oxidation and reduction reactions using 
planktonic cells (Foulkes et al., 2011), each oxidation step was maintained for two 
hours, and each reduction step was 45 minutes, to allow each reaction to proceed to 
completion. After five cycles of oxidation and reduction, the (R)-enantiomer was 
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present in an enantiomeric excess (e.e.) of 85% (Figure 5). The hypothetical value at 
this stage after 5 cycles of oxidation and reduction is a 96.876% e.e.  
 
 
Figure 5: The deracemisation of MTQ by palladised E. coli transformed with the mao-
N-D5 gene insert and immobilised in alginate beads, giving an e.e. of 85% (R)-MTQ (5 
cycles of air alternated with 5 cycles of hydrogen). Triplicates of each time point were 
tested, and the error bars show the standard error. 
 
When beads used in a 5-cycle biotransformation that generated an enantiomeric excess 
of 91% were collected and washed with MOPS buffer and used in further 
biotransformation experiments, it was found that the enantiomeric excess of (R)-MTQ 
was 88% in the second biotransformation and 78% in the third biotransformation 
(Table 1). Thus both the activity of either the recombinant enzyme or the Bio-Pd was 
slightly reduced in multiple rounds of biotransformation.  
 
In order to determine the impact of storage on the performance of the biocatalyst, beads 
that had been stored for 2 weeks were used in oxidation-only experiments. The results 
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showed the production of 24% MDQ in 2.5 hours, with 34% (S)-MTQ remaining. The 
same beads were subsequently used in a reduction-only experiment, in which all MDQ 
was reduced to racemic MTQ within 45 minutes, showing no loss in activity of the Bio-
Pd.  
  
Table 1: Enantiomeric excess following a biotransformation of five cycles of oxidation 
and reduction. 
Biocatalyst % (S)-MTQ % (R)-MTQ % e.e. 
Planktonic cells 3 95 90 
Immobilised cells (first 
biotransformation) 
4 95 91 
Immobilised cells (second 
biotransformation) 
6 94 88 
Immobilised cells (third 
biotransformation) 
11 89 78 
 
MEASURING THE LOSS OF PALLADIUM INTO THE REACTION SUPERNATANT 
Palladium in the reaction supernatant was measured in triplicate by ICP-MS, in order to 
determine the extent of Pd leaching by the immobilised biocatalyst compared with 
planktonic cells. The ICP-MS results showed that 9.8 ±0.2 μg l–1 palladium was lost 
into the reaction supernatant following deracemisation of MTQ using immobilised 
biocatalyst. When using planktonic cells, the level of palladium in the supernatant was 
63.4 ±0.3 μg l–1, demonstrating the improved stability of the palladium nanoparticles 
when immobilised in alginate.  
 
ENVIRONMENTAL SCANNING ELECTRON MICROSCOPY (ESEM) 
ESEM was used to examine the structural integrity of the beads following their use in a 
biotransformation experiment. Little difference was seen in the surface integrity of the 
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beads following their use in a 5-cycle deracemisation reaction (Figure 6), although 
some pitting of the surface appears. 
 
Figure 6: a) ESEM image of the surface of an alginate bead with immobilised 
palladised E. coli, before use in a 5-cycle deracemisation reaction; b) ESEM image of a 
bead after use in a deracemisation reaction. 
 
USE OF FREEZE-DRIED BEADS IN OXIDATION AND REDUCTION REACTIONS 
In order to discover whether the life of the biocatalyst could be extended, beads were 
freeze-dried and stored for up to six weeks under vacuum at 10°C. When freeze-dried 
beads were used immediately in oxidation-only experiments, results showed the 
production of 34% MDQ in 2.5 hours, with 20% (S)-MTQ remaining (Figure 7a). The 
same beads were subsequently used in a reduction experiment, in which all MDQ was 
reduced to racemic MTQ within 45 minutes, showing no loss in activity of the Bio-Pd. 
Freeze-dried beads that had been stored at 10°C for 2 weeks when used in an oxidation-
only experiment showed the production of 34% MDQ in 2.5 hours, with 20% (S)-MTQ 
remaining. Freeze-dried beads that had been stored at 10°C for 6 weeks when used in 
an oxidation-only experiment showed the production of 38% MDQ in 2.5 hours, with 
14% (S)-MTQ remaining. Despite the loss in activity due to freeze-drying therefore, the 
activity remained constant following storage, unlike the fresh beads which showed a 
considerable drop in activity after only 2 weeks. In the reduction-only experiment, all 
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MDQ was reduced to racemic MTQ within 45 minutes (Figure 7b), showing no loss in 
activity of the Bio-Pd despite freeze-drying and storage. 
 
 
Figure 7: a) The oxidation of (S)-MTQ to MDQ at 37°C, by E. coli transformed with 
the mao-N-D5 gene insert and immobilised in alginate beads before freeze-drying and 
testing immediately, after storage at 10°C for 2 weeks, and after storage at 10°C for 6 
weeks; b) The reduction of MDQ to rac-MTQ at 37°C, by palladised E. coli cells 
immobilised in alginate beads before freeze-drying and testing immediately using 
hydrogen gas as the electron donor, after storage at 10°C for 2 weeks, and after storage 
at 10°C for 6 weeks. Triplicates of each time point were tested, and the error bars show 
the standard error. 
 
DISCUSSION 
Having demonstrated that it is possible to engineer a biometallic catalyst capable of 
one-pot deracemization reactions, we have now shown that this biocatalyst can be 
successfully immobilised in an alginate matrix to improve its performance. These 
biocatalyst-containing beads facilitate the use of the biocatalyst and increase its 
stability based on the leaching of palladium into the reaction supernatant, and freeze-
drying prolongs the activity of the enzyme. 
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This study used aerobic cultures of E. coli for the hydrogen-dependent reduction of 
Pd(II), a procedure previously only performed using anaerobically grown cells. In 
addition to being easier to manipulate, aerobic cultures give higher cell yields, higher 
expression of recombinant proteins (Krause et al., 2010), and do not require additional 
processing steps for the removal of H2S which would otherwise poison the metal 
catalyst (Redwood et al., 2008). The reduction of Pd(II) using hydrogen as the electron 
donor is likely to involve biological mechanisms, as the time taken for complete 
reduction is significantly increased in cell-free controls and killed (autoclaved) controls 
(Yong et al., 2002). Pd(0) nanoparticles approximately 1 nm in diameter are located 
extracellularly, as shown in the transmission  electron micrograph of the palladised 
cells (Figure 3c), although the nanoparticles appear to be associated with the outer 
membrane of the cells. 
 
Palladised E. coli transformed with the mao-N-D5 plasmid is capable of performing 
both oxidation and reduction reactions required for the deracemisation of amines, as 
shown here and previously (Foulkes et al., 2011). The immobilisation of the biocatalyst 
in alginate was performed in order to facilitate its re-use, and extend its storage life. 
The activity of the immobilised biocatalyst was at first as high as that of the planktonic 
cells, and the product yield after three consecutive biotransformations was still high at 
89%. The capacity of the Pd(0) catalyst to reduce MDQ to MTQ was not affected by 
the re-use or storage of the beads, but the activity of the MAO-N-D5 enzyme was 
reduced over time. However, freeze-drying the beads prevented loss of activity of the 
enzyme, which was unaffected by six weeks of storage of the beads (the time limit of 
this particular experiment). The activity of the Pd(0) was also unaffected by freeze-
drying, making this a useful method for prolonging the life of this immobilised 
biocatalyst. 
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In conclusion, we have developed an immobilised biometallic catalyst, suitable for use 
in the two-step one pot deracemisation of 1-methyltetrahydroisoquinoline with high 
yield and e.e., and suitable for long-term storage without loss of activity. This method 
should also be applicable to the deracemisation of a range of other amine substrates, as 
demonstrated previously (Carr et al., 2005; Dunsmore et al., 2006), and using other 
enzyme/metal combinations, could be potentially useful for a range of industrial and 
biotechnological applications. 
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1.  The use of monoamine oxidase and biogenic palladium in the 
deracemization of the secondary amine 1-methyltetrahydroisoquinoline 
Joanne M. Foulkes, Kirk J. Malone, Nicholas J. Turner, Jonathan R. Lloyd 
 
A method was reported previously for a two-step, one pot deracemization of primary,
1
 
secondary,
2
 and tertiary
3
 amines. This method employs the enantioselective monoamine 
oxidase MAO-N-D5,
4, 5
 and a non-selective reducing agent. We have developed this 
method further by employing genetically transformed Escherichia coli cells expressing 
the monoamine oxidase, and biogenic nanoparticulate palladium produced 
extracellularly by the bacterium as the reducing agent (Figure 1).  
 
 
 
Figure 1 Transmission electron micrograph of thin sections of cells of E. coli with 
extracellular biogenic palladium associated with the outer membrane. 
 
This biometallic catalyst was used successfully for the conversion of  racemic 1-
methyltetrahydroisoquinoline (MTQ) to (R)-MTQ, via the intermediate 1-
methyldihydroisoquinoline (MDQ), with an enantiomeric excess of 93% (Figure 2). 
 
 
 
 
Figure 2 The cyclic deracemisation of 1-methyltetrahydroisoquinoline (MTQ) via 
the imine 1-methyldihydroisoquinoline (MDQ) using palladised bacterial cells with the 
mao-N-D5 gene expressed. 
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1.1 Procedure 1: Transformation and palladisation of Escherichia coli 
 
1.1.1 Materials and Equipment 
 
 E. coli BL21 competent cells (50 μL – Invitrogen) 
 plasmid pET16b (Novagen) containing the variant mao-N-D5 gene (2 μL) 
 SOC broth 
 Luria-Bertani (LB) agar in Petri dishes containing 100 μg mL-1 ampicillin 
 ice bath 
 water bath at 42°C 
 static incubator 
 Erlenmeyer flasks (500 mL and 1 L) with foam bungs 
 LB broth containing 100 μg mL-1 ampicillin 
 shaker/incubator 
 centrifuge 
 morpholinepropanesulfonic acid (MOPS) buffer (20 mM, pH 7.6) 
 gas bottles (25 mL), with butyl rubber stoppers and metal sealable caps 
 sodium tetrachloropalladate (7.3553 mg, 0.025 mmol) 
 hydrogen gas 
 
 
1.1.2 Procedure 
 
1. The plasmid was transformed into E. coli BL21 competent cells according to 
the manufacturer’s instructions. 
2. The transformed cell suspension (30 μL) was spread onto an LB-ampicillin agar 
plate and incubated at 37°C for 18 h. 
3. A single colony was used to inoculate 50 mL LB-ampicillin broth in a 500 mL 
Erlenmeyer flask (starter culture). This was incubated at 37°C, 180 rpm for 18 
h. 
4. The cell suspension (11 mL) was used to inoculate 99 mL of fresh LB-
ampicillin broth in a 1 L Erlenmeyer flask. This was incubated at 37°C, 180 
rpm for 24 h. 
5. Cells were harvested by centrifugation at 3000 g for 20 minutes. 
6. Cells were washed three times in MOPS buffer (12.5 mL), and wet cell pellets 
were resuspended in MOPS buffer to a cell mass of 250 mg mL
-1
. 
7. Cells (1 mL, 250 mg mL-1) were added to MOPS buffer (21.5 mL) in a 30 mL 
gas bottle, and sodium tetrachloropalladate solution (10 mM, 2.5 mL) was 
added. 
8. The cell suspension was incubated at 30°C, 180 rpm for 1 h, in order for the 
Pd(II) to biosorb to the cells.
6
 
9. The cell suspension was sparged with hydrogen gas for up to 5 minutes, during 
which time the soluble Pd(II) (light brown in colour) was reduced to insoluble 
Pd(0) enzymatically (black precipitate). 
10. Palladised cells were harvested by centrifugation at 3000 g for 20 minutes. 
11. Cells were resuspended in MOPS buffer to a volume of 1 mL, and used directly 
in Procedure 2 (Section 1.2). 
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1.2 Procedure 2: Deracemization of rac-MTQ 
 
1.2.1 Materials and Equipment 
 
 whole palladised cells expressing the variant MAO-N-D5 enzyme  
(250 mg mL
-1
) 
 potassium phosphate buffer (K2HPO4-KH2PO4) (9 mL, 0.1 M, pH 7.6) 
 racemic MTQ (14.7 mg, 0.1 mmol) 
 methyl-tert-butyl ether (MTBE) 
 anhydrous Na2SO4 
 gas bottle (100 mL), with butyl rubber stopper and metal sealable cap 
 shaker/incubator 
 microcentrifuge 
 hydrogen gas 
 nitrogen gas 
 
 
1.2.2 Procedure 
 
1. A 1 mL aliquot of palladised cells expressing the MAO-N-D5 variant enzyme 
was suspended in potassium phosphate buffer (0.1 M, pH 7.6, 9 mL). Racemic 
MTQ (14.7 mg, 0.1 mmol) was added. The gas bottle was sealed with a butyl 
rubber stopper and metal cap, and was incubated at 37°C, 225 rpm for 2 h. 
2. The cell/MTQ suspension was flushed with nitrogen gas, then sparged with 
hydrogen gas for 2 minutes, and was further incubated at 37°C, 225 rpm for 1 h. 
3. Five cycles of air/hydrogen incubation were performed with nitrogen flushing 
between each step, and samples (0.5 mL) were taken for analysis at the end of 
each reduction step. 
4. For high-performance liquid chromatography (HPLC) analysis: the reaction 
mixture was clarified by centrifugation at 14 000 g for 5 minutes, and the 
supernatant decanted and extracted with 1 mL MTBE. The MTBE phase was 
dried with Na2SO4 and concentrated in vacuo to yield the MTQ as a colourless 
oil. Samples were resuspended in 200 μL iso-hexane. 
5. Enantiomeric excess was determined by HPLC with a Daicel Chiralpak AD-H 
4.6 mm x 250 mm column, at a flow rate of 1 ml min
-1
 for 20 minutes at 40°C 
with a mobile phase of 88% isohexane, 2% ethanol, and 10% isohexane 
containing 0.5% diethylamine. The analytes were detected by UV-Vis 
spectroscopy, at wavelengths of 220 nm (MTQ), and 254 nm (MDQ). Major 
enantiomer Rt = 12.03 min, 93% ee. 
 
 
 
1.3 Conclusion 
 
This biometallic whole-cell catalyst provides a reproducible method for the 
deracemisation of amines that can potentially be applied to a wide range of substrates 
including primary, secondary, and tertiary amines, as reported previously.
1-3
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Chapter 8: Conclusions and future work 
 
Recent advances in the field of synthetic biology allow us to anticipate the possibility 
of creating “designer” biometallic catalysts, engineered precisely to the requirements 
of the desired chemical transformation. This study has shown that it is already 
possible to engineer an aerobically-grown biometallic catalyst capable of one-pot 
deracemisation reactions, and to extend the life of this biometallic catalyst by freeze-
drying whilst immobilised in an alginate matrix. 
 
Using chiral HPLC for the detection of (S)-MTQ, (R)-MTQ and MDQ, it was found that 
palladised E. coli transformed with the mao-N-D5 plasmid is capable of performing 
both oxidation and reduction reactions required for the deracemisation reactions 
studied here. However, it was not possible to perform both reactions simultaneously, 
with aerobic cells supplied with formate as an electron donor for the Pd-catalysed 
reaction, due to the formation of an unwanted product under these conditions, later 
identified as MIQ using LC-MS. However, this product was not seen when hydrogen 
was used instead of formate as the electron donor in the reduction reaction possibly 
as hydrogen drives the reduction of MDQ at a faster rate than formate (see section 
3.2.4). The use of hydrogen required the two reactions to be performed separately 
but in the same reaction vessel, in a cyclical manner. This simple approach should be 
amenable for use in a broad range of reactor configurations, including those using 
high densities of cells immobilised on a suitable support for easy re-use. As the two 
reactions are not run simultaneously, each discrete reaction step can be optimised 
fully, with prolonged activity for the catalyst demonstrated in this study.  
 
When the performance of enzymatically produced bioPd was compared to that of 
commercially available “conventional-Pd” in a biotransformation of 5 cycles of 
oxidation and reduction, both were found to adsorb the reactants and products of the 
biotransformation. However, the conventional-Pd adsorbed around 10% more than 
the bioPd (1 mM of the potential 10 mM final product in our study), indicating that 
the amine could not be desorbed from the catalyst even with multiple washing steps. 
It was also found that the conventional-Pd was present in the reaction supernatant at 
86 
 
 
higher levels than the bioPd, and had to be removed by an additional filtration step 
complicating downstream processing. The ease of removal of bioPd from the reaction 
mixture indicates both reduced contamination of the products with palladium, and 
improved recyclability of the catalyst. The re-use of bioPd cells following a 5-cycle 
biotransformation confirmed that the activity of the metallic biocatalyst was not 
affected significantly by recycling in this experiment. 
 
The immobilisation of the biocatalyst in a variety of matrices was performed in order 
to facilitate its re-use, and extend its storage life. Chitosan, sol-gel, and polyacrylamide 
were found to be unsuitable as immobilisation matrices in this case, primarily due to 
the instability of the matrix with the addition of Pd-loaded cells or when added to the 
amine substrate in solution. Alginate was found to be a suitable matrix as it remained 
stable throughout the deracemisation reaction, maintained the viability of the 
majority of the biocatalyst, and less than one-sixth the amount of palladium was lost 
into the reaction supernatant compared with planktonic cells. The activity of the 
alginate-immobilised biocatalyst was at first as high as that of the planktonic cells, and 
the product yield after three consecutive biotransformations was still high at 89%. 
Culture-based analysis of the reaction supernatant following biotransformation 
indicated that no viable cells were lost from the beads, and ESEM images showed that 
the integrity of the beads was not affected. The capacity of the Pd(0) catalyst to 
reduce MDQ to MTQ was not affected by the re-use or storage of the beads, but the 
activity of the MAO-N-D5 enzyme was reduced over time. However, freeze-drying the 
beads prevented loss of activity of the enzyme, which was unaffected by six weeks of 
storage of the beads (the time limit of this particular experiment). The activity of the 
Pd(0) was also unaffected by freeze-drying, making this a useful method for 
prolonging the life of this immobilised biocatalyst. 
 
Although previous studies investigating the bioreduction of palladium have used 
anaerobic cultures, this study has demonstrated that palladium reduction is possible 
with aerobic cultures of E. coli, using either hydrogen or formate as the electron donor. 
The use of aerobic cultures for the production of biometallic catalysts is preferable, 
due to increased cell yield, higher yields of recombinant proteins (Krause et al., 2010) 
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and in the case of SRB no production of H2S which can poison metallic catalysts 
(Redwood et al., 2008a). Although Pd(II) is reduced by hydrogen without the presence 
of bacteria, there is likely to be a biological mechanism for hydrogen-dependent Pd(II) 
reduction, due to the significantly  increased time taken for reduction to complete in 
cell-free and killed (autoclaved) controls (based on visual interpretation), as also seen 
by others (Yong et al., 2002b). For formate-dependent bioreduction of Pd(II), using 
ICP-MS to measure Pd(II) removal from solution indicates that Pd(II) bioreduction in 
these cultures is enzymatic, with reduction of palladium not occurring in the cell-free 
and autoclaved cells experiments irrespective of the length of incubation. Further 
investigation of the enzymatic systems involved using mutant E. coli strains with 
absent or disrupted hydrogenase and formate dehydrogenase enzymes indicated that 
the major enzymes involved include the formate dehydrogenases FDH-O and FDH-N, 
although bioreduction still occurs in strains without these enzymes albeit at a much 
lower rate. Other molybdoenzymes are most likely involved. The strain that lacked all 
molybdoenzymes however did still reduce the palladium, although this took 7 hours, 
compared with less than 30 minutes by the wild-type strains. Hydrogenases, 
implicated as the dominant Pd(II) reductases in other experimental systems 
(Deplanche et al., 2010; Mikheenko et al., 2008) are not expressed in aerobically 
grown cultures, and their lack of involvement was evident as the strain lacking any 
hydrogenase enzymes reduced palladium at the same rate as the wild-type strains.  
 
Although it was hoped that the location of the Pd(0) nanoparticles would implicate 
the enzymes responsible for their reduction, TEM images show the presence of 
elemental palladium as extracellular nanoparticles, associated with the cell surface 
and possibly with exopolysaccharides. EDX was used to confirm the presence of Pd(0) 
in these precipitates. Occasionally nanoparticles were seen inside the cell, possibly 
located on the inner surface of the plasma membrane. Furthermore, the extracellular 
precipitation of Pd(0) occurs with all strains of E. coli used in this study, including 
mutants, indicating that whichever biological system is responsible for the aerobic 
bioreduction system, there seems to be little impact on the site of Pd(0) deposition. It 
is possible that an electron transfer system to the surface of the outer membrane 
exists similar to that found in Geobacter sulfurreducens and Shewanella oneidensis 
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(Lloyd et al., 2003) that is as yet undiscovered in E. coli. It is also possible, as suggested 
by the electron tomography images obtained (Figure A2.1), that the first Pd(0) 
nanoparticles to form breach the outer membrane, and themselves form an electron 
conduit for further Pd(II) reduction outside the cell. The pH of the experiments in this 
study is also higher than others where Pd(0) nanoparticles accumulated in the 
periplasm (Redwood et al., 2008a), which were performed at around pH 2. The higher 
pH used here could result in the higher biosorption of cationic metals to the outer 
membrane and extracellular polymeric substances, which are then not able to enter 
the periplasm. The influence of a higher pH in the location of the Pd(0) may be 
confirmed by the observation that Pd(0) nanoparticles were located on the cell 
surface of D. desulfuricans when the bioreduction was performed at pH 7 (Yong et al., 
2002b).  
 
One further conclusion that may be drawn from the extracellular location of the Pd(0) 
nanoparticles is that whilst cells that lack the formate dehydrogenases are still capable 
of reducing Pd(II), when all of these enzymes are missing a cellular component 
associated with the outer membrane may be responsible. This is implicated by the 
TEM images of the MC4100 ΔmoaA strain (which lacks all molybdoenzymes), in which 
the majority of the Pd(0) nanoparticles are closely associated with the outer 
membrane (Figure 4e, Chapter 5). Furthermore, this formate oxidation activity is 
much weaker than that seen with the strains containing formate dehydrogenases, 
where Pd(II) reduction occurs much earlier. It is possible however that following the 
initial enzymatic reduction of a small percentage of the Pd(II), the Pd(0) nanoparticles 
formed may themselves be responsible for catalysing the reduction of the remainder 
of the Pd(II) (Yong et al., 2002b), which would mean that only a minor, initial biological 
input is required.  
 
One limitation of using ICP-MS for the measurement of the rate of Pd(II) reduction is 
that palladium removal is measured rather than a direct measurement of metal 
reduction. This meant that the formation of a brown precipitate which was not Pd(0) 
in the cell control lacking formate, and from 3-7 hours following formate addition in 
the MC4100 ΔmoaA strain, implied Pd(II) reduction to Pd(0) where none had 
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occurred. This precipitate may be formed due to increased biosorption of the Pd(II) to 
viable cells over time. The X-ray diffraction pattern did not show the presence of any 
peaks characteristic of Pd(0) in this precipitate, indicating that it was probably 
amorphous and non-crystalline. There is also removal of  soluble Pd(II) when using 
autoclaved cells, possibly indicating that the increased surface area of the lysed cells 
leads to increased sorption of the Pd(II) to the biomass. In some cases, the reduced 
palladium particles were so small that they could not be removed from the reaction 
supernatant, and gave a false impression of the amount of Pd(II) remaining in 
solution. Synchrotron radiation techniques such as X-ray absorption spectroscopy 
would be better to measure bioreduction directly, as it supplies information on the 
oxidation state of the palladium. EXAFS data confirm that the complete reduction of 
Pd(II) to Pd(0) occurs within minutes, and QEXAFS data confirm the reduction of Pd(II) 
directly to Pd(0), without the production of intermediate species. However, the time 
constraints involved in securing beam time meant that this approach was only 
available for the investigation of some of the bacterial strains used in this study. 
 
 In conclusion, we have demonstrated the presence of a novel biological mechanism 
responsible for the bioreduction of Pd(II) in aerobically-grown cultures of E. coli, 
catalysed mainly by molybdenum-containing enzyme systems. If active in a range of 
industrially important reactions, this new form of bioPd has the advantage over that 
produced by anaerobic culture as it is easier to produce and perform and provides 
increased biomass. There is also no requirement for additional processing steps to 
remove H2S (produced by SRB systems), and the use of formate instead of hydrogen 
gas means that the procedure is less hazardous and more controllable. This study has 
also demonstrated that it is possible to create an alginate-immobilised biometallic 
catalyst that expresses MAO-N as a model oxidase enzyme in palladised cells, and can 
perform both oxidation and reduction reactions leading to a 96% deracemisation of a 
secondary amine, without the addition of a separate chemical reductant and with 
limited contamination or adsorption of the reaction products by the catalyst. The 
biometallic catalyst can also be stored long-term entrapped in freeze-dried alginate 
beads without loss of activity. This method has a broad potential for simplifying or 
improving other enzyme/inorganic catalyst combinations, not being specific to either 
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E. coli or palladium, and could be potentially useful for a range of industrial and 
biotechnological applications.  
 
8.1 Future work 
The development of a biometallic catalyst for use in the deracemisation of MTQ has 
proved that the concept is possible, and it should be feasible to use the same catalyst 
for the deracemisation of a range of other primary, secondary and tertiary amine 
substrates, as previously performed using the MAO-N-D5 enzyme and a separate 
chemocatalyst (Alexeeva et al., 2002; Carr et al., 2003; Dunsmore et al., 2006). Using 
other racemic amines as substrates it may also be possible to develop the system 
using formate as the electron donor in the reduction step, rather than hydrogen gas 
which requires more complex bioprocess engineering. It may also be possible to 
develop a range of new metallic biocatalysts by transforming the bacterial host cell 
with alternative enzymes, for use in two-step biotransformations where metal 
catalysts are used, or in multi-step biotransformations where more than one enzyme 
is used. The bacterial host cell could also be loaded with other metals as required, 
such as platinum or gold nanoparticles, or a combination of metals. Biogenic gold 
nanoparticles have previously been used as the catalyst in oxidation reactions such as 
the oxidation of glycerol (Deplanche et al., 2007), and in combination with palladium 
for the oxidation of alcohols (Deplanche, 2010). Biogenic platinum has been used as 
the catalyst in fuel cells (Yong et al., 2007), and for the reduction of Cr(VI) to Cr(III) 
(Murray et al., 2007). Subsequent studies will investigate the catalytic activity of the 
Pd(0) nanoparticles produced during this current work in a range of industrially 
important reactions. 
 
Future work with the mutant strains of E. coli for the investigation of the processes of 
formate-dependent Pd(II) bioreduction should include a repeat of the data obtained 
using ICP-MS by synchrotron radiation techniques, such as EXAFS. This would show 
conclusively the rate of reduction of Pd(II) by strains where ICP-MS data is ambiguous, 
such as with the strain MC4100 ΔmoaA. ICP-MS however is useful for comparing rates 
of reduction between different strains. In order to determine exactly the mechanisms 
responsible for Pd(II) bioreduction in strain MC4100 ΔmoaA, more genes could be 
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knocked out, although this might prove to be detrimental to viability. It would be 
interesting to discover how the lack of hydrogenase and molybdoenzymes affects the 
cell metabolism, as the cell may be using alternative systems for the same functions 
which could include Pd(II) reduction. 
 
Further work could be performed with the alginate-immobilised biocatalyst, to 
investigate the viability of cells in freeze-dried beads, and also to determine the 
precise lifespan of the biocatalyst, which in the limited time available to this study was 
found to be at least six weeks with no loss of activity compared with day 1. The 
immobilised biocatalyst could also be used in a flow-through bioreactor, for the 
continuous production of the optically pure amine. Other immobilisation methods 
could also be used in which the cells are maintained in as natural a state as possible, 
such as membranes (Hartmeier, 1988) or biofilms (Cheng et al., 2010; Rosche et al., 
2009). Recently, a biofilm of E. coli transformed with the tryptophan synthase gene of 
Salmonella enterica was used to convert haloindoles and serine to L-halotryptophans, 
with improved activity over both planktonic cells and the immobilised enzyme itself. 
No loss of activity was reported with repeated re-use of the biofilm (Tsoligkas et al., 
2011). It is possible that this system could also be used to immobilise palladised 
biocatalyst for biotransformations. 
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Appendices 
Appendix 1: Analytical Techniques 
In this section, techniques that have been employed in this project are described. 
 
A1.1 High performance liquid chromatography (HPLC) 
Chromatography is used for the separation of substances, based on the way they 
distribute between two immiscible phases. This is known as the distribution or 
partition coefficient (Kd), derived by dividing the concentration in phase A by that in 
phase B, and is constant at a given temperature. The two phases are known as the 
stationary phase, which is immobilised onto a particulate matrix; and the mobile 
phase, or eluent, a liquid or a gas that is passed through the stationary phase after the 
addition of the analyte mixture. In high-pressure liquid chromatography, the matrix is 
packed into a stainless steel column and the samples are added to the top via an 
injector system. Separated analytes leave the column at different times based on their 
distribution coefficients; and a detector, such as a spectrophotometer or mass 
spectrometer, analyses the eluate as it leaves the column (see Figure A1.1). The back-
pressure generated within the HPLC column is more than 50 bar. This provides 
improved resolution of analytes, and so the technique is also known as high 
performance liquid chromatography. The system may be either normal-phase, where 
the stationary phase is polar and the mobile phase is non-polar; or reverse-phased, 
where the opposite situation is in effect. In reverse-phased LC, the most commonly 
used stationary phases are hydrocarbons chemically attached to silica, such as butyl 
(C4), octyl (C8), and octadecyl (C18) (Wilson, 2005). Analytes are drawn into the 
stationary phase by hydrophobic interactions with these molecules. The mobile phase 
may be constant, such as an aqueous buffer, methanol, or acetonitrile, or a pre-mixed 
solution of more than one of these (isocratic elution); or the composition may change 
gradually during column development (gradient elution), to improve separation of 
analytes. 
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Figure A1.1: Schematic representation of an HPLC system (adapted from Wilson, 2005). 
 
The data provided by the detector system is in the form of a chart known as a 
chromatogram, or chromatograph (see Figure A1.2). The presence of an analyte is 
demonstrated by peaks, with the position of each peak corresponding to the retention 
time of that particular analyte. If the analytes have been successfully separated, the 
peaks are said to be resolved. The use of mass spectrometry as a detection system 
however allows the identification of overlapping peaks, as detection is based on the 
molecular mass of the analyte. The area inside the peak on a chromatogram 
corresponds to analyte concentration, giving a quantitative result when compared to a 
calibration curve produced from a series of known standards. 
 
 
Figure A1.2: Chromatogram – each peak represents a different analyte; (S)-MTQ at 
10.024 minutes, and (R)-MTQ at 11.763 minutes. 
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A1.2 Mass spectrometry 
Mass spectrometry is a technique whereby molecules are detected on the basis of 
their mass-to-charge ratio (m/z) following conversion to gaseous ions. The abundance 
of ions at each m/z ratio provides the mass spectrum. The technique is useful for 
separating molecules that are very similar, and it also provides an accurate relative 
molecular mass (Mr). Molecules can be ionised by bombardment with electrons, 
photons, ions, or molecules (Skoog et al., 1998b). One new method for the ionisation 
of molecules is electrospray (ES), whereby molecules are sprayed into an electrical 
field. The ions are then accelerated to a specific velocity, and separated in a mass 
analyser according to their m/z ratio (Aitken, 2005). 
 
 
A1.3 Chiral chromatography 
Chiral compounds are those in which two forms of the molecule exist, often as mirror 
images. The two molecules, known as enantiomers, differ in the way they interact 
with plane-polarised light. A commonly used naming convention is the Cahn-Ingold-
Prelog system, whereby enantiomers are classified as R (Latin, rectus) and S (sinister) 
(Wilson, 2005), according to a set of rules regarding the atoms attached to carbon 
within the molecule. Although the functional groups on the two enantiomers are 
identical, their physical properties are different and thus they can be separated by 
chiral chromatography. The stationary phase may be Pirkle phases (amino acid 
derivatives), triacetylcellulose or cyclodextrins, bonded to silica. Separation may be 
due to hydrophobic interactions and van der waals forces (Pirkle phases), or the 
creation of a molecular cage in which the enantiomer is housed (cyclodextrins) 
(Wilson, 2005). 
 
 
A1.4 UV and visible light spectroscopy 
This technique measures the extent of absorption of light by a coloured sample (or 
chromophore) in solution, by determining the ratio of transmitted to incident 
radiation (transmittance) which when considered with the pathlength of the sample 
gives the absorbance (A). When the measurement is based on the scattering of light 
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rather than absorption (for example when estimating bacterial cell numbers), the 
term attenuation (D; previously known as optical density) is used instead of 
absorbance. The Beer-Lambert law (Equation A1 below) states that absorbance is 
proportional to both the concentration of a substance and its pathlength, 
 
A = cl     
(Equation A1.1: The Beer-Lambert law) 
 
where ε is the molar extinction coefficient at a particular wavelength of light (λ), c is 
the concentration of the solution, and l is the pathlength. The sample is compared to a 
solvent blank in order to minimise the effect of absorption by the solvent, and so the 
area illuminated by incident light is the same for both reference and sample and can 
be ignored. In order to determine the concentration of a compound, a calibration 
curve based on the absorbance versus concentration of a set of standards is produced, 
from which concentration of an unknown may be interpolated. The linearity of the 
curve is not indefinite, a phenomenon known as the Job effect, and results therefore 
should not be extrapolated from beyond the curve as to do so would introduce errors 
(Gordon, 2005). 
 
In a simple single beam spectrophotometer (see Figure A1.3), visible light is produced 
by a tungsten filament lamp, and UV light by a hydrogen or deuterium lamp, in order 
to produce a continuous spectrum. The light passes through a monochromator (either 
a prism or diffraction grating) to produce the required wavelength, which then passes 
through the sample contained in a low-absorbance plastic cuvette. Two 
photosensitive detectors (usually photocells, which produce a current proportionate 
to the intensity of light) are used, one for incident light and one for transmitted light. 
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Figure A1.3: The optical arrangements in a single-beam spectrophotometer (adapted 
from Gordon, 2005). 
 
In double-beam spectrophotometers, the light is split into two beams, one of which 
passes through the sample, and one through the reference. This prevents errors being 
introduced, for example from variations in beam intensity (Miller, 1993). 
 
As spectrophotometers can scan over the whole range from UV to visible light, an 
absorption spectrum for a particular molecule can be produced, by plotting 
absorbance against wavelength (Figure A1.4). Such spectra show at which 
wavelengths a chromophore absorbs light most strongly, for use in further 
spectrophotometric experiments. 
 
 
Figure A1.4: UV absorption spectrum of a Palladium (II) complex showing strong 
absorption at 350 nm (adapted from Park et al., 2008). 
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A1.5 Inductively coupled plasma - mass spectrometry (ICP-MS) 
Inductively coupled plasma - mass spectrometry (ICP-MS) is a technique for the 
characterisation of the elemental composition of samples, with a limit of detection 
potentially as low as 0.01 ppb. Inductively coupled plasma is formed by igniting a very 
high temperature inert gas with a high voltage discharge, and maintaining a 
radiofrequency (RF) current. The gas is ionised, making it electrically conductive, and 
reaches temperatures of up to 10 000 K. Liquid samples are aerosolised and 
introduced to the plasma via an argon gas stream. The plasma decomposes the 
sample contents to individual atoms, before stripping them of electrons to form ions. 
The ions are separated within the mass spectrometer, the commonest type of which is 
the quadropole mass filter. This is an arrangement of four rods, with alternating AC 
and DC voltages applied to opposite pairs of rods. Rapid switching of the voltages and 
an RF field allow the passage of ions of only a single mass-to-charge ratio at a time, 
making multi-element analysis of a sample possible (Abou-Shakra, 2004; Taylor, 2001). 
 
 
A1.6 X-ray diffraction (XRD) 
When an X-ray beam at angle θ strikes a crystal, some of the beam is scattered by the 
surface atoms and some of the beam passes through. This beam reaches the second 
layer of atoms, where the same events occur, and so on. The scattering of X-rays takes 
place only when striking the crystal faces at certain angles, and is also dependent on 
both the distance between the planes of atoms and the wavelength of the radiation. 
The pattern of diffraction of X-rays is therefore specific to a crystal, and depends on 
satisfying Bragg’s law: 
 
  nλ = 2d sin θ    
(Equation A1.2: Bragg Equation) 
 
where n is an integer and d is the interplanar space (Skoog et al., 1998a). Thus, the 
atoms that make up a crystal can be identified using this technique. 
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A1.7 X-ray absorption spectroscopy (XAS) 
X-ray absorption spectroscopy (XAS) provides information on the species and local 
arrangement of atoms in a sample by measuring the absorption of photons as a 
function of their energy. The energy of the X-ray beam is set below the binding energy 
of the core electrons (K-level) of the element studied, at which point there is no 
excitation of the electrons. With an increase in photon energy, a point is reached at 
which the core level electrons are excited (the K-edge), and begin to populate the 
empty states. This is known as the near edge region (see Figure A1.5), with XAS at this 
point specifically known as X-ray absorption near-edge spectroscopy (XANES). As the 
photon energy increases further, the photoelectron leaves the atom. This region is 
known as extended X-ray absorption fine structure (EXAFS), and extends for up to 
around 1000 eV. For isolated atoms, both XANES and EXAFS are featureless, but 
where atoms are surrounded by other atoms their local arrangement causes 
oscillations in the EXAFS region. The features in EXAFS are due to the wave-like nature 
of the photoelectron, which is scattered from surrounding atoms with new waves 
being emitted. With increasing photon energy, the interference between the waves 
alternates between constructive and destructive, which leads to oscillations in the 
spectrum. Examining these oscillations gives information on the number, species and 
distance of the surrounding atoms. A Fourier transform of the EXAFS region allows the 
contributions of different atoms to be detected. For heavier elements, it may not be 
possible to supply X-rays of sufficient energy, and so L3-edge EXAFS may be used 
instead of K-edge (University of Slovenia Group for Experimental Atomic Physics 
website). 
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Figure A1.5: XAS spectrum, showing near-edge and fine structure regions. 
 
Historically XAS spectra are recorded by comparing the intensity of the incident X-ray 
beam (I0) with the transmitted beam (It). If greater sensitivity is required, for example 
in very dilute specimens, fluorescence or total electron emission can be measured 
instead (Charnock, 1995; Sebilleau, 2006). 
 
The advantage of XAS over other X-ray spectroscopy techniques is that the technique 
can be used with solids, liquids or gases, without the need for long-range order of 
atoms within the sample (University of Slovenia Group for Experimental Atomic 
Physics website). 
 
A1.7.1 Synchrotron radiation for XAS 
The X-ray source for XAS is provided by synchrotron radiation. Figure A1.6 below 
shows a schematic representation of a synchrotron. To begin with, electrons are fired 
into the linac and boosted to almost the speed of light before entering the storage 
ring, which is actually a series of straight sections with electromagnets to direct the 
electrons between them. The RF system boosts the electrons with each circuit of the 
storage ring. Whilst in the storage ring, the constant acceleration experienced by the 
electrons causes them to lose energy in the form of X-rays, which are directed down 
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beamlines when the electrons pass through the bending magnets. Very high energy 
experiments use the more intense light produced when the electrons pass through 
insertion devices, arrays of magnets arranged as “wigglers” or “undulators”. 
 
After the X-rays are directed into a beamline, the beam is passed through a 
monochromator to generate photons of a single wavelength. The beam is then passed 
through a detector to measure the intensity of the beam, before passing through the 
sample and a further detector for measuring the intensity of the transmitted beam 
(see Figure A1.7). 
 
 
 
Figure A1.6: Schematic representation of a synchrotron. 1) linear accelerator (Linac), 2) 
booster ring, 3) storage ring and experimental hall, 4) insertion devices, 5) front end, 6) 
optics hutch, 7) experimental hutch, 8) user cabin, 9) radiofrequency (RF) system. 
Image courtesy of Diamond Light Source Ltd. 
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Figure A1.7: Experimental setup for EXAFS (adapted from Charnock, 1995). The arrow 
shows the path of the X-rays as they leave the synchrotron and enter the beamline.  I0 
and It are the ion chambers for detection of incident and transmitted light, If  is the 
fluorescence detector. 
 
EXAFS data for this study was collected from the XAS beamline (BM29) at the 
European Synchrotron Research Facility (ESRF), Grenoble, France, and the Super-XAS 
beamline at the Swiss Light Source (SLS), Paul Scherrer Institut, Villigen, Switzerland. 
 
 
A1.8 Transmission electron microscopy (TEM) 
The limit of resolution using light microscopy is based on the wavelength of the light 
used. In order to resolve images smaller than around 200 nm, electrons are used 
instead of light, which improves resolution by three orders of magnitude. The image 
formation in transmission electron microscopy (TEM) comes from the combination of 
both elastic scattering (where electrons are deflected by nuclei within a sample 
without loss of energy) and inelastic scattering (where interaction leads to energy loss) 
(Ellisman, 2006). Sectioning work for TEM studies in this thesis was performed at the 
School of Biological Sciences, University of Birmingham, and the EM facility in the 
Faculty of Life Sciences, University of Manchester. 
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A1.9 Electron tomography 
Electron tomography is a process using transmission electron microscopy by which 
tilt/rotate cartridges are used that allow a TEM sample grid to be tilted to 70° and 
rotated to 90°. By scanning through the thick section as it is being tilted, a series of 
images are produced at different angles which can then be recompiled in a stack to 
generate a 3-dimensional image, providing information for example about a bacterial 
cell surface and any structures associated with it. Precision is essential when moving 
the sample within the beam, as any errors in stage movement will interfere with the 
imaging process. The cartridge-based system increases stability and reduces such 
errors. 
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Appendix 2: Unpublished work 
A2.1 Pd(II) biosorption by E. coli BL21(DE3) cells 
Method 
To determine the amount of Pd(II) lost from solution by biosorption to the bacterial 
cells, rather than by bioreduction to Pd(0), cell suspensions were challenged with 1 
mM sodium tetrachloropalladate as previously (section 3.1.1) and incubated at 30°C 
for 1 hour. Aliquots were taken prior to and following incubation and centrifuged for 5 
minutes at 15,996 g in a Boeco M-24 microcentrifuge. The supernatant was added to 
an equal volume of 70% nitric acid and diluted to a final concentration of 2% nitric 
acid, and filtered using a syringe-driven 0.22 μm Millipore filter before analysis for the 
presence of palladium using ICP-MS. 
 
Results 
When cells were challenged with Pd(II) and incubated for one hour at 30°C, the level 
of Pd(II) found in the supernatant was reduced from 90 μg ml–1 to 87 μg ml –1. 
However, using killed (autoclaved) cells the level found in the supernatant following 
incubation was 18 μg ml –1. Live cells therefore take up very little Pd(II) by biosorption, 
but killed cells remove most of the Pd(II) from the supernatant, possibly due to the 
increased surface area of the biomass (due to cell lysis). 
 
In a 1 mM solution of sodium tetrachloropalladate, the amount of Pd(II) should be 
106.42 mg l–1, but the ICP-MS results consistently show less than this. The Pd(II) 
control (no cells) is measured at 97-99 mg l–1. This can be partially explained by the 
reported % of palladium in the Na2PdCl4, which is 35.4% (rather than 36.2%). This 
would return a result of 104 mg l–1. Of the remainder, it is possible that some Pd(II) 
sorbs to the cells immediately, reducing the Pd(II) in solution to a level between  
~98 mg l–1 and 90 mg l–1. 
 
In a previous study of Pd(II) biosorption to D desulfuricans, Yong et al. (2002c) 
determined that biosorption of palladium in PdCl4
2+ complexes was pH-dependent, 
with up to 70% removal of Pd(II) from solution at pH 4. At pH 7, the removal due to 
biosorption was <20%. They concluded that the high concentration of Cl– ions may 
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cause complexes with Pd(II) to form and reduce its affinity for cationic-specific 
biosorption sites. When a different Pd(II) complex, Pd(NH3)4
2+ was used, less than 30% 
biosorption was observed irrespective of pH (Yong et al., 2002c). As this current study 
uses pH 7.6 for bioreduction experiments in order to maintain the viability of the 
bacterial cells, this could explain the lower levels of biosorption seen in strains of E. 
coli. 
 
 
A2.2 Viability of cells 
Method 
Viability of palladised cells: Viability of palladised cells was determined using the 
Miles and Misra colony counting technique (Miles & Misra, 1938), whereby 20 μl of 
serial dilutions of the cell suspension were plated onto LB agar in triplicate. The 
dilution showing the closest to ~20 colonies is counted, and the number of colony 
forming units (cfu) in the original suspension calculated as follows: 
 
cfu ml–1 = average number of colonies in dilution x 50 x dilution factor 
 
(Equation A2.1) 
 
 
Viability of cells following deracemisation: The viability of biocatalyst used in a 
deracemisation reaction over 5 cycles of air and hydrogen was determined using the 
Miles and Misra colony counting technique. 
 
Viability of cells in alginate beads: The viability of the cells encapsulated in alginate 
was determined by first destabilising the ionic cross-linking of the alginate using 
potassium phosphate buffer (Smidsrod & Skjak-Braek, 1990), before plating out using 
the Miles and Misra colony counting technique. Cells were counted on day 1, 
immediately following encapsulation, and after 1 week of storage in 0.5% w/v CaCl2 
solution at 10°C. 
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Results 
Viability of palladised cells: Palladisation of the cells reduced the viability of the cells 
from 108 cfu ml–1 (thawed biocatalyst, 250 mg ml–1) to 106-107 cfu ml–1. This reduction 
in viability was most likely due to the disruption in the outer cell membrane seen in 
transmission electron micrographs (see section 4.1.9 and Figure 4.9). 
 
Viability of cells following deracemisation: The viability of the biocatalyst as 
determined using the Miles and Misra colony counting technique was calculated to be 
8 x 107 cfu ml–1 prior to the biotransformation, and 2 x 105 cfu ml–1 following the 
biotransformation, a reduction of two orders of magnitude. The fragility of the cells 
following palladisation was probably a factor, but the cells would also have been 
starved of nutrients at this point. 
 
Viability of cells in alginate beads: Immediately following encapsulation in alginate, 
the viable count for the biocatalyst was 4.5 x 105 cfu ml–1, a reduction in two orders of 
magnitude from 107 cfu ml–1. The alginate is non-toxic and the encapsulation 
conditions are very mild, which suggests that the increased fragility of the palladised 
cells is responsible. After one week of storage in 0.5% w/v CaCl2 at 10°C, the viable 
count was further reduced to 6 x 103 cfu ml–1. However, the cells had been starved of 
nutrients for all this period, and it is possible that a nutrient supply would extend the 
viability of the biocatalyst. 
 
 
A2.3 Electron tomography 
Method 
3-dimensional images of the palladised bacterial strains E. coli BL21(DE3), MC4100 and 
FTD128 were prepared using the FEI Polara 300kV FEG transmission electron 
microscope in the University of Manchester EM facility. These images were taken in 
order to provide clearer information as to the nature of the association of the Pd(0) 
nanoparticles with the cell surface. The sections were prepared in the same way as 
those used for TEM (section 3.1.8). 
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Results 
The 3-dimensional images of palladised cells obtained using the FEI Polara 300kV FEG 
transmission electron microscope in the University of Manchester EM facility showed 
the association of the Pd(0) nanoparticles with the outer membrane of the cells, and 
indicated that the clusters of nanoparticles might possibly cross the membrane into 
the periplasm (Figure A2.1). Similar results were obtained from cells with formate-
dependent bioreduced Pd(0) (MC4100 and FTD128) and hydrogen-dependent 
bioreduced Pd(0) (BL21(DE3)). However, the limitation of this technique is that the 
data must be viewed using animation software, otherwise the image is two-
dimensional only.  
 
  
Figure A2.1: Polara transmission electron micrographs of E. coli MC4100, showing 
palladium nanoparticles breaching the outer membrane (a) and located within the 
periplasm (b) (red arrows). Scales bars are not available, as these images were taken 
as screenshots from an animated sequence. 
 
 
A2.4 Amplification and purification of plasmid 
Method 
E. coli TOP10/P3 chemically competent cells were thawed on ice before adding 1 μl 
plasmid and incubating on ice for 30 minutes. The cells were heat shocked at 42C for 
30 seconds and transferred back to the ice for 2-3 minutes. 250 μl SOC medium (super 
optimal broth with catabolite repression) was added to the cells, which were then 
incubated at 37C for one hour. Transformed cells were subcultured onto LB agar 
a) b) 
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plates containing 100 μg ml-1 ampicillin (LB-ampicillin agar), and incubated overnight 
at 37C. Three isolated colonies were used to inoculate three 5 ml aliquots of LB-broth 
with 100 μg ml-1 ampicillin (LB-ampicillin broth), which were then incubated at 37C, 
shaking at 180 rpm for 18 hours. After centrifuging and removing all broth 
supernatant, the plasmid was purified using the QIAprep Spin Miniprep Kit from 
QIAGEN. 
 
Quantification of plasmid: Using a crystal microcuvette, the amount of plasmid 
obtained through amplification and purification was measured using a Camspec M501 
Single Beam Scanning UV/Visible spectrophotometer.  
 
Results 
Quantification of plasmid: DNA can be quantified using spectrophotometry, by 
measuring the absorbance of a sample at 260 nm. At this wavelength, an absorbance 
measurement of 1 is equal to 50 ng μl–1. As protein absorbs light at a wavelength of 
280 nm, the A260/280 ratio is used to detect protein contamination, with a ratio of 1.8-
1.9 for pure DNA. 
 
The amount of DNA obtained was calculated to be 56.31 ng μl–1, requiring 2 μl (~100 
ng) to be used in the transformation of E. coli BL21(DE3) cells. The A260/280 ratio was 
2.1, indicating that there was no protein contamination detected (although there may 
have been some RNA present). 
 
 
A2.5 Colorimetric assay 
The principle of the colorimetric assay is based on the reduction of molecular oxygen 
that accompanies the oxidation of MTQ, forming hydrogen peroxide. Horseradish 
peroxidase (HRP) catalyses the oxidation of the dye pyrogallol red, with the associated 
reduction of hydrogen peroxide. This leads to a colour change in the dye from deep 
red to straw-coloured, which can be measured by spectrophotometry. 
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Method 
Reagents were prepared by diluting in 100 mM potassium phosphate buffer at pH 7.6, 
to produce 1 mg ml–1 HRP, 0.6 mg ml–1 pyrogallol red dye, and 12.5 mM MTQ. Aerobic 
cells were used diluted 1:10, anaerobic cells were used neat. Twelve wells of a 96-well 
plate were used for the assay with samples and controls wells tested in triplicate, with 
each well containing a final volume of 100 μl as shown in Table A2. 
 
Table A2: Experimental set-up in a 96-well plate for the oxidation of pyrogallol red dye. 
1 2 3 4 5 6 7 8 9 10 11 12 
5 μl HRP 
5 μl cells 
10 μl dye 
80 μl MTQ 
5 μl HRP 
5 μl cells 
10 μl dye 
80 μl KPO4 
5 μl HRP 
5 μl KPO4 
10 μl dye 
80 μl MTQ 
5 μl KPO4 
5 μl cells 
10 μl dye 
80 μl MTQ 
 
The plate was placed immediately into the Bio-Tek Elx800 plate reader, and the 
absorbance read at 550 nm every 30 seconds for 45 minutes. 
 
Results 
The colorimetric assay produced a colour change in wells 1-3, which contained 
biocatalyst, horseradish peroxidase (HRP), pyrogallol red dye, and the MTQ substrate 
(see Figure A2.2). A slower change in colour was seen in wells 4-6, which were missing 
the substrate, and wells 7-9, which were missing the biocatalyst. No colour change 
was seen in wells 10-12, which were missing the HRP enzyme. 
 
 
Figure A2.2: Colorimetric plate assay, demonstrating the complete reduction of the 
pyrogallol red dye by horseradish peroxidase (wells 1-3), with partial reduction in 
wells 4-6 (no MTQ substrate) and wells 7-9 (no biocatalyst), and no reduction in wells 
10-12 (no HRP). 
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The rate of pyrogallol reduction by HRP (wells 1-3 only) can be seen in Figure A2.3, 
which compares three separate batches of biocatalyst. The rate of reduction is similar 
in all three batches. 
 
 
Figure A2.3: Rate of reduction of pyrogallol red by HRP for the comparison of batches 
of biocatalyst, as measured by UV/visible spectrophotometry. Each point is based on a 
single measurement. 
 
The colorimetric assay demonstrates the expression of MAO-N-D5 enzyme, but 
measures the activity of the HRP enzyme and so is useful only for comparing the 
activity of different batches of biocatalyst, for example as a screening assay for 
variants produced by directed evolution. A further assay using HPLC analysis was 
therefore designed in order to measure the activity of the MAO-N-D5 directly, based 
on the oxidation of (S)-MTQ to MDQ. 
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A2.6 Optimisation of oxidation step 1 – different biomasses of biocatalyst 
Methods 
The biocatalyst was prepared as in section 3.2.2. Cell pellets were adjusted to a mass 
of either 125 mg, 250 mg, or 500 mg based on the wet cell pellet, and resuspended in 
MOPS-NaOH to a volume of 1 ml. Aliquots were stored at -20°C. 
 
 
Results 
In a comparison of three different biomasses of biocatalyst, the 250 mg ml–1 
biocatalyst performed the best (Figure A2.4). The oxidation of (S)-MTQ with this 
biomass was complete within 2 hours, whereas the rate of oxidation with the  
500 mg ml–1 biocatalyst was faster at the beginning, but slower when the substrate 
concentration was <0.5 mM remaining and did not reach completion. With the  
125 mg ml–1 biocatalyst, >1 mM substrate still remained at 2.5 hours. 
 
 
Figure A2.4: Comparison of three different biomasses of biocatalyst in the oxidation of 
(S)-MTQ to MDQ. For clarity, (S)-MTQ only is shown. All data points represent mean 
values from triplicate measurements, with standard error bars. 
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A2.7 Optimisation of oxidation step 2 – different shaking speeds during incubation 
Methods 
Two different shaking speeds were compared with static incubation to determine the 
optimum conditions for deracemisation. The deracemisation experiment was 
prepared as in section 3.2.5. Samples were mixed on a 1 ml scale in a thermomixer at 
900 rpm, in a shaking incubator at 225 rpm, and in a static incubator. The incubation 
temperature was 37°C in all three experiments. Samples for extraction in MTBE (see 
section 3.2.3) were taken at 0 and 3 hours. 
 
Results 
Very little MDQ was produced in the samples shaking at 900 rpm (Figure A2.5), 
indicating that the speed was too fast for efficient reaction kinetics to take place, or 
that the enzyme was denatured. Slightly more MDQ was produced in the static 
samples, where the reaction kinetics were hindered by the lack of mixing of the 
substrate with the enzyme. Mixing at 225 rpm allowed the oxidation reaction to 
complete within 3 hours, and thus was the speed chosen for further experiments. 
 
Figure A2.5: MDQ generated from the oxidation of (S)-MTQ over three hours at 37°C, 
using three different speeds of shaking – 900 rpm, 225 rpm, and static incubation. 
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A2.8 Optimisation of reduction step 1 – reduction of MDQ with formate only 
This experiment was to demonstrate that reduction of MDQ to racemic MTQ does not 
take place with formate only, and that a palladium is necessary to catalyse the 
reaction. 
 
Methods 
Biocatalyst without palladium loading was prepared as previously (see section 3.2.2), 
and a reduction step was performed using formate (see section 3.2.4 for method). 
 
Results 
Over a 24 hour period, no MTQ was formed (see Figure A2.6), indicating that formate 
alone is insufficient for the reduction of MDQ to racemic MTQ to take place, and that 
a palladium catalyst is necessary. 
 
 
 
Figure A2.6: Incubation of substrate with cells and formate, no palladium. No 
reduction of MDQ takes place over a 24 hour period. 
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A2.9 Optimisation of reduction step 2 – loading of biomass with different 
concentrations of Pd(0) 
Method 
Pd-loaded untransformed E. coli BL21(DE3) cells were prepared as previously (section 
3.1.1), using hydrogen as the electron donor, with concentrations of either 0.5 mM or 
1 mM Pd(II). The Pd-loaded cells were then used to catalyse the reduction of MDQ to 
racemic MTQ, using hydrogen gas as the electron donor (see section 3.2.4 for method). 
 
Results 
When two different concentrations of palladium were used in the palladisation of the 
biocatalyst and compared in the reduction of MDQ, the higher concentration (1 mM 
palladium) performed better. The reduction of MDQ using the lower concentration of 
palladium (0.5 mM) was slower from the start, and had not reached completion by 45 
minutes, with almost 1 mM MDQ remaining (Figure A2.7). 
 
Figure A2.7: Comparison of two different concentrations of palladium in the 
generation of palladised cells, for the reduction of MDQ to racemic MTQ. For clarity, 
MDQ only is shown. All data points represent mean values from triplicate 
measurements, with standard error bars. 
 
114 
 
 
A2.10 Improving enantiomeric excess 
Methods 
In order to improve the enantiomeric excess of product obtained from a 4-cycle 
biotransformation using hydrogen as the electron donor, deracemisation was 
performed using various additional strategies as follows: 
1. The biotransformation was carried out at 40°C, instead of 37°C. 
2. The oxidation step was performed under pure oxygen, rather than air. 
3. The inducer isopropyl β-D-1-thiogalactopyranoside (IPTG) was used to 
upregulate expression of the MAO-N-D5 enzyme. IPTG (1 ml, 1 mM) was added 
to the 100 ml LB broth flask culture after 6.5 hours of incubation, during the 
mid-exponential growth phase. 
4. Catalase (0.1 mg ml–1) was added to the biotransformation, to ensure the 
removal of hydrogen peroxide from the reaction. 
5. 5 cycles of alternating oxidation and reduction were performed, rather than 4. 
 
Results 
Of the various strategies used, increasing the temperature to 40°C, using oxygen for 
the oxidation step, inducing expression of the enzyme, and the addition of catalase to 
the biotransformation had no effect on improving the e.e. Increasing the experiment 
from 4 cycles to 5 cycles increased the e.e. to 93% (Figure A2.8). 
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Figure A2.8: The deracemisation of MTQ, giving an e.e. of 93% (R)-MTQ (5 cycles of air 
alternated with 5 cycles of hydrogen). All data points represent mean values from 
triplicate measurements, with standard error bars. 
 
 
A2.11 Immobilisation of cells in chitosan 
Method 
Cells were immobilised in chitosan beads by adapting the method of Vorlop and Klein 
(1981). 72 μl acetic acid was added to 7.1 ml deionised water, into which 0.16 g 
chitosan was then dissolved.  
 
0.16 g chitosan was dissolved in 42 ml deionised water with 72 μl acetic acid, and 1 ml 
of palladised transformed E. coli cells (250 mg ml-1 in 20 mM MOPS-NaOH buffer at pH 
7.6) were added. The chitosan-cell suspension was then dropped into 50 ml of a 1.5% 
w/v sodium pyrophosphate solution at pH 9 using a plastic Pasteur pipette, whilst 
gently stirring to prevent bead aggregation. Chitosan beads were left stirring for 1 
hour to harden, after which time the beads were rinsed in 0.1 M potassium phosphate 
buffer at pH 7.6. Beads were stored potassium phosphate buffer at 10°C until use. 
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Results 
After storage overnight in 0.1 M potassium phosphate buffer, the cells had begun to 
drop out of the chitosan beads, as determined by the turbidity of the buffer. As the 
solution into which the beads were dropped was pH 9, the chitosan would have been 
precipitated rather than cross-linked (pH <6). The higher pH was chosen for its milder 
conditions, in producing beads of neutral pH, but was possibly the reason for the 
instability of the beads. The chitosan beads were therefore discarded without use in a 
deracemisation reaction. 
 
 
A2.12 Immobilisation of cells in sol-gel 
Method 
The method used for sol-gel encapsulation of biocatalyst was adapted from those of 
Nguyen-Ngoc and Tran-Minh (2007), and Nassif et al (2002). The sol-gel was prepared 
by mixing 2 ml 0.4 M sodium silicate with 6 ml 8.5 M LUDOX HS-40, and adjusting to 
pH 7 with 4 M hydrochloric acid. 1 ml of palladised transformed E. coli cells (250 mg 
ml-1 in 10% v/v glycerol) were added, and the mixture transferred to a 96-well plate 
where the sol-gel was left to harden overnight into pellets. 
 
Results 
Cells that had not been loaded with palladium were encapsulated into hardened sol-
gel pellets. Pd-loaded cells however were not, as the palladium appeared to have 
interfered with the cross-linking of the sol-gel in some way. The sol-gel pellets were 
therefore discarded without use in a deracemisation reaction. 
 
 
 
A2.13 Immobilisation of cells in polyacrylamide 
Method 
The polyacrylamide gel was prepared by mixing 15 ml acrylamide:bis-acrylamide (29:1) 
with 150 μl ammonium persulfate, and adding 1 ml of palladised transformed E. coli 
cells (250 mg ml-1 in 20 mM MOPS-NaOH buffer at pH 7.6). The gel was allowed to set 
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for one hour, before cutting into small cubes and storing in 0.1 M potassium 
phosphate buffer at pH 7.6 at 10°C until use. 
 
Results 
When the polyacrylamide gel cubes were added to the MTQ substrate, it immediately 
began to depolymerise and release the biocatalyst. The polyacrylamide gel was 
therefore discarded without use in a deracemisation reaction. 
 
 
A2.14 Activity of alginate-immobilised biocatalyst following storage 
Methods 
In order to determine the activity of the biocatalyst following storage at 10°C, the 
activity of beads used on day 1 in oxidation-only experiments was compared with that 
used after 1 week and 2 weeks of storage (see section 3.2.8 for method). The same 
beads were used immediately afterwards in reduction-only experiments. 
 
Results 
As can be seen from Figure A2.9, the activity of the MAO-N-D5 in alginate-immobilised 
biocatalyst is considerably reduced with time. On day 1, the (S)-MTQ is oxidised from 
50% to 7% within 2.5 hours, but after one week of storage, the amount of (S)-MTQ 
remaining is 26%. After a further week of storage, the amount of (S)-MTQ remaining is 
34%. With the reduction-only experiments however, it can be seen from Figure A2.10 
that there is no loss of activity of the Pd(0) nanoparticles. 
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Figure A2.9: The oxidation of (S)-MTQ to MDQ at 37°C, by E. coli transformed with the 
mao-N-D5 gene insert and immobilised in alginate beads before testing immediately, 
after storage at 10°C for 1 week, and after storage at 10°C for 2 weeks. Only (S)-MTQ 
is shown for clarity. All data points represent mean values from triplicate 
measurements, with standard error bars. 
 
 
Figure A2.10: The reduction of MDQ to rac-MTQ at 37°C, by palladised E. coli cells 
immobilised in alginate beads before testing immediately using hydrogen gas as the 
electron donor, after storage at 10°C for 1 week, and after storage at 10°C for 2 weeks. 
Only MDQ is shown for clarity. All data points represent mean values from triplicate 
measurements, with standard error bars. 
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Appendix 3: Conferences Attended 
10th-13th December 2010; Biocatalysis 2010, Cancun Mexico. Presentation entitled 
“Engineering microbial cells for bio-metallic catalysis”. 
 
6th-9th September 2010; Society for General Microbiology Autumn Meeting 2010, 
University of Nottingham. 
 
21st April 2009; RSC Biotechnology Group and the RSC Chemistry Biology Interface 
Forum meeting  Advances in Biocatalysis, University College London. 
 
15th July 2008; 5th NW Microbiology Group Meeting. Ness Gardens, Liverpool. 
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